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“It is a truth universally acknowledged, 
 that a single cell in possession of a good membrane,  
must be in want of a model…” 
Adapted from Pride & Prejudice,  
by Jane Austen 
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SUMMARY  
Introduction 
Heart diseases are the leading cause of death worldwide, both for men and 
women. However, the ionic mechanisms underlying many cardiac arrhythmias and 
genetic disorders are not completely understood, thus leading to a limited efficacy 
of the current available therapies and leaving many open questions for cardiac 
electrophysiologists. 
On the other hand, experimental data availability is still a great issue in this field: 
most of the experiments are performed in vitro and/or using animal models (e.g. 
rabbit, dog and mouse), even when the final aim is to better understand the 
electrical behaviour of in vivo human heart either in physiological or pathological 
conditions.  
Computational modelling constitutes a primary tool in cardiac electrophysiology: 
in silico simulations, based on the available experimental data, may help to 
understand the electrical properties of the heart and the ionic mechanisms 
underlying a specific phenomenon. Once validated, mathematical models can be 
used for making predictions and testing hypotheses, thus suggesting potential 
therapeutic targets.  
Aims 
This PhD thesis aims to apply computational cardiac modelling of human single 
cell action potential (AP) to three clinical scenarios, in order to gain new insights 
into the ionic mechanisms involved in the electrophysiological changes observed in 
vitro and/or in vivo: 
 The first context is blood electrolyte variations, which may occur in patients 
due to different pathologies and/or therapies. In particular, we focused on 
extracellular Ca
2+
 and its effect on the AP duration (APD). 
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 The second context is haemodialysis (HD) therapy: in addition to blood 
electrolyte variations, patients undergo a lot of other different changes during 
HD, e.g. heart rate, cell volume, pH, and sympatho-vagal balance. 
 The third context is human hypertrophic cardiomyopathy (HCM), a genetic 
disorder characterised by an increased arrhythmic risk, and still lacking a 
specific pharmacological treatment. 
The general aim of this PhD thesis can therefore be referred to as “From Cell to 
Bedside”, meaning to correlate single cell electrophysiology with some specific 
clinical patient phenotypes, by using in silico techniques to highlight the 
mechanisms more likely contributing to them at the ionic level. 
Methods 
Many computational AP models published in literature, both atrial and 
ventricular, have been considered during this thesis. These models have been 
modified when needed, to improve their suitability to specific conditions, not 
originally taken into account during their development/validation. In particular, a 
new hybrid ventricular model has been developed, by using an existing one as basis 
and changing part of its original formulation. 
All models provide a full description of the ionic currents and intracellular 
dynamics underlying the cardiac cell AP, represented by means of ordinary 
differential equations solved by using a variable order solver, based on numerical 
differentiation formulas. The models have been implemented mostly in Matlab 
(Mathworks Inc.) and CHASTE (Cancer, Heart and Soft Tissue Environment, 
University of Oxford), an open-source software specifically developed for cardiac 
modelling and based on C
++
.  
In addition to the traditional single cell modelling techniques, the population of 
models (POMs) approach has been considered in the last Section of the thesis: 
instead of a single AP model, representative of the average cell behaviour, 
simulations have been run on thousands of models at the same time, hence 
representing the effect of biological variability. 
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Results Outline 
Here below is a summary of the main results for the three different conditions 
investigated in this PhD thesis, each one illustrated in a different Section: 
 In Section I the effects of extracellular Ca2+ ([Ca2+]o) changes on the human 
ventricular AP have been investigated: an increase of [Ca
2+
]o shortens AP and a 
decrease of [Ca
2+
]o lengthens it. Both AP duration (APD) increase and decrease 
are associated with a higher arrhythmic risk; therefore this dependence has to be 
considered in all the situations in which [Ca
2+
]o variations may occur. However, 
most of the AP models currently available in literature do not reproduce properly 
the effect of [Ca
2+
]o changes on AP. 
 In Chapter 3 a new Markov model for the L-type Ca2+ current has been 
proposed and integrated into the O’Hara-Rudy human ventricular AP: this 
hybrid model well simulates the inverse APD-[Ca
2+
]o dependence, not 
reproduced by the original one. Its development has been driven by the 
hypothesis that Ca
2+
-dependent inactivation is usually underestimated in AP 
models: our simulations confirmed the crucial role of this mechanism in 
determining the APD-[Ca
2+
]o relationship. Therefore, the hybrid model can be 
applied to clinical conditions in which blood electrolyte concentrations 
change overtime, to evaluate the corresponding changes at the AP level and 
potential pro-arrhythmic effects. 
 In Chapter 4, the hybrid model described in Chapter 3 has been used to 
investigate the impact of blood electrolyte changes measured during bed-rest. 
Bed-rest is a ground-based experiment used to simulate on Earth the effect of 
microgravity on the human body, thus assessing the possibly increased 
arrhythmic risk for astronauts during space flights. Simulation results in single 
cells and 1D cable were compared with ECG data analysis, providing 
evidence of a biphasic trend in repolarisation: RT intervals decrease during 
bed-rest and increase afterwards. The electrolyte concentrations have been 
used as model inputs to simulate volunteer conditions before, during, and after 
bed-rest. Simulated AP and pseudo-ECG were both in agreement with the 
recorded ECG, suggesting that electrolyte variations occurring during bed-rest 
may be responsible for the repolarisation changes, and thus correlating the 
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electrophysiological phenotype with the modification at the cellular level. This 
project has been done in collaboration with Prof. Enrico G Caiani (Department 
of Electronics, Information and Bioengineering, Politecnico di Milano, Italy) 
and the experimental data have been acquired by the European Space Agency 
(ESA). 
 Section II investigates the impact of haemodialysis (HD) therapy on the 
electrical activity of the heart, focusing on the electrolyte variations occurring 
during a regular HD session and evaluating the corresponding changes at cellular 
level. Here, human atrial AP models have been considered, since atrial 
fibrillation (AF) incidence is high in end-stage renal disease (ESRD) patients.  
 Chapter 5 presents a benchmarking of all the atrial AP models currently 
available in literature, with respect to their suitability to the HD context. All 
models have been tested for variations in cell volume, extracellular electrolyte 
(K
+
, Ca
+
 and Na
+
) and acetylcholine concentration, computing a set of AP and 
Ca
2+
-transient biomarkers to compare simulation results with the expected 
behaviour, based on literature review. Some models proved to be more 
appropriate than others for single aspects, butall of them showed some 
drawbacks. Suggestions have been given for the potential development of a 
new atrial model, expected to reproduce properly all the HD-induced effects 
on human atrial AP. 
 Chapter 6 illustrates the case study of an ESRD patient showing recurring 
paroxysmal AF during HD therapy. Experimental data, i.e. blood electrolyte 
concentrations and heart rate, have been used to reproduce in silico the patient 
pre-HD and pre-AF conditions at cellular level, using a modified version of 
the Courtemanche atrial AP model, described in Chapter 5. By integrating 
simulation results and clinical observations, we formulated a new hypothesis 
about the mechanisms involved in AF onset during HD: AF episodes are 
induced by the presence of a trigger (ectopic beats) that acts upon an acute 
substrate induced by intra-dialytic electrolyte variations, especially K
+
 
(increased AP depolarization time and shortened refractory period), on the 
background of autonomic nervous system changes. This project has been 
Summary                                                                                                                                              17 
 
Computational Modelling of Cardiac Electrophysiology: from Cell to Bedside 
done in collaborations with Simonetta Genovesi, MD and Antonio Vincenti, 
MD (Department of Health Sciences, University of Milano Bicocca, Italy).  
 In Section III (Chapter 7) the population of models (POMs) approach has 
been used to study the electrical remodelling occurring in human hypertrophic 
cardiomyopathy (HCM), in order to identify possible therapeutic targets for 
this disease. The POMs approach accounts for inter- and intra- subjects 
variability, which indeed seems to play an important role in HCM and which 
cannot be taken into account when considering a single AP model, 
representative of the average cellular behaviour.  
 As first, a control (CTRL) population of models has been built to 
reproduce an experimental dataset of AP and Ca
2+
 transient (CaT) 
biomarkers, acquired on human single cells from non-failing non-
hypertrophic controls. 
 Then, a HCM population has been developed by applying to the CTRL 
population the electrophysiological changes measured in diseased cells, 
together with a few novel hypotheses based on literature review. The 
simulated HCM biomarkers resulted to be in agreement with the 
experimental ones, and the contribution of each single electrophysiological 
change to the global HCM phenotype has been evaluated.  
 The occurrence of repolarisation abnormalities, e.g. early after-
depolarisations (EADs) and repolarisation failure (RF), has been 
investigated in the HCM population and the ionic mechanisms more likely 
to be responsible for them have been identified. 
 Since specific compounds are already available, the Late Na+ current (INaL) 
and the Na
+
/Ca
2+
 exchanger (INCX) have been considered as potential 
therapeutic targets. Both INaL and INCX selective blocks showed an anti-
arrhythmic effect, partially reversing the HCM phenotype and suppressing 
repolarisation abnormalities. The combination of both proved to be even 
more effective, suggesting the simultaneous block of INaL and INCX as a 
successful anti-arrhythmic therapy in human HCM. 
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 This project has been done as a visiting student in the Department of 
Computer Science, University of Oxford (UK), under the supervision of 
Prof. Blanca Rodriguez, Alfonso Bueno-Orovio, PhD and Ana Mincholé, 
PhD, and in collaboration with Raffaele Coppini, MD and Elisabetta 
Cerbai, MD (NeuroFarBa Department, University of Florence, Italy).  
To summarize, the results presented in this thesis have improved the 
understanding of the ionic mechanisms underlying electrophysiological properties 
related to arrhythmic risk in specific clinical contexts, thus confirming 
computational modelling as a valuable tool in cardiac electrophysiology, especially 
when fully integrated with experimental data. 
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SOMMARIO  
Le malattie cardiache e cardiovascolari sono ad oggi la causa principale di morte 
nel mondo. Tuttavia, i meccanismi ionici responsabili di aritmie o di altre malattie 
cardiache non sono ancora del tutto conosciuti: questo spesso porta a una minore o 
mancata efficacia delle terapie attualmente disponibili, e lascia numerose domande 
aperte per gli elettrofisiologi. Inoltre, la difficoltà di acquisizione dei dati 
sperimentali rimane ancora uno dei problemi più grandi in questo campo. Infatti la 
maggior parte dei dati vengono raccolti in vitro e/o utilizzando modelli animali 
come coniglio, ratto o cane, sebbene l’obiettivo ultimo sia quello di una più 
completa comprensione del comportamento elettrico del cuore in vivo e nell’uomo, 
in condizioni sia fisiologiche sia patologiche. 
In questo contesto, la modellistica computazionale costituisceuno strumento 
indispensabile: infatti, le simulazioni in silico permettono di superare, almeno in 
parte, i limiti sperimentali, e di investigare i meccanismi ionici alla base di specifici 
fenomeni a diversi livelli (singola cellula, tessuto, intero cuore). Una volta validati 
sui dati sperimentali, i modelli matematici possono essere dunque utilizzati per fare 
predizioni, testare ipotesi e valutare l’efficacia di eventuali interventi farmacologici.  
Lo scopo di questa tesi di dottorato è stato quello di applicare tecniche di 
modellistica matematica a problemi di elettrofisiologia cardiaca, in particolare 
utilizzando modelli di potenziale d’azione (PA) umano in tre diversi contesti: 
 Variazioni del livello di elettroliti (Na+, K+ e Ca2+) nel sangue, che possono 
verificarsi nei pazienti a causa di diverse patologie e/o terapie, con possibili 
conseguenze pro-aritmiche. Sono state considerate in particolare variazioni di 
Ca
2+
 e il loro effetto sulla durata del PA ventricolare, aspetto solitamente 
trascurato nei modelli a oggi disponibili. È stato sviluppato un nuovo modello di 
PA, integrando una nuova formulazione per la corrente di Ca
2+ 
in un modello già 
esistente: il modello ibrido così ottenuto costituisce uno strumento importante 
per esplorare i contesti clinici in cui le variazioni elettrolitiche possono 
verificarsi. Come esempio applicativo, sono stati analizzati dati sperimentali 
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raccolti dall’Agenzia Spaziale Europea (ESA) per valutare l’eventuale rischio 
aritmico per gli astronauti durante i voli nello spazio. Questo studio è stato svolto 
in collaborazione con il Prof. Enrico Caiani (Dipartimento di Elettronica, 
Informazione e Bioingegneria, Politecnico di Milano, Italia). 
 Variazioni elettrofisiologiche che avvengono durante la terapia dialitica. In 
questo contesto non si modificano soltanto le concentrazioni elettrolitiche ma 
anche la frequenza cardiaca, il volume cellulare e l’attività simpato-vagale. Dal 
momento che la fibrillazione atriale (FA) ha un’incidenza elevata nei pazienti in 
dialisi, sono stati considerati modelli di PA atriale, confrontando le loro 
caratteristiche e la loro applicabilità in questo contesto. Come esempio, è stato 
analizzato il caso di una paziente che presentava FA parossistica in ogni seduta 
dialitica. Questo studio è stato svolto in collaborazione con la Dott.ssa Simonetta 
Genovesi e il Dott. Antonio Vincenti, (Dipartimento di Scienze della Salute, 
Università degli Studi di Milano-Bicocca, Italia). 
 Cardiomiopatia ipertrofica (HCM), una malattia genetica caratterizzata da un 
alto rischio aritmico e causa principale di morte cardiaca improvvisa nei giovani 
adulti (<35 anni). Per tener conto della variabilità biologica, che sembra avere un 
ruolo determinante in questa patologia, soprattutto nella risposta individuale a un 
possibile trattamento farmacologico, è stato utilizzato un nuovo approccio 
computazionale: le popolazioni di modelli. Questo studio è stato svolto durante 
un periodo di ricerca all’estero presso il Dipartimento di Computer Science 
dell’Università di Oxford, sotto la supervisione della Prof. Blanca Rodriguez, il 
Dott. Alfonso Bueno-Orovio, e la Dott.ssa Ana Mincholé. 
Il filo conduttore di questa tesi può quindi essere riassunto dall’espressione 
“Dalla Cellula al Paziente”. Non a caso, in tutti gli scenari analizzati, lo scopo 
principale è stato quello di correlare i cambiamenti elettrofisiologici a livello 
cellulare con il fenotipo osservato a livello macroscopico nel paziente, per 
identificare i meccanismi ionici che vi contribuiscono e suggerire di conseguenza 
possibili approcci farmacologici. I risultati ottenuti hanno confermato l’importanza 
dei modelli matematici come supporto all’elettrofisiologia cardiaca, specialmente 
quando l’approccio in silico viene utilizzato in sinergia con quello in vitro.
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THE CARDIAC ELECTRICAL ACTIVITY 
The heart is situated slightly to the left of the middle of the thorax, underneath 
the sternum, between the lungs. It is supported inside a structure known as the 
pericardial sac, a double membrane structure containing a serous fluid to reduce 
friction during heart contractions.  
There are four major chambers in the heart: the larger, lower, thicker walled 
chambers are the ventricles, while the smaller, upper, thinner chambers are the atria. 
The bottom of the ventricles is called the apex and their top part is known as the 
base. Both the atria and the ventricles are separated into independent left and right 
halves by the septal wall. The function of the right atrium is to collect deoxygenated 
blood from the body. After contraction of the atria, this blood is passed to the right 
ventricle and pumped into the lungs (pulmonary circulation) to produce the gas 
exchange between carbon dioxide and oxygen. The re-oxygenated blood from the 
lungs is then collected in the left atrium, from where it moves to the left ventricle 
which pumps it out to the body. Since the right ventricle only pumps blood through 
the pulmonary circulation system of the lungs, whilst the left ventricle pumps blood 
to the rest of the body, the left ventricle is considerably thicker than the right. 
Mechanical contraction of the heart is caused by the electrical activation of 
myocardial cells. The electrical activation sequence (Figure 1.1, left side) of the 
human heart starts at the sinoatrial node, located in the right atrium at the superior 
vena cava. This node consists of specialized muscle cells which are self-excitatory, 
pacemaker cells, able to generate an electrical impulse at a rate of about 70 per 
minute. From the sinoatrial node, the wave of electrical activation propagates 
throughout the atria, but cannot propagate directly across the annulus of separation 
between the atria and the ventricles. The atrioventricular node, located at the 
boundary between the atria and ventricles, is the only conducting path from the atria 
to the ventricles in a normal heart. Conduction velocity through the atrioventricular 
node is considerably delayed in order to supply enough time to the atria to fill the 
ventricles with blood before the beginning of their contraction. Propagation then 
proceeds through a specialized conduction system, called the bundle of His. After a 
short distance, it separates into two bundle branches propagating along each side of 
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the septum, constituting the left and right bundle brunches. Both branches then 
continue to subdivide into a complex network of fibres called the Purkinje fibre 
network, which spreads across the endocardial surface and into the sub-endocardial 
region of both ventricles. The fast conduction through the bundle branches and 
Purkinje fibres causes the entire endocardium to be excited almost simultaneously, 
although apical regions contract first and the basal regions are usually the latest to 
be excited. 
 
Figure 1.1: Electrophysiology of the heart. The different action potentials for each of the specialized 
cells found in the heart, and their contribution to the total electrocardiogram waveform are shown 
(modified from [1]). 
Cardiac Action Potential and ECG 
Cardiac muscle cells or myocytes are approximately flattened tubes, about 80-
100 μm long in human ventricular tissue, with elliptic cross sections with a major 
axis of 10-20 μm. They are arranged in discrete layers of fibres called sheets, 
roughly parallel to the heart surfaces (epicardium and endocardium), with the fibre 
axis continuously rotating counter clockwise from epicardium to endocardium in a 
range of 100°-120° as viewed from the top of epicardium. Each cardiac muscle cell 
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is bounded by a thin (5-7 nm) phospholipid membrane or sarcolemma. This 
membrane encapsulates a small volume that is known as the intracellular space, 
whereas the extracellular or interstitial space is therefore defined as the space that 
lies outside the sarcolemma. The membrane is heterogeneous, with numerous large, 
complex proteins embedded within it, combined to form small pores in the cell 
membrane. Under most circumstances these pores are selectively permeable, 
allowing the pass of only specific ions through the membrane and only under 
certain conditions, reason why they are commonly called ion channels. 
The main ions that are of interest in cardiac electrophysiology are Na
+
, K
+
, Ca
2+
 
and Cl
−
. At resting, the intracellular and extracellular concentrations of each ion are 
substantially different. In principle, this difference on concentrations would produce 
a chemical force that would make ions to flow down their concentration gradient to 
create a uniform distribution at both sides of the membrane. Nevertheless, different 
ionic concentrations also imply a net electrical charge difference between both sides 
of the membrane, what causes the establishment of an electrical gradient that acts to 
oppose the chemical gradient, thus allowing intra- and extracellular concentrations 
to be different. Consequently, at rest the cell membrane maintains a net membrane 
potential, which for cardiac muscle cells generally is between -90 and -80 mV, and 
the cell membrane is said to be in a polarized state.  
However, under electrical excitation of the cell this electrochemical equilibrium 
is broken: this allows ions to flow through those ion channels to which they are 
permeable, if opened. Any positive increase of the transmembrane potential towards 
zero is therefore known as depolarization, while the term repolarization refers to the 
returning of the cell to its negative resting state.  
Small perturbations in the potential difference across the cell membrane produce 
only a passive, linear response of the cardiac cell, followed by the returning of the 
transmembrane potential towards its resting state. On the contrary, when a 
sufficiently large stimulus is applied (i.e. able to rise the transmembrane potential 
above the threshold potential), an active, non-linear response, known as the action 
potential (AP) will be elicited.  
Depending on the region of the heart, the cardiac AP may have different shapes 
and properties (Figure 1.1, right side): all these differences, together with the 
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particular activation sequence described above, are responsible for the 
macroscopical electrical activity of the heart, as measured in the electrocardiogram 
(ECG). In a conventional 12 lead ECG, ten electrodes are placed on the patient's 
limbs and on the surface of the chest. The overall magnitude of the heart's electrical 
potential is then measured from twelve different angles and recorded over a period 
of time. In this way, the overall magnitude and direction of the heart's electrical 
depolarization is captured at each moment throughout the cardiac cycle. The graph 
of voltage versus time produced by this non-invasive medical procedure, and 
referred to as ECG, is characterised mainly by 3 waves: a P wave (atrial 
depolarization), a QRS complex (ventricular depolarization) and a T wave 
(ventricular repolarization). 
Despite these differences in shape and properties, the cardiac AP it is mainly 
characterised by 5 different phases, related to the opening/closing of the different 
ion channels (mainly Na
+
, Ca
2+
 and K
+
), as shown in Figure 1.2: 
 Phase 0 (upstroke) when the threshold is reached, there is a rapid influx of Na+ 
through the Na
+
 channels, creating the fast Na
+
 current (INa) who rise the 
membrane potential up to positive values. 
 Phase 1: the Na+ channels close, while K+ channels open. Throughout the whole 
action potential duration there are different K
+
 currents that tend to bring the 
transmembrane potential back to its resting value. In this phase, the main 
contribution is the one of the transient outward K
+
 current, which causes a small 
deflection in the membrane voltage, called “notch”. 
 Phase 2: the outward K+ currents are counteracted by the opening of Ca2+ 
channels, responsible for the “plateau phase”, in which the membrane potential 
decreases very slightly. The duration of this phase may vary from one cell to the 
other, e.g. it is very short in atrial cells and longer in ventricular ones. 
 Phase 3: when the Ca2+ channels close, the “rapid” and “slow” delayed rectifier 
K
+
 currents (IKr and IKs respectively) play the major role, bringing the 
transmembrane potential back to its resting value. 
 Phase 4: the cell is in its resting state; the resting membrane potential is 
depending mostly on the inward rectifying K
+
 current (IK1). 
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Figure 1.2: Representative action potential trace of a human ventricular endocardial cell. 
Different cell types may have different ionic currents and formulations, causing 
the differences in shapes, e.g. ventricular vs atrial cells. An example is given in 
Figure 1.3, by comparing atrial and ventricular cells. 
 
Figure 1.3: Main differences between atrial (left) and ventricular (right) action potentials, with the 
underlying ionic currents (modified from  [2]). 
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Arrhythmias and pro-arrhythmic mechanisms 
Sudden Cardiac Death (SCD) is a sudden, unexpected loss of heart function: the 
heart stops beating and blood stops flowing to the brain and other vital organs, 
causing death if not treated within minutes. Most SCD are caused by abnormal 
heart rhythms, called arrhythmias, in which heart beat is too fast, too slow or 
irregular: they are due to problems with the electrical conduction of the heart.  
There are different types of arrhythmias: extra beats, either atrial or ventricular, 
supraventricular tachycardia, which include atrial flutter and atrial fibrillation, 
ventricular arrhythmias, i.e. ventricular tachycardia or fibrillation, and brady-
arrhythmias. Most arrhythmias can be effectively treated, by medications or 
medical procedures, such as a pacemaker and surgery. 
There are many pro-arrhythmic mechanisms which make the heart more 
vulnerable to arrhythmias. As an example, in Figure 1.4 and Figure 1.5 APD 
alternans and after-depolarisations (early, EADs and delayed DADs) are shown. 
 
Figure 1.4: Cardiac action potential traces showing APD alternans, i.e. a beat to beat variability in 
the AP duration (modified from [3]).  
 
Figure 1.5: Cardiac AP illustrating EAD and DAD mechanisms (modified from [4]).  
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MODELLING THE CARDIAC ELECTRICAL 
ACTIVITY 
Equivalent Electric Circuit of the Membrane 
The action potential (AP) represents a transient change of the transmembrane 
voltage of the cell, and it is the result of all the ionic currents (mostly Na
+
, K
+
 and 
Ca
2+
) flowing across the membrane. Considering the equivalent electric circuit, the 
membrane itself can be represented by a dielectric, with a capacitance of about 
1µF/cm
2
, and each ionic current can be represented by a resistor (Figure 1.6). 
 
Figure 1.6: Equivalent electric circuit of cell membrane. 
 
The action potential of a single cell can be then reconstructed by solving the 
following differential equation, where Vm represents the transmembrane voltage, Cm 
the capacitance of the cell and Itot the total current flowing, consisting of the sum of 
all the different ionic currents (Iion) and the stimuls current (IStim), required from the 
cell to reach the voltage threshold, thus developing a full action potential.
 
 
𝐼𝑡𝑜𝑡 = 𝐼𝑖𝑜𝑛 + 𝐼𝑆𝑡𝑖𝑚 =  𝐶𝑚 ∙
𝑑𝑉𝑚
𝑑𝑡
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The Hodgkin and Huxley formalism 
The first AP mathematical model was developed by Alan Lloyd Hodgkin and 
Andrew Huxley, in 1952 [5], to explain the ionic mechanisms underlying the 
initiation and propagation of neural APs in the squid giant axon. In 1963, they 
received the Nobel Prize in Physiology or Medicine. 
The Hodgkin-Huxley model was developed by performing a series of voltage 
clamp experiments on giant squid axons, i.e. holding the membrane to a constant 
voltage value, and measuring the corresponding current flow. 
They identified three different contributions to the total current: 
- Na+ current 
- K+ current 
- Leakage current (carried by unspecified ions) 
The leakage current was formulated simply as a maximal conductance times the 
corresponding driving force, while Na
+
 and K
+
 current formulations included also a 
voltage-dependent gating mechanism, regulating the channel opening/closing. 
 
 
 
Here, gNa = 120, gK = 36 and gL = 0.3 (mS/cm
2
) are the maximal conductances 
associated with the Na
+
, K
+
 and leakage currents, respectively. ENa = 115, EK = −12 
and EL = 10.613 (mV) are the reversal potentials of each ion, according to the 
Nernst equation and relative to the resting membrane potential. Gating variables m, 
h and n are voltage dependent and their values (always between 0 and 1) describe 
the probability for the channel to be in an open state. When their value is 0 the gate 
is completely close and no current will flow, whereas when the value is 1 the gate is 
completely open. The leakage current does not have any gating mechanisms, the K
+
 
current has only a gating variable, while the Na
+
 current has two of them: therefore, 
𝐼𝑁𝑎 =  𝑔𝑁𝑎 ∙ 𝑚
3 ∙ ℎ ∙ (𝑉𝑚 − 𝑉𝑁𝑎) 
𝐼𝐾 =  𝑔𝐾 ∙ 𝑛
4 ∙ (𝑉𝑚 − 𝑉𝐾) 
𝐼𝐿 =  𝑔𝐿 ∙ (𝑉𝑚 − 𝑉𝐿) 
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the state of the Na
+
 gate relies on the product of both gating variable, and only when 
they are both equal to 1 the gate is completely open. 
Each gating variable is described by a differential equation: 
 
Here, αn and βn are known as rates and are usually voltage-dependent. Figure 1.7 
shows the action potential generated by the Hodgkin-Huxley model, again relative 
to the resting membrane potential, and the three gating variable traces over time. 
 
Figure 1.7: Transmembrane potential generated by the Hodgkin and Huxley model 
(left panel) and the corresponding gating variables over time (right panel). 
From Hodgkin-Huxley to Cardiac Models 
Starting from Hodgkin and Huxley, AP mathematical models have gained a 
relevant role in the investigation of cellular electrophysiology. Their possible 
application to the heart has been soon realized and right from the beginning, cardiac 
cell modelling allowed to gain insights by predicting phenomena which have been 
later confirmed experimentally. 
The earliest example consists in the pioneering work by Noble, who modified the 
Hodgking-Huxley model to simulate Purkinje fibres in mammals, identifying the 
energy-saving properties of the inward rectifier potassium current [6]. 
Due to the limited availability of human cardiomyocytes for experimental 
research, most electrophysiological models had been formulated for animals 
(mouse, guinea pig, rabbit, dog, etc.). However, animal and human cardiomyocytes 
𝑑𝑛 
𝑑𝑡
= 𝛼𝑛 ∙ (1 − 𝑛) − 𝛽𝑛 ∙ 𝑛 
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differ in major aspects, such as action potential shape and duration, range of normal 
heart rates, action potential restitution and relative importance of ionic currents in 
the action potential generation. As all these factors may influence the mechanism of 
arrhythmias initiation and dynamics, simulation results obtained with animal 
models may prove inadequate to represent phenomena observed in human. 
In recent years, more and more data on human ionic currents have been gathered 
from human cardiomyocytes. In addition, by cloning techniques voltage-clamp 
measurements of human ion channels have been acquired in heterologous cells. As 
a consequence, new several models have been developed to describe the origins of 
the human cardiac action potential, an important step towards a wider application in 
clinical practice. 
In 2012, two comprehensive reviews of human atrial models have been 
published, [7, 8], comparing the different structure and ionic current formulations, 
and discussing the differences in AP and Ca
2+
 transient biomarkers. 
As for ventricular cells, there is not any comprehensive review which includes 
the most recently published AP models. Therefore, in the next chapter we present a 
literature review of the current state of the art in human ventricular AP models. 
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MODELS ON THE MARKET  
Human ventricular cells modelling has begun in 1998 with a study by Priebe and 
Beuckelmann [9] (PB98), aimed at understanding the effects of electrophysiological 
alterations in heart failure. They used the Luo–Rudy model of guinea pig 
ventricular myocytes [10] as basis, parameterized anew with available human data, 
measured in normal and diseased myocytes. 
The PB98 model has been the only one available until 2004, when two further 
models of human ventricular cells were introduced by Iyer et al. [11] 
(IW04) and Ten Tusscher et al. [12] (TP04). Both these models provide a more 
detailed description of ionic currents and fluxes, which reflects new insights in 
channel function understanding as well as the availability of new measurements 
from human cells and channels. The IW04 model describes the electrophysiology of 
sub-epicardial cells (Epi), applying Markovian models for most channels: however, 
this choice lead to a significant increase in complexity and hence computational 
time required for simulation. In contrast, the TP04 model uses the common 
Hodgkin-Huxley formulation for all currents, and in addition to Epi also considers 
sub-endocardial (Endo) and Midwall (M) cells. A comprehensive comparison of 
PB98, TP04 and IW04 models, including ion currents, action potential morphology 
and duration, rate adaptation and other properties, has been performed by Ten 
Tusscher et al. [13]. A revisited version of TP04 has been published by the same 
group in 2006 [14] (TP06), including more details on intracellular Ca
2+
-handling 
and cell compartmentalisation.  
Two years later, Bueno-Orovio et al. [15] performed a new comparison of these 
models, proposing at the same time a minimal ventricular human model, 
specifically designed to reproduce tissue-level characteristics. An additional 
comparison of the IW04 and TP04 models as been performed by Niederer et al. 
[16], highlighting their significant differences in terms of voltage, ionic currents and 
concentrations during an action potential, although both models aim to represent the 
same physiological system. These differences can be partially explained by the 
different experimental data which have been used to characterise them. 
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More recently (2010), a model of human ventricular AP has been proposed by 
Grandi et al. [17] (GB10), using the rabbit model proposed by Shannon et al. [18] 
as basis, and including new formulations of ionic current densities and kinetics, 
according to novel human experimental data. With respect to the TP06 model, the 
GB10 shows a better steady-state AP response to frequency changes and to 
potassium current blockades. However, the GB10 model does not properly 
reproduce S1S2 restitution properties nor APD rate adaptation dynamics, as reported 
by Carro et al. [19]. Those drawbacks probably have been acquired from the rabbit 
model used as basis, since S1S2 restitution and APD rate adaptation are notably 
different in rabbit with respect to human. Indeed, in a recent review the GB10 
model  has been even referred to as a rearrangement of a rabbit model rather than a 
real new human model [20].  In 2011, Carro et al. [19] developed a refinement of 
the GB10 model (CP11), to rectify these drawbacks. In particular, they 
reformulated the L-type calcium current dynamics, in order to accurately reproduce 
S1S2 restitution and APD rate adaptation. 
The most recent model of human ventricular cell has been proposed by O’Hara 
et al. [21] (OR11) in 2011. This model was developed and validated by using an 
extensive dataset, including many previously unpublished experimental data, from 
more than 100 undiseased human hearts. Due to the extensive validation on these 
new data, the authors claimed to have substantially increased human specific model 
accuracy: in fact, the model was shown to reproduce several physiological 
behaviours and drug blocks. Moreover, the effects of Ca
2+
/Calmodulin-dependent 
protein kinase II (CaMKII) were incorporated as well.  
In Table 2.1 the published models of human ventricular electrophysiology 
available in literature are listed, together with a non-exhaustive reference to their 
extensions and/or refinements. Indeed, cardiac computational modelling has 
reached the stage in which many of the more recent works are focused on ‘fixing’ 
problems in previous models, as soon as new and better data become available and 
modellers discover possible applications for which the published models are not 
well-suited [20]. We chose to neglect minimal/reduced models, in which a single 
mathematical process represents multiple channel properties, since they have been 
developed mainly for multicellular simulations, while in this thesis we are mostly 
using single cells.  
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Table 2.1: Computational models of human ventricular cell electrophysiology. 
Model 
Model 
extensions 
Cell 
types 
Citations 
Scopus 2014 
Comments 
Ref 
# 
Priebe & 
Beuckelmann 
(PB98) 1998 
 n.s. 244 
First human model, but 
largely based on animal 
data. Formulations for 
normal and failing hearts.  
 [9] 
 
Seemann et al. 
2003 
Endo, 
M, Epi 
19 
Focus on regional 
heterogeneity 
 [22] 
Iyer et al. 
(IW04) 2004 
 Epi 130 
Joint first human models 
prevalently based on 
human data.  
 [11] 
Ten Tusscher et 
al. (TP04) 2004 
 
Endo, 
M, Epi 
477  [12] 
 
Ten Tusscher 
et al. (TP06) 
2006 
Endo, 
M, Epi 
217 
More detail on 
intracellular calcium 
handling 
 [14] 
 
Fink et al. 
2008 
Epi 40 
From TP06, new 
formulations for IK1 and 
HERG, 
 [23] 
 
Grandi et al. 
2009 
Endo, 
M, Epi 
17 
From TNNP04, new ICaL 
formulation to reproduce  
APD shortening with 
increased [Ca]o 
 [24] 
      
Grandi et al.  
(GB10) 2010 
 
Endo, 
Epi 
90 From Shannon et al. 2004.  [17] 
 
Carro et al. 
2011 
Endo, 
Epi 
11 
From Grandi et al. 2010 
to study arrhythmias 
 [19] 
O’Hara et al. 
(OR11) 2011 
 
Endo, 
M, Epi 
96 
Substantially increased 
human-specific model 
accuracy from human data 
 [21] 
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Upon consideration of all these models, a legitimate question could be: “Why so 
many different models of the same human ventricular cell? Which one is the best?”. 
Unfortunately, the answer is not a simple one. In fact, each model has to be 
evaluated in its specific context, i.e. the experimental data which have been 
considered for its parameters identification and validation. Therefore, all the listed 
models (even the oldest ones) may have their advantages as well as their 
limitations, depending on the applications taken into account; i.e. a particular model 
may reproduce correctly the effects of a specific currents blockade, but it may be 
unsuitable for rate dependence analysis.  
As an example, it is worth noting that the model with more citations in literature 
(based on Scopus Data, updated 31/12/2014) is TT04: in fact, even if quite old, this 
model is still widely used, especially for multidimensional simulations, because it is 
relatively good in variety of context and computationally much more efficient than 
its updated version (TT06) or the most recent models, as OR11 or GB10, which 
includes a very detailed description of intracellular processes and compartments. 
MODELS COMPARISON 
Among all the models included in Table 2.1, we chose to compare the 6 ones 
which have been more widely used: PB98, IW04, TT04, TT06, GB10 and OR11. 
Action Potential Properties 
All the considered models have been implemented in Matlab (Mathworks, Inc) 
and paced at 1 Hz until steady state (500 s), i.e. intracellular concentrations (Na
+
, 
Ca
2+
 and K
+
) stable over time. The current stimulus has been set to 2 ms of 
duration, with amplitude equal to twice the AP threshold for each model. Since 
PB89 and IW04 don’t reproduce different cell types, and their AP shape is similar 
to epicardial cells, we considered Epi cells only for all the models. 
Simulated AP traces are shown in Figure 2.1Errore. L'origine riferimento non 
è stata trovata.. Each model has been represented using a different colour, but all 
the other model traces are shown in grey, to facilitate comparison. The high 
variability of AP shapes and duration among the models is mostly dependent on the 
different data used to construct them. In fact, after fitting the model parameters on 
Introduction – Chapter 2                                                                                                                     41 
 
Computational Modelling of Cardiac Electrophysiology: from Cell to Bedside 
voltage-clamp data, current conductances are often “manually” adjusted to fit the 
AP data available.  
For each model a set of AP biomarkers has been evaluated: the results are 
compared in Table 2.2 together with the time required for the simulations. 
 
Figure 2.1: Simulated AP traces for the six considered models. 
Table 2.2: AP biomarkers comparison for the six considered models 
 
PB98 IW04 TP04 TP06 GB10 OR11  
RMP (mV) -89.8 -90.7 -86.3 -86.0 -81.4 -87.9 
AP peak (mV) 61.0 31.7 42.1 44.1 42.6 33.6 
dV/dtMAX (V/s) 422 210 355 365 384 205 
APD50 (ms) 298 278 232 268 232 184 
APD90 (ms) 418 319 266 299 287 229 
nODEs - 22 67 17 19 39 55 
tSIM (n.u.) 1.18 4.36 1.00 1.04 1.83 2.42 
RMP: resting membrane potential; AP peak: max AP voltage; dV/dtMAX: max upstroke velocity; 
APD50 and APD90: AP duration, computed at 50% and 90% of repolarization; nODEs: number of 
ordinary differential equations in the model; tSIM: time required to compute 500 s, normalised 
according to the fastest model. 
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As expected, the computational time is highly dependent on the number of 
differential equations: it is therefore very easy to understand why TT04 is still one 
of the most used human ventricular AP model, even if not very recent. At the same 
time, it is obvious how the large number of Markovian current models in IW04 
affect its computational performances. 
Intracellular Compartments 
Intracellular compartments and Ca
2+
 release from the sarcoplasmic reticulum 
(SR) were first introduced in cardiac models by DiFrancesco and Noble [25]: 
indeed, their Purkinje cell model described intracellular Ca
2+
 dynamics in details, 
by including separate pools for cytosolic, non-junctional SR (NSR) and junctional 
SR (JSR) Ca
2+
 concentrations. Later on, it has been acknowledged that both the 
cellular and sub-cellular structure considerably shape the temporal evolution of 
Ca
2+ 
concentration profiles.  
However, model design in terms cellular compartmentalisation may be very 
different from one model to the other. Within human ventricular models, structure 
ranges from the simplest approach, as in TP04 (cytosol and SR only), to the most 
complex models with many different sub-compartments (cytosol, junctional space, 
sub-sarcolemma, NSR and JSR). In addition, most of the models also include 
different Ca
2+
 buffers for each compartment, especially the most recent ones, i.e. 
GB10 and OR11.  
Table 2.3 shows the main structural properties of the considered human 
ventricular models, e.g. the number and size of intracellular compartments and the 
corresponding Ca
2+
 buffers. 
The main challenge of the compartmental approach is the lack of corresponding 
distinct anatomical structures inside the cell. Thus, there is not a straightforward 
way of choosing the appropriate compartmentalization. This also explains the great 
variability among the different models.  
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Table 2.3: Main properties of the considered human ventricular AP models. 
 
PB98 IW04 TP04 TP06 GB10 OR11 
Cell 
Volumes 
(pL) 
CYTO 
25.85 
25.84 
16.40 
16.40 
21.45 
25.85 
SL 0.66 
JS 0.0012 0.0547 0.0178 0.7603 
SR 
NSR 2.10 2.10 
1.09 1.09 1.16 
2.10 
JSR 0.18 0.16 0.18 
TOT 28.13 28.10 17.50 17.55 23.29 28.89 
Calcium 
Buffers 
(mM) 
CYTO 
CMDN 0.05 0.05 
0.15 
0.20 
0.02 0.05 
TRPN low 
0.07 
0.07 0.07 
0.07 
TRPN high 0.14 0.14 
JS 
BSR - - 
0.40 
0.02 0.05 
BSL low 
- - 
0.13 
1.12 
BSL high 0.05 
SR CSQN 10 15 10 10 2.6 10 
The six compartments refer to: bulk myoplasm (cytosol, CYTO); network SR (NSR); junctional SR 
(JSR); junctional space (JS); sub-sarcolemmal space (SSL). The Ca2+ buffers are: Calmodulin 
(CMDN), Troponin (TRPN), Calsequestrin (CSQN), SR Ca2+ buffers (BSR); junctional and 
sarcolemmal Ca2+ buffers (BSL). 
Extracellular and Intracellular Concentrations 
Extracellular ionic concentrations are quite similar in all the considered models, 
since they are the ones used for experimental recordings in single cells, often done 
in standard conditions. As for intracellular ionic concentrations, the differences 
between models are higher, especially when considering Ca
2+
 concentrations in the 
different compartments. A summary of the extra- and intra- cellular concentrations 
for every model is shown in Table 2.4: . Extracellular concentrations are constant in 
the models, while for intracellular concentrations the reported values are the 
diastolic ones, after pacing the models for 500 s at 1 Hz. 
44                                                                                                                    Introduction – Chapter 2 
Elisa Passini 
It is worth noticing that the GB10 model is the only one including Cl
-
 
concentrations, together with the Ca
2+
 activated Cl
-
 current and a background Cl
-
 
current. We ran a few simulations blocking this current, and actually its effect on 
the AP is quite negligible, at least in physiological conditions. In addition, in GB10 
both intracellular K
+
 and Cl
-
 are clamped to constant values. 
Table 2.4: Extracellular and intracellular ionic concentrations for the considered models. 
 
PB98 IW04 TP04 TP06 GB10 OR11 
Extracellular 
Concentrations 
[Na
+
]o (mM) 138 138 140 140 140 140 
[K
+
]o (mM) 4.0 4.0 5.4 5.4 5.4 5.4 
[Ca
2+
]o (mM) 2.0 2.0 2.0 2.0 1.8 1.8 
[Cl
-
]o (mM) - - - - 150 - 
Intracellular 
Concentrations 
[Na
+
]i (mM) 10.6 9.8 11.6 10.4 8.4 7 
[K
+
]i (mM) 140 125 140 140 120* 144 
[Ca
2+
]i (nM) 
200 
86 
200 
130 
87 
85 
[Ca
2+
]SL (nM) 100 
[Ca
2+
]JS (nM) 140 360 200 85 
[Ca
2+
]SR (mM) 2.5 0.3 0.2 3.7 0.6 1.6 
[Cl
-
]i (mM) - - - - 15* - 
[Y]o: extracellular concentration for Y; [Y]i: intracellular concentration for Y; SL: 
sarcolemmal space; JS: junctional space; SR: sarcoplasmic reticulum. 
* in GB10, [K
+
]i and [Cl
-
] i are clamped to constant values. 
Membrane Ionic Currents and Ca
2+
 subsystem 
The main ionic currents are presents in all the considered models: INa, ICaL, Ito, 
IK1, IKr, IKs, Na
+
/K
+
 pump (INaK) and Na
+
/Ca
2+
 exchanger (INCX). However, there are 
a few differences in the small currents (e.g. background ones), and in Ca
2+
 related 
channels/pumps distribution. To avoid unnecessary complexity, we will focus on 
the differences between the three most recent models: TP06, GB10 and OR11. 
A summary of ionic currents distribution is shown in Table 2.5, together with the 
corresponding intracellular compartments in which they are distributed. As for ionic 
fluxes, the two connected compartments for each of them are shown. 
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Table 2.5: Ionic currents and fluxes with the corresponding intracellular compartments for 
the six considered human ventricular AP models. 
 PB90 IW04 TT04 TT06 GB10 OR11 
Na
+
 currents 
INa CYTO CYTO CYTO CYTO 
11% JS 
89% SL 
CYTO 
INaL - - - - - CYTO 
ICaNa - - - - 
90% JS 
10% SL 
JS 
INaB CYTO CYTO CYTO CYTO 
11% JS 
89% SL 
CYTO 
Ca
2+
 currents 
ICaL CYTO CYTO CYTO JS 
90% JS 
10% SL 
JS 
ICab CYTO CYTO CYTO CYTO 
11% JS 
89% SL 
CYTO 
K
+
 currents 
Ito CYTO CYTO CYTO CYTO CYTO CYTO 
IK1 CYTO CYTO CYTO CYTO CYTO CYTO 
IKr CYTO CYTO CYTO CYTO CYTO CYTO 
IKs CYTO CYTO CYTO CYTO CYTO CYTO 
ICaK - CYTO - - 
90% JS 
10% SL 
JS 
IKp - - CYTO CYTO 
11% JS 
89% SL 
CYTO 
Cl
-
 currents 
IClB - - - - CYTO - 
IClCa - - - - 
11% JS 
89% SL 
- 
Pumps and 
Exchangers 
INaK CYTO CYTO CYTO CYTO 
11% JS 
89% SL 
CYTO 
INCX CYTO CYTO CYTO CYTO 
11% JS 
89% SL 
20% JS 
89% 
CYTO 
IpCa - CYTO CYTO CYTO 
11% JS 
89% SL 
CYTO 
SR 
Fluxes 
Jrel 
JSR <-> 
CYTO 
JSR <-> 
JS 
SR -> 
CYTO 
SR <-> 
JS 
JSR  
<-> JS 
JSR -> JS 
Jleak 
NSR -> 
CYTO 
- 
SR <-> 
CYTO 
SR <-> 
CYTO 
JSR  
<-> JS 
NSR -> 
CYTO 
Jup 
CYTO  
-> NSR 
CYTO  
<-> NSR 
CYTO  
-> SR 
CYTO  
-> SR 
CYTO  
<-> SR 
CYTO  
-> NSR 
Jtr 
NSR <-> 
JSR 
NSR <-> 
JSR 
- - - 
NSR <-> 
JSR 
Intracellular 
Fluxes 
JdiffCa - 
CYTO  
˂-˃ JS 
- 
CYTO  
˂-˃ JS 
CYTO/SL 
SL/JS 
CYTO  
˂-˃ JS 
JdiffNa - - - - 
CYTO/SL 
SL/JS 
CYTO  
˂-˃ JS 
JdiffK - - - - - 
CYTO 
˂-˃ JS 
As an example, in TP06 and OR11, all the ICaL actually flows into the JS. Even if 
it is well know that most of the L-type Ca channels are located in the junctional 
portion of the membrane, this seems to be a rather extreme choice. More 
realistically in GB10, based on rat data [26], 90% of the channels are located in the 
JS membrane and the remaining 10% in the cytoplasm.  
Another difference is in the INCX distribution. It is still not completely clear if 
Na
+
/Ca
2+
 exchanger proteins are located preferentially in T-tubules [27] or have a 
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more uniform distribution in the ventricular sarcolemma [28]. In GB10 the INCX 
channels are distributed evenly throughout the cell membrane (89% in the SL, 11% 
in the JS), while in OR11 the fraction located in the JS is slightly higher (20%). 
O’Hara et al. indicated this choice as necessary in order to correctly reproduce the 
rate dependence of intracellular Ca
2+
 peak [21]. It is worth noticing that all the ionic 
currents were considered uniformly distributed throughout the cell membrane in the 
GB10 model (89% in the SL, 11% in the JS), as suggested e.g. for INaK in 
mammalian cardiomyocytes [29]. On the contrary, they were considered absent 
from JS membrane in TP06 and OR11. 
A visual comparison of TT06, GB10 and OR11, showing all the ionic currents, 
fluxes and compartments for this three models, is given in Figure 2.2. 
 
Figure 2.2: Visual comparison of the three most recent human ventricular model properties, in 
particular showing the distribution of each ionic current on the cell, and the ions diffusion (credit: 
Caterina Passini). 
It is worth noticing that, after this literature review has been completed (2013), a 
new mathematical model have been published for human ventricular cells by 
Asakura-Noma [30], as well as a new paper comparing the behaviour of some of the 
human ventricular models considered here in tissue, by Elshrif and Cherry [31]. 
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Abstract 
Extracellular calcium concentration ([Ca
2+
]o) affects cardiac action potential 
(AP): their inverse dependence has already been assessed in vivo and in vitro. 
Both shortening and prolongation of AP are associated with an increased risk of 
arrhythmias and [Ca
2+
]o variations may occur in many different contexts (e.g. 
pathological hypo/hyper-calcaemia, haemodialysis therapy, bed-rest experiments). 
Computational modeling could provide a useful support to investigate this 
phenomenon: however, [Ca
2+
]o dependence is not reproduced properly by most of 
the commonly used human AP models 
The aim of this study has been to modify one of the most recent human 
ventricular cell model in order to improve its response to [Ca
2+
]o changes. 
The original L-Type Ca
2+
 current formulation has been replaced by a new 
Markov model with 8 states and a cubical structure. The inverse dependence of 
APD vs [Ca
2+
]o has been achieved mainly by strengthening the Ca
2+
-dependent 
inactivation mechanism (CDI), with respect to the Voltage-dependent one (VDI), 
thus confirming that CDI plays an importan role in this context. 
The modified model has been validated against the same experimental data used 
for the original one, in order to verify its consistency, and it can then be used to 
explore “in silico” the effects of electrolyte unbalances on the electrical activity of 
human cardiomyocytes. 
INTRODUCTION 
It is well know that extracellular calcium concentration ([Ca
2+
]o) affects cardiac 
action potential (AP): in fact, an increase of [Ca
2+
]o shortens AP while [Ca
2+
]o 
decrease lengthens it, as observed in different species [1–5], e.g. guinea pig (Figure 
3.1, panel A), and human atrial cell [6] (Figure 3.1, panel B). More recently, new 
experimental data acquired in human ventricular cells confirmed this dependence 
[7] (Figure 3.1, panel C). Finally, when considering consistency between action 
potential duration (APD) changes and corrected QT interval (QTc), further 
confirming data can be found in the literature, e.g. [8] (Figure 3.1, panel D). 
Since both APD increase and decrease may lead to arrhythmia onset, [Ca
2+
]o 
dependency of repolarization may have important implications in all clinical 
contexts where electrolyte changes occur, e.g. haemodialysis therapy (HD), 
pathological hypo/hypercalcemia, head-down bed-rest experiments, etc.  
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Figure 3.1: Experimental Data from literature showing the inverse dependence of APD vs [Ca2+]o: 
A) guinea pig ventricular cells (modified from [2]); B) human atrial cells (modified from [6]); C) 
human atrial cells (modified from [7]); D) QTc interval vs [Ca2+]o variations measured in different 
patients during Heamodialysis theraphy (modified from [8]). 
From earlier studies [9], L-type Ca
2+
 current (ICaL) seems the one mostly 
responsible for the APD-[Ca
2+
]o dependence. Two contrasting mechanisms are 
involved: e.g. when [Ca
2+
]o is higher, it increases the ICaL driving force which, by 
itself, would enhance the current and prolong the APD; on the other hand, a larger 
ICaL increases its Ca
2+
-dependent inactivation (CDI) mechanism as well. Since the 
final outcome is APD shortening, it is apparently CDI which plays the 
overwhelming role. A summary of these two mechanisms is shown in Figure 3.2.  
 
Figure 3.2: Schematic representation of the two mechanisms involved in APD-[Ca2+]o dependence. 
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However, many other ionic mechanisms are involved and this is why the APD-
[Ca
2+
]o dependence is not completely understood. Computational modeling may 
help to investigate this phenomenon by analysing the single ionic currents involved. 
However, most of the commonly used human ventricular AP models have been 
developed considering a single [Ca
2+
]o value, and they are not able to reproduce 
properly the effects of [Ca
2+
]o changes: often, their APDs vary in an opposite way, 
e.g. in the O’Hara-Rudy [10] and in the Grandi-Bers models [11] (Figure 3.3). 
 
Figure 3.3: APD-[Ca2+]o dependence in two of the most recent human ventricular AP models: 
O’Hara-Rudy [10] (blue line) and Grandi-Bers [11] (green line). APD has been computed at 90% of 
repolarisation, after pacing the models at 1 Hz for 1 s. 
The aim of this study has been to modify the most recent human ventricular AP 
model (O’Hara-Rudy, [10]) in order to improve its APD-[Ca2+]o dependence 
without altering model behaviour in control condition, as similarly done for older 
models in previous works  [6, 9]. 
The proper dependence should be achieved by acting mainly on ICaL, for which 
a new formulation is proposed, strengthening the Ca
2+
-dependent inactivation (CDI) 
with respect to the V-dependent one (VDI). 
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METHODS 
The O’Hara-Rudy model of human ventricular myocyte (ORd, [10]) was used as 
basis. However, the L-Type Ca
2+
 current has been completed revisited: its original 
Hodgkin-Huxley formulation has been replaced by a new Markov model (Figure 
3.4), similar to the one used by Decker-Rudy for canine epicardial cells [12]. 
 
Figure 3.4: Schematic representation of the new Markov model of L-Type Ca2+ current:VDI and 
CDI are represented as two separate loops, interconnected by specific up/down rates 
This Markov model consists of two structurally identical loops (Figure 3.5), each 
including 4 transitions: activation (from C to O), fast inactivation (from O to I1), 
slow inactivation (from I1 to I2) and recovery (from I2 to C).  
Activation and recovery rates are exactly the same in the two loops; they have 
been directly derived from the ORd time constant and steady state values of the 
corresponding gating variables. As for fast and slow inactivation, rates on the CDI 
loop are 10 times faster than the ones in VDI loop.  
All transition  rates, even  the ones on  the CDI  loop, are actually V-dependent, 
according to the hypothesis by Kim et al. [13], where CDI was observed to function 
simply as a faster VDI, activated by elevated Ca
2+
.  
In fact, in this model CDI and VDI are implemented on two different loops, 
interconnected by specific up/down rates, modulated by Ca
2+
 concentration, by 
means of the n gate, used to calculate the rup/rdown rates (Figure 3.6). 
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Figure 3.5: VDI (blue) and CDI (pink) loops. Activation and recovery rates (black) are the same in 
the two loops, while inactivation rates are 10 times faster in the CDI loop.  
  
Figure 3.6: VDI (blue) and CDI (pink) loops are interconnected by up/down rated, related to Ca2+ 
concentration by means of the n gate.  
In the ORd model, the n gate represents the fraction of channels operating in 
CDI mode, and it is the only state variable, among the ones involved in ICaL 
kinetics, which is directly dependent on intracellular Ca
2+
 concentration ([Ca
2+
]i).  
The n formulation is based on the interaction between [Ca
2+
]i and Calmodulin 
(CaM) bound to L-type Ca
2+
-channels (Figure 3.7): [Ca
2+
]i binds to CaM, 
constitutively attached to the L-Type Ca
2+
 channels (k1/k-1 rates) and when 4 Ca
2+
 
ions are bound, the complex may activate CDI (k2/k-2 rates). The original equations 
for the n gate has been preserved in the modified model, even if kinetic rates have 
been slightly modified, in order to increase its sensibility to [Ca
2+
]i variations.   
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Figure 3.7: Simplified diagram of the n gate (modified from  [10]), which depend on Ca2+ and it has 
been used to computer the up/down rates between CDI/VDI loops. 
 
In addition to ICaL formulation, other changes in Ca
2+
-handling were needed to 
refine the modified model. These changes mostly addressed Ca
2+
 diffusion, release 
and uptake from the sarcoplasmic reticulum (SR): 
- Since experimental evidence is not clear about Ca2+ movement inside the SR 
[14], Ca
2+
 diffusion inside the SR has been initially speeded  up, according to 
[15]. Afterwards, we decided to simplify model structure, leaving only a 
single compartment for the SR, instead of the separation between Network 
SR (NSR) and Junctional SR (JSR);  
- 10-fold increase of SERCA pump maximal current; 
- 2-fold increase in Ca2+ diffusion from sub-sarcolemmal space to cytoplasm; 
- 1.2-fold increase of Na+/Ca2+ exchanger maximal current 
Model differential equations were implemented in Matlab (Mathworks Inc) and 
solved with a variable order solver (ode15s), based on numerical differentiation 
formulas [16]. Simulations were run with the original and modified models at 
variable [Ca
2+
]o in the clinically relevant range 0.6-3 mM. Pacing at 1 Hz was 
maintained until steady state AP was reached (1000 s) and APD was measured as 
the interval between AP upstroke and the 90% repolarization level (APD90). 
The modified model equations, as implemented in the corresponding Matlab 
function file, are included in Appendix A. 
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RESULTS 
Model Validation 
The modified model has been validated against most of the voltage-clamp and 
current-clamp experimental data considered in the original ORd model, especially 
the ones concerning ICaL dynamics. Different voltage-clamp protocol have been 
reproduced in simulations, and the modified model results was in agreement with 
both the corresponding experimental data and the original ORd model.  
ICaL steady state activation, inactivation and I-V curves have been compared with 
data from Magyar et al. [17] (Figure 3.8, Figure 3.9 and Figure 3.10 respectively). 
The I-V curve is slightly different from the experimental data, especially when 
considering positive voltage, even if it perfectly overlaps the one from the original 
ORd model. This is related to the activation of the current, which indeed was not 
modified. Recovery from inactivation has been evaluated using the P1P2 protocol, as 
in Fulop et al. [19] (Figure 3.11).  
 
Figure 3.8: Comparison of ICaL steady state activation curves: original ORd model (blue line), 
modified ORd model (pink line) and experimental data from  [18] (black squares). 
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Figure 3.9: Comparison of ICaL steady state inactivation curves: original ORd model (blue line), 
modified ORd model (pink line) and experimental data from  [18] (black squares). 
 
 
 
Figure 3.10: Comparison of ICaL I-V curves: original ORd model (blue line), modified ORd model 
(pink line) and experimental data from [18] (black squares). The original and modified ORd model 
curves are almost identical, but different from the experimental data, especially for positive 
potential. This is mostly related to the activation property of the L-type Ca2+ current. 
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Figure 3.11: Recovery from inactivation, evaluated using the P1P2 protocol: original ORd model 
(blue line), modified ORd model (pink line) and experimental data from [19] (black squares). The 
modified ORd model actually gets closer to the experimental data than the original one. 
Experimental results of CDI blocks are in agreement with the ones reported in 
the ORd paper [10], measured when considering Ba
2+
 instead of Ca
2+
 current, 
therefore in absence of CDI: in fact, ICaL inactivation is much slower than in 
presence of both CDI and VDI. When blocking CDI, the original and modified ORd 
models  show the same qualitative effect (Figure 3.12). 
 
Figure 3.12: A) Experimental recording of Ca
2+
 and Ba
2+
 currents [10]: the latter, in 
absence of CDI mechanism, shows a much slower inactivation; B) Effects of CDI block on 
the L-Type Ca
2+
 current for the original and modified ORd models (top and bottom panel, 
respectively): both models show a slower inactivation, as expected. 
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Finally, the APD restitution curve, obtained by using a S1S2 protocol, is 
qualitatively reproduced by the modified ORd model. Simulation results are even 
more close to the experimental data then the ones obtained using the original ORd 
model Figure 3.13. 
 
Figure 3.13: Comparison of the S1S2 restitution curves: original ORd model (blue line), modified 
ORd model (pink line) and experimental data from [10] (black squares). 
 
APD-[Ca
2+
]o dependence 
When [Ca
2+
]o was set to the control value (1.8 mM), the modified and the 
original ORd models provided almost the same simulation results (Figure 3.14, solid 
lines): ionic currents and AP were very similar in shape and length. In the modified 
model, ICaL during AP plateau had a lower amplitude, due to the increased CDI.  
When [Ca
2+
]o variations have been simulated, however, significant differences 
were found in the two model results, both for AP and ICaL (Figure 3.14, dashed and 
dotted lines).  
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Figure 3.14: Simulation results for the original and modified ORd models, showing APs (top panels) 
and ICaL (bottom panels) for different [Ca
2+]o concentrations. In control conditions ([Ca
2+]o=1.8 
mM) the two model traces are quite similar, but when varying [Ca2+]o their behave in two opposite 
ways: the original model APD increases with [Ca2+]o, while the modified model APD decreases. 
 
In the original ORd model, when [Ca
2+
]o is set to high values, the increase in 
driving force causes a larger ICaL, which in turn lengthens AP. In the modified 
model, instead, the increase in driving force is compensated by a higher CDI, and 
the corresponding AP is shorter than in control. Only in the modified model the 
inverse relationship between APD and [Ca
2+
]o is reproduced correctly (Figure 3.15).  
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Figure 3.15: The APD-[Ca2+]o dependence for the original and modified ORd model: only the 
latter is well reproducing the inverse relationship between APD and [Ca2+]o. 
Qualitative comparison with Experimental Data 
The modified ORd model can be used in all clinical contexts where electrolyte 
variations occur, in order to assess a possible increased risk of arrhythmias for 
patients. A typical case of study is haemodialysis therapy, where patients regularly 
undergo relevant electrolyte changes (especially Ca
2+
 and K
+
) in a few hours.  
This kind of analysis had already been performed in a previous study [8], using 
experimental electrolyte data acquired during hemodialysis sessions as input of 
another human ventricular AP model [20]. Considering consistency between APD 
changes and QTc, simulation results had been compared with ECG data. The same 
comparison has been performed using the modified ORd model presented in this 
work, and simulation results are shown in Figure 3.16..  
Another possible application is head-down bed-rest experiments, used to 
simulate microgravity effects on the cardiovascular system: during bed-rest blood 
electrolyte concentrations changes over time, with possible impact on cardiac 
repolarization [21]. As an example, the next Chapter will present a simulation work 
done by combing bed-rest data and the modified ORd model described above. 
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Figure 3.16: Comparison of [Ca
2+
]o dependence of measured QTc interval duration and 
simulated APD (modified ORd model). Scatter plot and regression line show the significant 
inverse correlation between QTc interval duration and serum [Ca
2+
] changes measured 
during haemodialysis sessions (data from [8]). Simulated APD values were normalized to 
the APD value obtained at the average pre-dialysis Ca
2+ 
concentration, i.e. 1.2 mM 
DISCUSSION AND CONCLUSIONS 
APD dependency on extracellular Ca
2+
 concentration has been analysed in the 
most recently published human ventricular AP mathematical model [10]. Since this 
model does not reproduce properly the inverse APD-[Ca
2+
]o dependence, observed 
both in vitro and in vivo [6], some modifications have been implemented, in order 
to improve its response to [Ca
2+
]o changes. 
L-type Ca
2+
 current has been replaced by a new Markov model, and CDI 
mechanisms has been strengthened with respect to VDI. Both inactivation processes 
have been implemented as voltage-dependent, the former 10 times faster than the 
latter: therefore, CDI in the modified model works simply as a faster VDI. 
The modified model has been validated against the ICaL experimental data used 
for the original one, in order to verify consistency between the two models in 
control conditions.  
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Response to extracellular [Ca
2+
]o in the 1-3mM range has been considered, and 
the modified model succeeded in reproduce the proper variations on APD. 
Since the modifications applied to the original ORd model involved mostly ICaL 
CDI strengthening, it is suggested that this inactivation mechanism may be usually 
underestimated in computational cardiac models. 
The modified model here described may be used to explore a variety of contexts 
where electrolyte changes occur, e.g. haemodialysis sessions or head-down bed-rest 
experiments, in order to assess the possible arrhythmic risk for patients.  
Limitations and Future Works 
The modified ORd model has been validated on most of the experimental 
protocols shown in the original ORd paper. However, there are many other aspects 
that should be investigated more in details. 
As an example, we considered only the S1S2 protocol to assess rate dependence 
properties in the modified model, while in the original ORd one they consider 
different simulation protocols, checking also the changes occurring in every single 
ionic current. In addition, in the original ORd model there is a lot of work showing 
model results when considering different degrees of IKr blocks, showing early-after 
depolarisations (EADs) when blocking 85% of the current. 
Therefore, future works will address a further validation of the modified models, 
to check the consistency in all the aspects considered in the original one. 
Finally, the modified model could be used in a population of models study like 
the one described later on (Chapter 7), as an alternative to the original ORd model. 
It would be very interesting to see how the changes in Ca
2+
 current and Ca
2+
-
handling may affect the results, especially when considering pro-arrhythmic 
mechanisms related to Ca
2+
, such as EADs or DADs. 
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Abstract 
Several episodes of ventricular arrhythmias have been reported during 
spaceflights, and cardiovascular deconditioning induced by microgravity exposure 
has already been assessed.  
Strict Head-Down Bed Rest (HDBR) can be used to simulate microgravity effects 
on the cardiovascular system. Therefore, it represents an invaluable opportunity to 
study and analyse this phenomenon. 
The aim of this work has been to evaluate the possible effect of blood electrolyte 
changes induced by 21 days of HDBR on the electrical activity of the heart, by 
using a computational model of human ventricular myocyte. 
Simulation results point out a biphasic course of action potential duration, which 
shortened during HDBR and recovered after the end of it, accordingly with RT 
interval measurements from ECG data analysis. 
INTRODUCTION 
It is well known that microgravity affects the cardiovascular system: indeed, 
there are many effects associated with spaceflights, e.g. reduction in plasma 
volume, decrease in left ventricular mass and modifications of the autonomic 
nervous system. Moreover, several episodes of cardiac arrhythmias and conduction 
disorders have been reported during space missions, such as Gemini and Apollo 
[22, 23], and aboard space stations [24, 25].  
However, the specific causes leading to this suggested increased risk of 
arrhythmias have not been entirely understood. To further explore this 
phenomenon, ground-based experiments, such as strict Head Down Bed Rest 
(HDBR), represent a great opportunity to analyse simulated microgravity effects on 
cardiovascular system, by monitoring ECG signal and different physiological 
parameters over time [26]. In this context, computational modeling constitutes a 
useful tool as well: in fact, changes observed experimentally may be tested in silico 
in order to evaluate their possible impact on cardiac electrical activity. 
The aim of this work has been to verify if the blood electrolyte variations 
occurring during 21 days of HDBR can be directly linked to the corresponding 
changes observed in cardiac repolarization phase, by using a computational model 
of human ventricular action potential (AP) and comparing simulation results with 
ECG data analysis, PRE, during and POST bed-rest. 
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METHODS 
Bed-Rest Protocol 
Experimental data were recorded during a mid-term (21 days) strict -6º Head-
Down Bed-Rest (HDBR) campaign held at the German Aerospace Center (DLR, 
Koln, Germany) by the European Space Agency (ESA) from September 2011 to 
April 2012.  
Ten healthy subjects (aged 23-42 years)  were enrolled for this study in a cross-
over design, including a control and a countermeasure (CM) group, with a washout 
period of about 1.5 months between the two HDBR sessions. Subjects in the CM 
group received a daily supplementation of whey protein (0.6 g/kg body weight) and 
potassium bicarbonate (KHCO3, 90 mmol). In this study, our attention will be 
focused on the CM group only. Each subject underwent a comprehensive medical 
examination during the selection process and provided written informed consent to 
participate in this study, approved by the independent ethics committee 
Aerztekammer Nordrhein, Duesseldorf, Germany.  
The volunteers had to stay in bed with their head down, at 6° below the 
horizontal, for all the HDBR session (Figure 4.1). They may not stand up, unless a 
research programme demands it, and must perform all daily activities in bed 
including eating, showers and sometimes specific exercise. In this way, their bodies 
start to adapt as if they were in space, where there is no gravity. 
 
Figure 4.1: During head-down bed-rest studies, volunteers have to stay in bed with their 
head down, at 6° below the horizontal, for all the experiments session (copyright: ESA) 
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Experimental Data Acquisition 
ECG signals have been acquired using a 24-h high resolution (sampling 
frequency: 1000 Hz) 12-lead Holter digital recorder (H12+, Mortara Instrument Inc, 
Milwaukee, WI, USA). Acquisitions were performed 8 days before the beginning of 
the test (PRE), after 5, 16 and 21 days of Head-Down Tilt (HDT5, HDT16 and 
HDT21 respectively) and 4 days after the end (POST). 
The RR values classified as “sinusal rhythm” (H-scribe and SuperECG software, 
Mortara Instrument Inc, Milwaukee, WI, USA) have been considered and the night 
period only (from 23:00 to 6:30) has been taken into account, in order to avoid 
possible noise due to subject daily movement.  
Selective beat averaging technique [26, 27] was used to obtain averages of P-
QRS-T complexes preceded by the same stable heart rate (cycle length from 900 to 
1200 ms, 10 ms RR bins). Repolarization phase has been evaluated considering the 
time distance from the QRS peak and the T-wave end (RT interval). 
Blood samples have been collected 7 days before the beginning of the test 
(PRE), at HDT10 and 5 days after the end (POST). Electrolyte concentrations 
([Na
+
], [K
+
], [Cl
-
] and total [Ca
2+
]) were measured, together with many other 
physiological parameters (e.g. cell volume, glucose, pH, etc.) which will not be 
considered in this study. Since no direct measurement of ionised Ca
2+
 was 
available, we chose to estimated it as half of th total Ca
2+
 concentration. 
A schedule of the considered HDBR epochs and data acquisitions is reported in 
Figure 4.2, showing the three different situations: PRE, HDT and POST.  
PRE and POST data have been compared to the ones acquired during HDBR 
test, i.e. HDT16 for ECG and HDT10 for electrolyte concentrations, since 
measurements have been recorded in different HDT days. Of course, the HDBR 
effects on HDT16 should be much more pronounced than in HDT10: therefore, 
simulation results which are based on electrolyte concentrations may show smaller 
electrophysiological changes, compared to the ones observed in the ECG data.  
Finally, experimental results shown in the next section refer to only 8 subjects 
out of 10, since one participant left during the test and another one had some ECG 
recording problems.  
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Figure 4.2: Time course diagram of the 21 days Head-Down Bed-Rest (HDBR) campaign 
considered in this study. The arrows indicate the epochs in which 24-h Holter acquisition 
and blood analysis have been performed. 
Computational Modeling 
The most recent human ventricular mathematical model (O’Hara-Rudy,  [10]) 
has been used as basis for simulations. However, the original model is not able to 
reproduce properly the effects of extracellular Ca
2+
 variations on action potential 
duration (APD). Therefore, as similarly done in previous works with different 
models [6, 9], specific modifications were needed in order to reproduce the inverse 
relationship between extracellular [Ca
2+
] and APD. The original L-type Ca
2+
 current 
formulation has been replaced by a new Markov model and Ca
2+
-dependent 
inactivation has been strengthened. Other minor changes were need to preserve the 
physiological properties of the whole cell [28]. The modified model has been 
described in the details in the previous Chapter. 
Extracellular electrolyte concentrations were considered in equilibrium with 
blood and used as model inputs to simulate PRE, HDT10 and POST conditions, as 
similarly done in a previous work for haemodialysis patients [8].  
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Single Cell Simulations 
Model differential equations were implemented in Matlab (Mathworks Inc.) and 
solved with a variable order solver (ode15s), based on numerical differentiation 
formulas  [16]. Pacing at 1 Hz was maintained until a steady state AP was reached 
and APD was measured as the interval between AP upstroke and the 90% 
repolarization level (APD90). 
Multicellular simulations 
One dimensional fiber (2 cm length) composed by 100 endo- and 100 epi-cardial 
cells has been considered. Model equations have been translated into cellML 
language using COR environment [29] and monodomain equations have been 
solved with Chaste Software [30, 31], considering an intracellular conductivity of 
0.50 mS/cm.  
Pseudo-ECG signal has been computed as described by Gima-Rudy [32]; RT 
interval has been evaluated considering a slope inferior to 1e-4 V/s as T wave end.  
RESULTS 
Experimental data analysis 
ECG analysis provided evidence of a biphasic trend in repolarization: RT 
interval considerably shortened during bed-rest (HDT16) and then completely 
recovered at POST, reaching values even higher than in PRE for each considered 
RR bin, as shown in Figure 4.3. 
Since computational simulations have been run considering a cycle length of 
1000 ms, we chose to compare simulation results with data from the RR bin 
between 995 and 1005 ms. Here, the RT interval changes were quite relevant, as 
shown in Figure 4.4: -19 ms in HDT16vsPRE and -30 ms POSTvsHDT16 .  
Non parametric Friedman and Wilcoxon tests were applied and significant 
differences (p<0.001) were found for the three considered groups: PRE, HDT16 and 
POST.  
 
76                                                                                                                          Section I – Chapter 4 
Elisa Passini 
 
Figure 4.3: Relationship between RR and RT interval. Wisker-plot represents median and 
25-75th percentiles for each RR bin in PRE, HDT16 and POST conditions. 
 
Figure 4.4: RT intervals for RR bin between 995-1005 ms in PRE, HDT16 and POST 
conditions: the biphasic trend in repolarisation it is quite clear. Data are presented as 
median(25
th
-75
th
). 
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As for electrolyte concentrations, blood Ca
2+
 concentration showed an opposite 
trend compared to RT interval: it increased during HDBR and then recovered at 
POST , as shown in Figure 4.5. Non parametric Wilcoxon test was applied and 
differences resulted significant in HDT10vsPRE and POSTvsHDT10 (p<0.05).  
 
Figure 4.5: Blood Ca
2+
 concentrations in PRE, HDT10 and POST conditions: the biphasic 
trend is opposite to the one found in the RT interval. Data are shown as median(25
th
-75
th
). 
Relevant differences were found in blood K
+
 concentration, even if there was a 
lot of variability from one subject to the other, and sometime K
+ 
variations were in 
an opposite direction. In average, K
+
 increased during HDBR and decreased at the 
end of it, although not completely recovered at POST, as shown in Figure 4.6.  
 
Figure 4.6: Blood Ca
2+
 concentrations in PRE, HDT10 and POST conditions: the biphasic 
trend is opposite to the one found in the RT interval. Data are shown as median(25
th
-75
th
). 
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Changes in [Na
+
] and [Cl
-
] were almost negligible (not shown).  
A summary of experimental data results is reported in Table 4.1, considering 
only the 995-1005 ms bin for the RT interval data.  
Table 4.1: Experimental data in PRE, HDT and POST conditions. Since computational 
simulations have been performed at 1Hz pacing, only the RT interval corresponding to the 
905-1005 ms RR bin are shown. Data are presented as Median(25th-75th). 
 RT interval (ms) % changes 
PRE 362.5(337.0-382.5) - 
HDT16 343.5(335.3-373.3)  -5.24% vs PRE 
POST 373.5(351.5-385.3) +8.73% vs HDT16 
 total [Ca
2+
](mM) % changes 
PRE 2.33(2.28-2.39) - 
HDT10 2.36(2.33-2.44) +1.29% vs PRE 
POST 2.31(2.27-2.35)  -2.12% vs HDT10 
 [K
+
] (mM) % changes 
PRE 4.25(4.08-4.39) - 
HDT10 4.40(4.24-4.59) +3.53% vs PRE 
POST 4.33(4.18-4.46)  -1.59% vs HDT10 
Computational Results 
Single cell simulations were run separately for each of the subjects, setting the 
extracellular electrolyte concentrations equal to the ones measured in PRE, HDT10 
and POST conditions.  
Consistently with RT interval, APD usually decreased during HDBR and 
recovered at POST. Indeed, median variations were relatively small (-1.22% HDT10 
vs PRE, +0.46% POST vs HDT10), but when considering individual subjects with 
larger electrolyte variations, there were many subject in which concurrent changes 
of Ca
2+
 and K
+
 produced a greater effect. However, sometimes APD variations were 
contrasting in different subjects, especially when considering POST vs HDT10. All 
the APD and electrolyte variations are shown in Table 4.2. 
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Subject #3 is the one showing the most relevant changes, both in HDT10 vs PRE 
(APD90 -20 ms) and POST vs HDT10 (APD90 +18 ms). The corresponding AP 
traces are shown in Figure 4.7. 
Table 4.2: Simulation results in terms of APD for each subject during PRE, HDT10 and POST 
conditions, together with the corresponding electrolyte variations. Notable changes are marked in 
bold. 
 HDT10 vs PRE  POST vs HDT10 
Subject Δ [Ca2+]% Δ [K+]% Δ APD90  Δ [Ca
2+
]% Δ [K+]% Δ APD90 
#1 +1.66% +3.87% -3.0 ms 
 
-6.94% +6.70% +2.0 ms 
#2 +0.43% +2.65% -3.2 ms  -0.85% +2.35% -0.7 ms 
#3 +3.64% +38.44% -20.0 ms 
 
-4.30% -15.76% +18.0 ms 
#4 +1.75% +2.00% -4.8 ms 
 
-0.43% - 2.84% +0.8 ms 
#5 +2.67% +3.21% -5.7 ms  -0.43% +0.44% -0.4 ms 
#6 -1.26% +1.77% -4.1 ms 
 
-4.66% -12.58% +10.1 ms 
#7 +5.17% -2.78% -3.2 ms  -0.82% +0.48% -1.5 ms 
#8 +2.20% +2.63% -2.5 ms  -21.98% - 4.88% +14.8 ms 
 
Figure 4.7: Simulated AP traces for subject #3 in PRE, HDT10 and POST conditions. 
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One dimensional simulations have been performed as first considering median 
electrolyte variations only. Pseudo-ECG was computed and the simulated RT 
interval varied in accordance both to single cell APD and measured RT interval (-
1.70% HDT10 vs PRE, +0.75% POST vs HDT10).  
Pseudo-ECG was simulated also for the single subject presenting the higher 
APD variations (#3): here the changes of RT interval were significantly larger (-
12.45% HDT10vsPRE, +5.53% POSTvsHDT10). His pseudo-ECG traces and T 
wave in PRE, HDT10 and POST conditions are shown in Figure 4.8. 
 
Figure 4.8: Pseudo-ECG for subject #3. Repolarization phase varied considerably in the 
three different conditions: simulated RT interval highly decreased during HDBR (-36 ms 
HDT10 vs PRE) and only partially recovered at the end of it (+14 ms POST vs HDT10). 
DISCUSSION AND CONCLUSIONS 
Experimental data acquired from 8 subjects during 21 days of HDBR have been 
presented and analysed, in order to assess the effects of simulated microgravity on 
the cardiovascular system, and possibly clarify the underline mechanisms involved.  
ECG recording  showed a significant decreased of RT interval during HDBR 
with respect to PRE and POST conditions. Blood test provided the extent of 
extracellular electrolytes variations, especially Ca
2+
 and K
+
. 
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A computational model of human ventricular myocyte has been used to simulate 
subject conditions PRE, POST and during HDBR, considering the corresponding 
electrolyte concentrations as inputs. Simulations results showed small but consistent 
changes in APD and simulated RT interval. 
These findings support the hypothesis that electrolyte imbalances occurring 
during HDBR may be linked to the electrical changes observed experimentally.  
However, several additional mechanisms are affected by microgravity. 
Therefore, for a more comprehensive computational analysis, other factors should 
be considered in simulations. 
Limitations and Future Developments 
Simulations have been performed using electrolyte data acquired on HDT10, and 
compared with ECG analysis from HDT16. 24-h Holter and blood samples collected 
at the same day could lead to a more precise comparison. Moreover, ionized Ca
2+
 
concentration has been estimated as half total Ca
2+
, since no direct measurements 
were available.  
A new mid-term HDBR campaign, involving one control and two CM groups, 
has been recently completed by ESA. Experimental data, including ionized Ca
2+
 
concentration, will be available for further investigations in the near future.   
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Abstract 
During haemodialysis (HD) sessions, patients undergo significant alterations in 
the extracellular environment, mostly concerning plasma electrolyte 
concentrations, pH and volume, together with a modification of sympatho-vagal 
balance. All these changes may affect cardiac electrophysiology, possibly leading 
to an increased arrhythmic risk: in particular, intra-dialytic atrial fibrillation 
incidence is really high.  
Computational modelling may help to investigate the impact of HD-related 
changes on atrial electrophysiology, exploring their effects on the action potential 
(AP). However, many human atrial AP models are currently available, each one 
with a peculiar structure and different current formulations. In addition, these 
models have been developed using the standard electrolyte concentrations used for 
experiments. Therefore, they may respond in a different way to the same 
environmental changes.  
After an overview of what has been done using the computational approach to 
investigate the effect of HD therapy on cardiac electrophysiology, the aim of this 
work has been to review the current state of the art in human atrial AP models, with 
respect to their suitability in the HD context.  
All the published human atrial AP models have been considered (Courtemanche 
et al. 1998, Nygren et al. 1998, Maleckar et al. 2009, Koivumaki et al. 2011, Grandi 
et al. 2011, Colman et al. 2013) and tested for extracellular electrolytes and volume 
changes, as well as different acetylcholine concentrations.  
Some models proved to be more appropriate than others when considering a 
single modification, but finally all of them showed some drawbacks. Therefore, 
there could be room for a new AP model, hopefully able to physiologically 
reproduce all the HD-related effects on the human atrial AP.  
At the moment, works are still in progress in this specific field. 
INTRODUCTION 
In the last fifteen years, the increasing interest towards atrial electrophysiology 
and atrial fibrillation (AF), together with a greater availability of experimental data, 
led to remarkable developments in human atrial action potential (AP) models [1–6].  
As a matter of fact, cardiac computational modelling constitutes an efficient tool 
to investigate the ionic mechanisms involved at cell level, and has already been 
used in a variety of clinical contexts, linking patient manifestations to the 
underlying electrophysiological mechanisms, thus providing useful insights into 
different atrial pathologies, including AF, especially whenever experimental 
measurements were lacking or unavailable [6–15]. 
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Haemodialysis (HD) therapy represents a unique model to test in vivo, in human, 
the effects of sudden changes in plasma ionic concentrations and blood volume: in a 
few hours, patients undergo significant plasma electrolytes variations, together with 
a significant decrease in extracellular volume. In particular, the  HD session causes 
removal of excess Na
+
 and water, the extent of which depends on the inter-dialytic 
weight gain of the patient. Plasmatic K
+
 concentration increases during the inter-
dialytic interval, so that during all HD sessions its level must decrease, while Ca
2+
 
variations might change depending on the dialysate Ca
2+
 concentration and its 
relationship with pre-HD plasma Ca
2+
 levels [16, 17].  
These processes often lead to an increased arrhythmic risk for the patient, both 
during HD and in the hours following the therapy. Indeed, the incidence of AF in 
end-stage renal disease patients is high: reported rates vary between 7% and 27% 
[18, 19], and HD session may promote AF onset [20, 21]. 
The aim of this work is as first to briefly review the literature concerning 
applications of the computational approach to the study of the impact of HD therapy 
on cardiac electrophysiology. After that, we compared all the currently available 
human atrial AP models, focusing on their ability to reproduce the 
electrophysiological changes typically induced by HD sessions, i.e. plasma 
electrolytes and blood volume variations.  
The 6 published human atrial models have been considered: Courtemanche [1], 
Nygren [2], Maleckar [3], Koivumaki [4], Grandi [5] and Colman [6]. All models 
have been tested for different concentrations of extracellular electrolytes (Na
+
, Ca
2+
 
and K
+
) and for cell volume changes. A set of AP and Ca
2+
-transient (CaT) 
biomarkers has been considered to compare simulation results, e.g. AP duration 
(APD), resting membrane potential (RMP), effective refractory period (ERP), CaT 
duration (CaTD), etc.  
In addition, since a modification of the sympatho-vagal balance in favour of 
vagal activity may occur during HD sessions in patients showing intra-dialytic AF 
episodes [20], the acetylcholine-activated K
+
 current (IKACh) has been added to all 
models, and the effect of different acetylcholine concentrations has been considered 
as well. 
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CARDIAC CELL MODELLING  
AND HAEMODIALYSIS 
Computational models of cardiac AP have already been applied several times to 
assess the acute effects of HD therapy on cardiomyocyte electrophysiology. 
The first attempt in this context was the computational analysis of the heart rate 
changes during HD [22–24]. Since a reliable model of human sinoatrial node (SAN) 
AP was lacking (as it is still today), these studies were based on a model of rabbit 
SAN AP, considering the DiFrancesco-Noble model [25, 26], as modified by Dokos 
et al. [27]. Simulation results pointed out that changes of blood K
+
, Ca
2+
 and pH 
produce large heart rate variations, showing how electrolyte and pH changes within 
physiological range may have a remarkable impact on the pace-making rhythm, 
independently of the autonomic outflow.  
The computational approach has been also used to analyse how Ca
2+
 and K
+
 
changes during HD can alter ventricular repolarization and therefore AP duration 
[28]. In this work, a model of human ventricular AP was considered [29] and model 
predictions on AP prolongation were validated against a wide range of experimental 
data, i.e. QT interval prolongation recorded during HD sessions. Simulation results 
pointed out how computational modelling of ventricular AP may be useful to 
quantitatively predict the complex dependence of AP duration on simultaneous 
changes in both Ca
2+
 and K
+
. From this study, a model-based clinical indication was 
inferred: Ca
2+
 content in the dialysis bath should be designed in order to prevent a 
critical reduction of serum Ca
2+
, especially in HD sessions with a risk of end-HD 
hypokalaemia.  
The same approach has been applied to atrial electrophysiology: a computational 
model of human atrial AP has been used to confirm that the intra-dialytic reduction 
of plasma K
+
 level is associated with P-wave prolongation [30]. When comparing 
the simulated atrial APs at the beginning and at the end of multiple HD sessions, 
imposing in the model the extracellular electrolyte concentrations and heart rate 
equal to the experimental values measured in vivo, simulation results showed an 
increase in the time needed to depolarise and a reduction of the effective refractory 
period (ERP), both occurring during HD. These two phenomena, in presence of a 
trigger, i.e. repeated premature atrial impulses, frequently induced by a HD session, 
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might form the electrical substrate for intra-dialytic AF episodes onset. Consistent 
results were also obtained when performing the same analysis in a multi-scale 
model of the human atrium and considering a simulated ECG [31]. 
More recently, we applied computational modelling of atrial cellular 
electrophysiology to the individual case of a patient in which HD regularly induced 
paroxysmal AF [20]. Simulation results provided evidence of a slower 
depolarization and a shortened refractory period in pre-AF vs pre-HD conditions, 
and these effects were enhanced when adding acetylcholine effect in simulation. 
Starting from these findings, the possible mechanisms leading to intra-dialytic AF 
onset were reviewed and re-interpreted, as described in the next chapter. Notably, in 
a subsequent study, Buiten et al. [21], using the implantable cardioverter 
defibrillator remote monitoring function, showed that HD is a trigger for AF 
episodes. In particular, they showed that a lower concentration of K
+
 in the dialysis 
bath is associated with a higher probability of AF episodes, as predicted by our 
model-based simulation results. 
It is worth noting that in all these studies, model inputs were set using 
experimentally measured quantities, i.e. plasma electrolyte concentrations and heart 
rate. However, the actual in vivo extracellular fluid is the interstitial fluid, rather 
than the blood. Therefore, it could be questioned whether the plasma electrolyte 
concentrations are a reliable estimate of the interstitial ones, even if this is usually 
accepted. Indeed, the distribution of free ions between vascular and interstitial 
compartments has been reported to agree with Donnan theory, which predicts a 
theoretical ratio between interstitial and plasma concentrations very close to 1 [32].  
ATRIAL CELL MODELLING:  
MATERIALS AND METHODS 
Computational Models of Human Atrial AP  
Starting from the first two human atrial cell models (Courtemanche [1];  Nygren  
[2]), both published in 1998, four more have been released in the last few years 
(Maleckar, 2009 [3]; Koivumaki, 2011 [4]; Grandi, 2011 [5]; Colman 2013  [6]). 
Hereafter, the six models will be referred to using the initial letter of the first and 
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last authors (i.e. CN, NG, MT, KT, GB and CZ respectively). All models consist 
of a set of ordinary differential equations, each one representing a specific dynamic 
process occurring in the cell, and the number of equations is related to their 
complexity: the first models are very simple compared to the most recent ones, 
where a more detailed description of Ca
2+
 handling and cell compartments is 
included (see Table . 1). Moreover, the different parameters and ionic current 
formulations lead to distinct AP morphologies and properties, e.g. AP duration 
(APD), CaT duration (CaTD), etc. 
Since 1998 several papers comparing atrial model performances have been 
published, mainly concerning CN and NG models, which for many years have been 
the only ones available [33–39]. The two most recent reviews [38, 39] compared all 
models except CZ, considering simulations from single cell to whole heart and 
including both physiological and pathological conditions, thus assessing the current 
state of the art in atrial computational modelling. Therefore, the comparison of the 
peculiar properties of these atrial models exceeds the purpose of this work, which 
rather aims to investigate the acute effects of HD therapy on atrial 
electrophysiology.  
The CN and NG models are almost based on the same human atrial data, and 
they share most of the transmembrane ionic current formulations: however, CN is 
developed from the guinea pig ventricular model by Luo and Rudy [40], while NG 
is developed from the atrial rabbit model by Lindblad et al. [41]. The main 
differences between the two models are related to Ca
2+
-handling and the CaT is 
much shorter and with a larger amplitude in NG. As a result, their AP shapes are 
quite different: a spike-and-dome AP for CN, and a more triangular one for NG (see 
Figure 5.1, pink and blue traces).  
The MT and KT models are subsequent extensions of NG: the main changes for 
MT are new formulations for the transient outward (Ito) and ultra-rapid delayed 
rectifier (IKur) currents, while the KT gives a much more detailed description of 
Ca
2+
-handling, especially concerning Ca
2+
 release. The sarcoplasmic reticulum (SR) 
is divided into 4 different compartments, including also a spatial dimension: as a 
result, the CaT is slower compared to the previous model ones, but its duration is 
increased (see Figure 5.2, purple trace). The GB model has been developed from 
the ventricular model published by the same group [42]: most of the ionic current 
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formulations have been preserved and adapted to experimental data acquired in 
human atrial isolated cardiomyocyte. The AP is quite triangular shaped (see Figure 
5.1, green line), and the Ca
2+
 handling is mostly derived from the rabbit ventricular 
model by Shannon et al. [43], again adapted to human atrial data. It is worth noting 
that in this model the intracellular K
+
 concentration is kept constant. 
The CZ model is the most recent one: it is based on CN, from which he inherited 
all the ionic current formulations, except for Ito and IKur, which come from MT. 
Furthermore, the Ca
2+
 handling has been modified using a structure for the SR 
similar to the one used in KT, together with the corresponding formulation for Ca
2+
 
release and pumps. Conductances have been slightly tuned, to preserve consistency 
with the original CN model. 
In addition to the models listed above, a different version of the CN model has 
been considered (from now on referred to as CN*), slightly modified in order to 
improve its long term stability [44, 45]. This CN* model has been recently used to 
investigate the specific case study of a HD patient which presented recurrent intra-
dialytic AF mention above, and described in details in the next chapter [20]. 
Moreover, the KT model has been recently modified by the same authors, 
improving model prediction in chronic AF [14]. The changes involved mostly L-
type Ca
2+
 current (ICaL) formulation and this new version of the model (from now 
on referred to as KT*) has been considered as well.  
Finally, since this study is mainly focused on extracellular electrolyte changes, 
the known dependence on extracellular K
+
 for both the inward and delayed rectifier 
K
+
 currents has been added to the atrial models, when not already included [46–49]. 
Hereafter, each model will be identified by a specific colour (CN/CN*, pink; 
NG, blue; MT, cyan; KT/KT*, purple; GB, green; CZ, red) and simulation results 
for CN and KT will be shown only when a different behaviour with respect to their 
updated versions (CN* and KT*) is found.  
Simulated APs and CaTs for all the considered models are shown in Figure 5.1 
and Figure 5.2 respectively, to allow a quick visual comparison of their main 
properties.  
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Figure 5.1: Simulated AP traces for all the considered atrial models: each panel shows a specific 
model AP with its reference colour; all the other model traces have been added in grey, to facilitate 
the comparison. 
 
Figure 5.2: CaT traces for all the considered atrial models: the notable differences in timing and 
amplitude are related to the corresponding different formulations of Ca2+ release from the SR. 
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AP and CaT shapes are very different in each model. As far as the CaTs are 
concerned, experimental values of diastolic intracellular Ca
2+
 concentration 
reported in literature span from 120 to 230 nM [50–52]: CN, KT, GB and CZ have 
values in this range, whereas NG and MT compute lower diastolic concentrations. 
Measured CaT amplitudes range from 265 to 345 nM [50, 51] and this is best 
reproduced by CZ and KT. GB produces a slightly smaller CaT while CN, NG and 
MT show much higher amplitudes. In addition, the CaT has been reported to decay 
with a time constant of about 200 ms or even slower [51, 53]: such a slow decay is 
well reproduced by GB and CN only, while in all the other models is much faster. 
Model differential equations have been implemented in Matlab (Mathworks Inc.) 
and a variable order solver has been used to solve them (ode 15s [54]). Pacing was 
simulated by a current pulse train (pulses of 3 ms, 1 Hz), maintained for 150 s, in 
order to allow all the models to reach a proper steady state, i.e. intracellular 
concentrations (Na
+
, Ca
2+
 and K
+
) stable over time.  
Stimulus current (IStim) amplitude was set to twice the AP threshold for all 
models, as previously done in [106] (see Table 5.1). When using this stimulus, 
however, the GB model produces an AP quite different from the one published in 
the original GB paper: indeed, some of the biomarkers e.g. AP amplitude and 
upstroke velocity, are highly stimulus-dependent in this model. Therefore, all 
simulations with the GB model have been done using the stimulus amplitude 
needed to preserve the original AP characteristics, which is about 6 times the AP 
threshold and more close as current density to the ones used for the other models.  
A summary of all the considered atrial models is shown in Table 5.1, together 
with some of their main structural properties, i.e. membrane capacitance, 
intracellular volumes and compartmentalisation, amplitude used for the current 
stimulus, the number of state variables (each one represented by an ordinary 
differential equation) and the corresponding publication.   
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Table 5.1: List of the human atrial AP models considered in this study and some of their properties: 
 
CN/CN* NG MT KT/KT* GB CZ 
Cm (pF) 100 50 50 50 110 100 
Cell 
Volumes 
(pL) 
CYTO 
13.67 
5.88 5.88 8.10 21.45 13.67 
SSL 0.12 0.12 - 0.66 - 
JS - - 0.05 0.02 0.10 
SR 1.21 0.44 0.44 0.18 1.16 0.27 
whole cell 20.10 49.42 49.42 13.90 33.01 20.10 
Istim (pA/pF) 15.0 19.6 19.2 18.8 19.5 12.0 
# ODEs 21 29 30 43 62 39 
Ref  [1]  [2]  [3]  [4, 14]  [5]  [6] 
Year 1998 1998 2008 2011 2011 2013 
Cm, membrane capacitance; CYTO, cytosol; SSL, sub-sarcolemmal space; JS, junctional space; 
SR, sarcoplasmic reticulum; Istim, stimulus current amplitude; # ODEs, number of differential 
equations in the model; Ref, reference paper; Year. year in which the model was first published. 
Simulation of the HD-induced effects 
In order to investigate the reliability of each atrial model in reproducing the 
effects of extracellular electrolyte changes possibly occurring during a regular HD 
session, we performed a sensitivity analysis by varying the extracellular 
concentrations ([Na
+
]o, [Ca
2+
]o and [K
+
]o) around the original model values (130-
140 mM, 1.8 mM and 5.4 mM, respectively).  
The explored ranges have been set according to the measured values reported in 
literature for HD patients, extending them to include also possible outliers, as 
described in details in the next Section.   
 At the beginning of the HD session the patient is overhydrated: for this reason, 
2-3 litres (or even more) of water are removed from his blood during the treatment. 
Such a removal is compensated by water refilling from the interstitial fluid and 
eventually from the intracellular compartment. How fluid accumulation during the 
inter-dialytic period and fluid removal during the HD session reflects into variations 
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of intracellular volumes is actually not known in quantitative terms. Therefore, we 
investigate the effects of a quite large range (±20%) of volume changes.  
Finally, to explore the effect of vagal stimulation, we added the acetylcholine-
activated K
+
 current (IKACh) to all the models, according to the formulation used in 
[5], and considering the changes induced by 0-15 nM of acetylcholine (ACh). 
AP and CaT Biomarkers  
In order to compare simulation results from a qualitative point of view, we 
computed a set of AP biomarkers, considering in particular the ones already used in 
previous simulation works either to compare the different atrial AP models [39] or 
to evaluate the effects induced by electrolyte variations on atrial electrophysiology 
[30]: action potential duration (APD) was measured as the interval between the AP 
upstroke and the 90% of repolarization (APD90); resting membrane potential (RMP) 
was measured at the end of diastole; the AP upstroke duration (APud) was defined 
as the time needed by membrane voltage to reach 0 mV, starting from the beginning 
of the pacing pulse [20, 30]; AP amplitude (APamp) was measured as the difference 
between the AP peak and RMP; maximum upstroke velocity (dV/dtMAX) was 
computed as the maximum derivative of membrane voltage over time during the AP 
upstroke; the effective refractory period (ERP) was measured by simulating a S1–S2 
protocol: it has been defined as the longest S1–S2 interval which failed to elicit a S2 
AP of amplitude > 80% of the preceding S1 AP [55].  
A summary of all the considered AP biomarkers is shown in Figure 5.3, 
considering the CN* model AP trace as an example. 
In addition, some Ca
2+
 transient (CaT) biomarkers have been considered as well, 
i.e. CaT duration (CaTD), measured at 90% of CaT decay (CaTD90), the time 
needed to reach the CaT peak, starting from the beginning of the current stimulus 
(CaTttp) and the CaT amplitude (CaTamp). Finally, intracellular concentrations 
([Ca
2+
]i, [Na
+
]i and [K
+
]i) have been monitored in all simulations and the 
corresponding values at the end of diastole have been considered for comparison. 
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Figure 5.3: AP biomarkers considered to compare simulation results: AP duration at 90% of 
repolarization (APD90); resting membrane potential (RMP); AP upstroke duration (APud); AP 
amplitude (APamp); maximum upstroke velocity (dV/dtMAX); effective refractory period (ERP), 
computed using a S1–S2 protocol and considering the longest S1–S2 interval which failed to elicit a S2 
AP of amplitude > 80% of the corresponding S1 AP.  
ATRIAL CELL MODELLING:  
EFFECTS OF HD-RELATED CHANGES 
Potassium Variations 
In all the considered models the extracellular K
+
 concentration ([K
+
]o) is set to 
the standard value used in the perfusion bath during V-clamp experiments, i.e. 5.4 
mM. K
+
 increases during the inter-dialytic interval and is removed during the HD 
session: therefore, HD patients often show hyper-kalaemia at the beginning of the 
therapy and hypo-kalaemia at the end. In order to explore both clinical conditions, 
we considered the range 3-9 mM. The lower [K
+
]o  value (3 mM) has been set 
considering the experimental post-HD measurements available in literature (e.g. 
3.9±0.4 [30], 3.6±0.6 mM [56]). The upper [K
+
]o value (9 mM) is actually a bit high 
compared to the pre-HD measurements available (e.g. 4.9±0.5 mM in [30], 5.3±0.9 
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mM in [56]): we extended the range since there are clinical contexts, such as acute 
ischemia, in which [K
+
]o can locally rise up to 9 mM or more [57]. 
The main effect of a [K
+
]o decrease should be a hyperpolarization of the cell 
membrane, due to a different Nernst potential for K
+
 ions. In addition, a [K
+
]o 
decrease leads to a QT interval increase [28], a macroscopic marker of prolonged 
ventricular APD: therefore, a prolongation of atrial APD is expected as well [58]. 
On the contrary, ERP should decrease [58, 59], since APD and ERP may be 
“uncoupled” when varying [K+]o, as experimentally observed by Downar et al. [60]. 
Finally, while slowed cardiac tissue conductivity is a well-known effect of 
severe hyperkalemia, in the range of [K
+
]o concentrations usually measured in HD 
patients, a positive dependence of conduction velocity on [K
+
]o has been observed: 
this phenomenon is known as supernormal conduction  [61–63]. Consistently, an 
increase in PWd during hemodialysis, significantly correlated to K
+
 decrease, has 
been reported [30]. In a previous simulation study [30] we have shown how both 
hypo- and hyper-kalaemia can cause slowed cardiac tissue conductivity: in hypo-
kalaemia, the RMP is significantly lower (hyperpolarized), and therefore the cell 
needs more time to reach the membrane potential threshold for AP upstroke; in 
hyper-kalaemia, the RMP is significantly higher (depolarized) and, as a 
consequence, Na
+
 current availability is decreased and the current is much smaller 
than usual. In single cell simulations, a slow conduction can be associated to a 
smaller upstroke velocity and to an increase in the time needed for the voltage to 
rise toward the AP peak: APud and dV/dtMAX are then expected to show some kind 
of U-shape dependence when considering the full [K
+
]o range.  
A summary of the AP biomarkers for all the different [K
+
]o is shown in Figure 
5.4. When some models fail to repolarise with low [K
+
]o, the corresponding 
biomarkers have not been computed. 
The models show quite different trends for some of the biomarkers, especially 
APD90 and ERP (Figure 5.4, panel A and B). In NG, MT and KT* (Figure 5.4: blue, 
cyan and purple traces), both the RMP and APD90 behave as expected: however, 
these models fail to repolarise when [K
+
]o is set to low values, exhibiting early after 
depolarisations (EADs, see e.g. Figure 5.5).  
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Figure 5.4: AP biomarkers vs [K+]o for all the considered models. 
Indeed, a decrease in [K
+
]o leads to a reduction in the conductance of the K
+
 
repolarising currents, i.e. IKr and IK1, thus prolonging the APD: in these models this 
effect seems to be over dimensioned, probably due to a low repolarisation reserve, 
and therefore the membrane potential is not able to go back to its resting value. As 
an example, in Figure 5.5 are shown the AP traces corresponding to different [K
+
]o 
levels for the NG model. 
This is indeed a great limitation when aiming to apply these models to clinical 
contexts, since normal plasma K
+
 levels are between 3.5 and 5 mM, and especially 
critical for HD patients because they need to remove the K
+
 accumulated during the 
inter-dialytic period, primarily in the intracellular pool, and therefore they usually 
end the HD session in hypo-kalaemia. 
No significant changes have been observed in these models for dV/dtMAX  and 
APud, while the ERP follows the APD90 as expected. Finally, the APamp is inversely 
related to RMP. 
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Figure 5.5: AP traces corresponding to different [K+]o for the NG model. When decreasing [K
+]o, 
the RMP becomes lower and the APD90 increases, both as expected. However, the model doesn’t 
repolarise for [K+]o values lower than 4 mM. 
As for the GB model (Figure 5.4: green traces), APD90 and RMP are quite 
similar to NG, MT and KT*, but their trends change for low [K
+
]o: the model 
repolarises properly for all [K
+
]o, but when considering values lower than 4mM the 
RMP is higher (more depolarised) than expected: therefore, APD90 and APamp are 
affected accordingly. APud  and dV/dtMAX show the expected U-shape, related to a 
reduced conduction for both low and high [K
+
]o. As for the ERP, in this model it is 
always much longer than the corresponding APD90, even if it shows a similar 
dependence on [K
+
]o. In addition, probably due to the high stimulus amplitude 
needed to stimulate the GB model (as explained in the methods section), the ERP 
could not be computed for most of the [K
+
]o: when considering values below 4 mM 
or above 6 mM, the S2 AP peak was never lower than 80% of the corresponding S1, 
no matter how short the diastolic interval considered.
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As for the CN* and CZ models (Figure 5.4: pink and red lines), they develop a 
proper AP for all [K
+
]o and they both show a very strong linear dependence of RMP 
on [K
+
]o: this dependence, by itself, should prolong the APD when decreasing 
[K
+
]o, since the membrane potential needs more time to repolarize and then 
reaching its resting value.  
However, in these models the AP phase 2 shortens as well, so the overall APD90 
is almost constant, or even decreasing with [K
+
]o, in contrast with the expected 
behaviour; this effect is even more pronounced when considering the ERP. As an 
example, in Figure 5.6 the AP traces corresponding to different [K
+
]o levels for the 
CN* model are shown. 
 
Figure 5.6: AP traces corresponding to different [K+]o for the CN model. When decreasing [K
+]o, 
the RMP becomes lower as expected, but the APD90 is almost constant. 
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In these two models, the APamp is again inversely related to RMP, and both APud 
and dV/dtMAX suggest a reduced conductivity in the [K
+
]o range boundaries, 
especially when considering high [K
+
]o.  
No significant changes were found in CaT biomarkers and intracellular 
concentrations, in any of the considered models (Figure 5.7). 
 
Figure 5.7: CaT biomarkers (left) and diastolic intracellular ionic concentrations (right) vs [K+]o 
for all the considered atrial models. 
Calcium Variations 
In all the models the extracellular Ca
2+
 concentration ([Ca
2+
]o) is set to the 
standard value used in the perfusion bath during V-clamp experiments, i.e. 1.8 mM, 
which is quite high compared to the normal serum Ca
2+
 measured in vivo (1-1.3 
mM), as discussed in detail in [64]. During a regular HD session, depending on the 
dialysis bath concentration, serum Ca
2+
 can either raise or decrease. Two previous 
simulation studies explored the effects of [Ca
2+
]o on cardiac electrophysiology, 
Section II -  Chapter 5                                                                                                                        107 
Computational Modelling of Cardiac Electrophysiology: from Cell to Bedside 
considering the range 1-3 mM  [64, 65]. However, serum Ca
2+
 is lower than 1 mM 
in several patients: reported pre-HD concentrations are e.g. 1.18±0.09 mM in [30] 
and 1.06±0.16 mM in [28]. Therefore, we decided to extend the explored range to 
0.6-3 mM. A summary of the AP biomarkers for the different [Ca
2+
]o is shown in 
Figure 5.8. 
 
Figure 5.8: AP biomarkers vs [Ca2+]o for all the considered models. 
The expected effect of [Ca
2+
]o increase is a significant decrease of APD  [64, 
66]: the increment in driving force enhance the L-type Ca
2+
 current (ICaL) peak, but 
at the same time the Ca
2+
-dependent inactivation mechanism is strengthened, thus 
reducing the overall ICaL and therefore shortening the APD.  
Even if the data showing this inverse relationship between APD and [Ca
2+
]o has 
been recorded in ventricular cells, there are a few recordings confirming that the 
trend is the same for human atrial cells [64].  
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Indeed, CN, NG MT, KT* and CZ models are able to reproduce this effect, 
together with a consistent reduction of ERP (Figure 5.8, panel A and B). Notably, 
the original KT model shows an opposite trend for both APD90 and ERP, fixed in its 
improved version, where precisely the ICaL formulation was changed. On the 
contrary, GB proves to be not very stable to [Ca
2+
]o variations: APD90 and ERP 
show a biphasic trend, both considerably increasing with [Ca
2+
]o from 0.6 to 2.5 
mM, and then decreasing until 3 mM, value in which EADs appear (Figure 5.9).  
RMP, APamp and APud are almost constant in all models (Figure 5.8, panel C, D 
and F). As for dV/dtMAX, only GB, CN and CZ show a slight linear dependence 
with [Ca
2+
]o (Figure 5.8, panel E), related to the increase of ICaL peak, which in 
these models has a greater contribution to the AP phase 0.  
 
Figure 5.9: AP traces corresponding to different [Ca2+]o for the GB model. When increasing 
[Ca2+]o, the APD90 first highly increases and then decreases. For [Ca
2+]o  = 3 mM an EAD appears. 
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As expected [66], diastolic Ca
2+
 increases with [Ca
2+
]o for all the considered 
models (Figure 5.10, panel D), whereas a couple of unexpected observations can be 
made on the CaTs (not shown): CZ seems almost insensitive to [Ca
2+
]o and GB fails 
to produce a significant CaT for [Ca
2+
]o lower than 1 mM, in which CaT becomes 
really slow and almost negligible in amplitude.  
 
Figure 5.10: CaT biomarkers (left) and diastolic intracellular ionic concentrations (right) vs 
[Ca2+]o for all the considered atrial models. 
CaTamp increases with [Ca
2+
]o for all models (Figure 5.10, panel C), in agreement 
with [66], while CaT timing (CaTttp e CaTD90) is not much affected by [Ca
2+
]o  
(Figure 5.10, panel A and B), and neither is [K
+
]i (Figure 5.10, panel F). 
On the contrary, [Na
+
]i is finely tuned by Ca
2+
: the raise of [Ca
2+
]o increases the 
outward Na
+
/Ca
2+
 exchanger current (INCX), but the corresponding increase of 
intracellular Ca
2+
 contrasts this effect. At the same time, the Na
+
/K
+
 pump 
counteracts [Na
+
]i variations, in both ways. As a result, [Na
+
]i concentration is not 
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much sensitive to [Ca
2+
]o in most of the models (Figure 5.10, panel E). However, in 
CN and CZ, the direct effect of [Ca
2+
]o on the INCX plays the major role and as a 
consequence the [Na
+
]i decreases slightly. In GB, instead, [Na
+
]i increases, because 
when [Ca
2+
]o increases the inward INCX is highly strengthened, due to the sub-
sarcolemmal space in which [Ca
2+
]i locally increases considerably.  
Unfortunately, there are no experimental data available in literature on [Na
+
]i, 
INCX or Na
+
/K
+
 pump for different [Ca
2+
]o , either to confirm or deny these findings. 
Sodium and Volume Variations 
In all the considered models the extracellular Na
+
 concentration ([Na
+
]o) is set to 
the standard value used in the perfusion bath during V-clamp experiments, i.e. 130 
mM for CN, GB and CZ, 140 mM for NG, MT and KT, in agreement with the 
normal serum levels of 135-145 mM. Na
+
 variation during a regular HD session are 
usually quite small (e.g. from 139.8±3.4 to 141.6±3.1 in [30], from 129/132 to 
133/135 in [20]) and we explored the 120-150 mM range base on the corresponding 
data available in literature [67, 68]. 
APD90 and ERP slightly increase with [Na
+
]o in all the models except GB, in 
which they both stay constant (Figure 5.11, panel A and B). RMP and APud are 
almost constant for all the models: the first slightly increases with [Na
+
]o and the 
other slightly decreases (Figure 5.11, panel D and F). In NG, MT and KT, dV/dtMAX 
increase with [Na
+
]o, together with AP peak and therefore also APamp (Figure 5.11, 
panel E and C), while they don’t vary in the other models, i.e. CN, CZ and GB. 
No significant differences were found in CaT biomarkers nor intracellular 
concentrations for any of the models, apart from an obvious increase in [Na
+
]i (not 
shown). Finally, it is worth noting that in CZ and CN, [Na
+
]i regularly shows a 
stronger sensitivity to changes in extracellular concentrations.  
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Figure 5.11: AP biomarkers vs [Na+]o for all the considered models. 
Volume effects have been evaluated by scaling the intracellular volumes of 
±20%. The corresponding AP biomarkers variations are all negligible (not shown), 
e.g. KT shows the maximum APD90 change: +22.5 ms on the whole range. The 
CaTs become slightly slower when the volume increases, but notable changes have 
been found only in GB: CaTD90 increases of +104 ms on the whole volume range, 
together with an increase of CaTttp and a reduction of CaTamp (Figure 5.12, panel A, 
B and C). [Ca
2+
]i also increases with volume in GB, while no other significant 
changes occurr in intracellular concentrations (Figure 5.12, panels D, E and F).  
Unfortunately there are not experimental data on the effect of changes in [Na
+
]o 
or volume on cardiac cells to either confirm or deny these findings. 
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Figure 5.12: CaT biomarkers (left) and diastolic intracellular ionic concentrations (right) vs vs 
volume % changes for all the considered models. 
Acetylcholine effects 
To analyse the effect of a possible increase in vagal activity, we simulated the 
effects of acetylcholine in the 0-15 nM range, adding to all models the same IKACh 
formulation used in [5].  
The expected effect of an additional outward K
+
 current is a more hyperpolarized 
RMP, together with a shortening of APD and ERP. This has been confirmed by 
experimental data [69–71] as well as by previous modelling studies [5, 72, 73].  
When considering concentrations higher than 3 nM, all  the considered models 
show a significant decrease of both APD90 and ERP  (Figure 5.13, panel A and B). 
In addition, the RMP is indeed hyperpolarised, especially in NG and MT (Figure 
5.13, panel D). The APud is inversely related to RMP changes (Figure 5.13, panel 
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F), whereas APamp  and dV/dtMAX keep almost constant (Figure 5.13, panel C and 
E): therefore, the overall conductivity is slowed down by ACh.  
In fact, starting from a more hyperpolarized potential and with no significant 
changes in dV/dtMAX, the cell needs more time to reach the threshold for INa 
activation, to produce the upstroke. On the contrary, in GB both APamp and 
dV/dtMAX increase with ACh, mostly due to a larger Na
+
 current for lower RMP, 
thus compensating this effect and limiting the theoretical APud increase and the 
corresponding reduced conductivity.  
Negligible effects were found in CaT biomarkers and intracellular concentrations 
(not shown) when including acethylcoline. 
 
Figure 5.13: AP biomarkers vs ACh concentrations for all the considered models. 
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DISCUSSION AND CONCLUSIONS 
We have briefly pointed out that computational models of cardiac action 
potential (AP) have been successfully applied to investigate HD-related effects on 
the electrophysiology of different cardiac tissues (sinoatrial node, ventricle, atrium) 
often leading to relevant interpretations of macroscopic observations made in 
clinical ECG and/or useful suggestions about HD treatment personalisation.  
However, all these studies have been performed by using cardiac cell models 
that had been developed on the basis of in vitro experimental data, almost always 
acquired using standard Tyrode’s solutions as extracellular fluid. It is obviously 
correct to simulate the electrical activity of cardiac cells by imposing the same 
conditions used in experimental protocols as far as the aim is a comparison with in 
vitro experimental data. On the contrary, it can be incorrect to use the same constant 
concentrations when the ultimate aim of simulations is the analysis of in vivo, and 
therefore dynamical, conditions, such as a HD session. Sometimes, this possible 
cause of discrepancy has been mitigated by few changes to the original models, e.g. 
introduction of the effect of extracellular pH on the Na
+
/K
+
 pump activity in the 
DiFrancesco-Noble model of SAN cell [22], strengthening of the ICaL Ca
2+-
dependent inactivation in the Ten Tusscher model of human ventricular A [28].  
However, a systematic analysis of the applicability of cardiac cell models to 
reproduce the specific conditions occurring during HD or, in general, when the 
extracellular fluid composition changes, is still lacking. In the present paper, we 
addressed this kind of problem by focusing on human atrial cell models and on the 
following “cell environment” changes: extracellular electrolyte concentrations (K+, 
Ca
2+
 and Na
+
), cell volume and acetylcholine.  
We pointed out that several human atrial models are available, with significantly 
different behaviour upon such environment changes. 
Unfortunately, experimental data on human atrial cells induced by extracellular 
concentrations changes are really rare in literature. This makes a stringent 
quantitative comparison between simulations and experimental measurements not 
possible for most of the considered electrophysiological properties.  
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On the other hand, some qualitative behaviour is expected based on the overall 
evaluation of: i) knowledge of physiological mechanisms (e.g. the link between 
membrane resting potential and Nerst K
+
 potential); ii) in vitro data measured in 
different cell types and species (e.g. [50, 64]); iii) in vivo data on macroscopic ECG 
markers known to be related to atrial cellular electrophysiology (e.g. PWd). 
We found a major problem in the NG, MT and KT models: they all fail to 
repolarize and to produce physiological APs when [K
+
]o is lower than 4 mM. This 
makes these models not appropriate to simulate the cardiac impact of HD. Indeed, 
the change in plasma [K
+
]o is one of the more important and quantitatively large 
effects of HD, since K
+
 removal is one of the treatment aims and the end-HD [K
+
]o 
is almost always much lower than 4 mM [30, 56]. Indeed, even in control condition 
([K
+
]o = 5.4 mM), the repolarising K
+
 currents (especially IKr and IKs) of these 
models are quite tiny when compared to the ones of CN* or CZ, who repolarise 
properly up to [K
+
]o = 3 mM (current peaks are about 10 times smaller). In the NG 
paper the authors explicitly say that the IKr conductance has been reduced to fit AP 
data and that this current has been assigned a very low density [2]. Therefore, an 
increase of it may improve the performance of these models for low [K
+
]o.  
The GB model exhibits several shortcomings as well. First of all, although it 
produces a proper AP at all the tested [K
+
]o, it behaves non-physiologically when 
[K
+
]o is lower than 4 mM: the RMP depolarizes instead of hyperpolarize and, as a 
consequence, the APD90 also goes in the opposite way (shortening) and dV/dtMAX 
dramatically decreases. Moreover, the excessive sensitivity to the amplitude of the 
stimulus current makes the computation of the ERP very unstable, leading to too 
long ERP values or no ERP at all. Since also in GB the repolarising K
+
 currents 
(both IKr and IKs) are quite small in amplitude, increasing their magnitude may 
improve the model stability for low [K
+
]o concentrations. Finally, the GB model 
responds poorly to [Ca
2+
]o changes too: the APD90 trend is opposite to what 
observed in human atrial cells [64], i.e. instead of showing an inverse dependence, 
it is increasing with [Ca
2+
]o, even displaying EADs for [Ca
2+
]o equal to 3 mM, and 
the intracellular Ca
2+ 
transient is almost non-existent when [Ca
2+
]o is lower than 1 
mM. Therefore, the GB model turns out to be completely unsuitable to simulate the 
HD conditions.  
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As for the wrong dependency of APD on [Ca
2+
]o a possible solution should 
address a modification of the L-type Ca
2+
 current, increasing the Ca
2+
-dependent 
inactivation with respect to the Voltage-dependent one, in order to reduce the 
overall current for higher Ca
2+
 levels, despite the increase in driving force. Indeed, 
Ca
2+
-dependent inactivation seems to be underestimated in many AP models [64], 
and previous modelling works managed to reproduce the inverse APD-[Ca
2+
]o just 
by strengthening this mechanism [65, 74].  
The CN* model responds properly to [K
+
]o changes, at least from a qualitative 
point of view. It also reproduces well the “uncoupling” between APD and ERP 
variations when [K
+
]o is increased (APD slightly decreases whereas ERP increases): 
this was experimentally reported by Downar et al. [60] when perfusing cardiac cells 
with hyperkalaemic ‘ischemic blood’ and interpreted as a secondary effect to 
changes in resting potential, which is known to affect, in turn, the Na
+
 channels. In 
addition, simulation results for the CN* model predict a decrease in intracellular 
Na
+
 when increasing [Ca
2+
]o: we are not aware of any available experimental data 
to confirm/deny this observation, which could have relevant implications.   
The CZ model exhibits a good stability, with none repolarization failure nor 
EADs occurrence. However, it also has a few discrepancies with respect to the 
expected behaviour:  APD decreases with [K
+
]o , while the opposite should happen 
[28] and CaTamp is insensitive to [Ca
2+
]o while in all the other models it increases 
with it, in agreement with experimental data reported in [66]. 
As for the quantification of cardiac side-effects of HD therapy, overall 
simulation results confirm that changes in [K
+
]o and [Ca
2+
]o are the ones mostly 
affecting cellular electrophysiology [28, 30], whereas [Na
+
]o and volume seem to 
have a minor impact.  
A qualitative summary of the expected variations in [K
+
]o and [Ca
2+
]o during HD 
and of the corresponding biomarker changes is shown in Table 5.2 and Table 5.3 
respectively, comparing experimental/computational data from the literature with 
the simulations results of this study. 
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Table 5.2: Qualitative summary of HD-induced [K+]o variation on selected AP biomarkers: 
[K
+
]o 
RMP APD ERP APud 
 
   
 [28, 60]  [59, 60]  [30, 59] 
CN - + - + 
NG - + + - 
MT - + + - 
KT* - + + - 
GB - + + - 
CZ - - - + 
Table 5.3: Qualitative summary of HD-induced [Ca2+]o variation on selected AP biomarkers and 
intracellular ionic concentrations. Results are shown for a Ca2+ increase, but depending on the 
[Ca2+] concentration in the dialysis bath, a decrease could occur as well, with opposite effects. 
[Ca
2+
]o 
APD ERP CaTamp [Ca
2+
]i [Na
+
]i 
    
? 
 [30, 64–66]  [66] 
CN - - + + - 
NG - - + + = 
MT - - + + = 
KT* - - + + = 
GB + + + + + 
CZ - - = + - 
 
RMP: resting membrane potential; APD: AP duration; ERP: effective refractory period; APud: 
upstroke delay, inversely correlated with conduction velocity; CaTamp: Ca
2+-transient amplitude; 
black arrows: expected increase/decrease during HD, with the corresponding references, 
green/light green: moderate/large biomarker variation in the expected direction;  
red/light red: moderate/large biomarker variation in the opposite direction. 
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Simulation results of acetylcholine effect show a reduction of APD and ERP in 
all the models, together with a more hyperpolarised RMP, in agreement with 
experimental data and previous modelling studies [5, 69–73]. In addition, all the 
models except GB show a reduction in APud, suggesting a slower conductivity, also 
consistent with the increased vulnerability to arrhythmias, such as AF, due to an 
increased vagal activity [20, 70]. However, there are not experimental evidence to 
confirm or deny this results, and a more detailed description of autonomic 
regulation should be considered for future improvements in computational 
modelling of acetylcholine effects.  
Other HD-related effects (e.g. acidosis correction) have not been addressed in 
our analysis and are left to further investigations.  
Finally, it is worth to remember that HD patients are first of all uremic patients: 
this pathological condition (e.g. “uremic intoxication”) can also affect some aspects 
of cardiac cellular electrophysiology and should be incorporated into the models. 
As a relevant example, down-regulation of the Na
+
/K
+
 pump and high levels of 
circulating Na
+
 pump inhibitor, have been reported in uremic patients compared to 
individuals with normal renal function, by several investigators [75–80]. 
In conclusion, computational modelling of human atrial cells constitutes a very 
useful tool to investigate the electrophysiological changes occurring in patients 
undergoing HD therapy. Nevertheless, it is always important to select carefully the 
specific model to use, depending on the particular aspect of interest.  
Currently, CN* seems to be the more suitable human atrial model to analyse 
HD-related effects on atrial electrophysiology, though it is the oldest one and, 
therefore, it has a less detailed description of several cellular mechanisms: this is 
why this model has been chosen for the work presented in the next chapter. 
Therefore, an additional model could be developed, trying to integrate and 
reconcile the knowledge of cellular and sub-cellular processes and their reactions to 
changes in the extracellular environment, taking into account the possible 
suggestions given above.  
In this respect, works are still in progress in this specific field. 
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Recurrent Intradialytic Paroxysmal 
Atrial Fibrillation: Hypotheses on Onset 
Mechanisms Based on Clinical Data 
and Computational Analysis 
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Abstract 
Atrial fibrillation (AF) incidence is high in end-stage renal disease (ESRD) 
patients, and haemodialysis (HD) session may induce paroxysmal AF episodes.  
Structural atrium remodelling is common in ESRD patients, moreover, HD 
session induces rapid plasma electrolytes and blood volume changes, possibly 
favouring arrhythmia onset. Therefore, HD session represents a unique model to 
study in vivo the mechanisms potentially inducing paroxysmal AF episodes.  
Here, we present the case report of a patient in which HD regularly induced 
paroxysmal AF. In four consecutive sessions, heart rate variability analysis showed 
a progressive reduction of low/high frequency ratio before the AF onset, suggesting 
a relative increase in vagal activity. Moreover, all AF episodes were preceded by a 
great increase of supraventricular ectopic beats.  
We applied computational modelling of cardiac cellular electrophysiology to 
these clinical findings, using plasma electrolyte concentrations and heart rate to 
simulate patient conditions at the beginning of HD session (pre-HD) and right 
before the AF onset (pre-AF), in a human atrial action potential model.  
Simulation results provided evidence of a slower depolarization and a shortened 
refractory period in pre-AF vs. pre-HD, and these effects were enhanced when 
adding acetylcholine effect.  
Paroxysmal AF episodes are induced by the presence of a trigger that acts upon 
a favourable substrate on the background of autonomic nervous system changes 
and in the described case report all these three elements were present. Starting 
from these findings, here we review the possible mechanisms leading to 
intradialytic AF onset. 
INTRODUCTION 
The prevalence of atrial fibrillation (AF) in patients with end-stage renal disease 
(ESRD) undergoing haemodialysis (HD) treatment is high. A recent review by 
Zimmerman reported a mean prevalence of this type of arrhythmia of 11.6%, even 
if within a wide range (5.4–27%) [18], presumably due to the different 
methodologies of the studies taken into consideration. Data from the United States 
Renal Data System have shown an important increase in AF prevalence (from 3.5% 
in 1992 to 10.7% in 2006) in HD patients [19]. Many of the risk factors that are 
associated with AF are the same as those observed in people without ESRD, such as 
age, the presence of hypertension, heart failure, ischaemic heart disease, and 
cerebrovascular disease [81]. Moreover, there are some arrhythmic risk factors 
specific to HD patients, like sudden changes in blood volume and electrolytes 
plasma level due to the HD session. Like in all other patients the presence of AF is 
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associated with an increased mortality in patients on HD treatment as well [82]. 
Episodes of AF induced by HD sessions are phenomena that have not been studied 
very extensively so far, but are well-known by nephrologists: often they concern 
episodes of paroxysmal AF which resolve spontaneously. Quite frequently these 
episodes are interrupted by pharmacological interventions or electrical 
cardioversion, when they cause any haemodynamic instability that does not allow 
the completion of the HD session or when it is not possible to keep the patient in the 
dialysis unit until spontaneous resolution of the episode. On the other hand, many of 
the asymptomatic episodes are probably not recognized as AF. Starting from the 
study of a representative case report and its clinical and computational analysis, this 
review aims to define the mechanisms that may cause episodes of intradialytic AF. 
In fact, AF episodes triggered by the session in HD patients, offer us a unique 
occasion to study the characteristics of paroxysmal AF onset: an occasion that 
cannot easily be found in other patients, whose AF episodes are much less 
predictable and assessable. 
CASE REPORT 
Four consecutive HD sessions were analysed in a 73-year-old woman with 
ESRD, in which HD regularly induced AF episodes that disappeared spontaneously 
shortly after the end of the HD session. Informed consent was obtained from the 
patient for the study. 
Intradialytic Parameters 
In all HD sessions, body weight loss, systolic, and diastolic arterial pressure 
were monitored hourly. Plasma Na
+
, K
+
, and Ca
2+
 concentrations were measured at 
the start and at the end of the treatment in Sessions #1 and #2, and hour by hour in 
Sessions #3 and #4, used for computational analysis. 
Electrocardiogram Analysis 
A 24 h ECG was recorded from the start of each HD session. All recordings 
were obtained using a three-channel Holter recorder, (Sorin Group Company). The 
AF onset time was identified. Arrhythmias were examined during the whole 
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recording time and expressed as the number of supraventricular ectopic beats 
(SVEBs), couples, or runs (more than three consecutive ectopic beats). The mean of 
SVEBs during the 30 min period before AF onset was compared with the mean of 
all other 30 min periods of registration. A signal-averaged P-wave recording was 
done before and after an HD session in which AF episodes were not observed. P-
wave duration (Pwd) was analysed by using a dedicated software derived from the 
work by Stafford et al.  [83] (Sorin Group Company). 
Heart Rate Variability 
Spectral components of heart rate variability (HRV) were calculated by fast 
Fourier transform over 256 s (1024 sampling points) epochs. The power spectral 
components recommended by the Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology [84] 
were calculated: (i) very low frequency (VLF) from 0.00 to 0.04 Hz, (ii) low 
frequency (LF) from 0.04 to 0.15 Hz, (iii) high frequency (HF) from 0.15 to 0.4 Hz. 
The total spectral power corresponds to the power of the whole spectrum from 0 to 
1 Hz. Very low frequency, LF, and HF power components were normalized 
(normalized units) for total power and the LF/HF ratio was considered.  
Statistical Analysis 
The differences between the recorded variables during the pre-HD and the pre-
AF phases were analysed by using Student’s t-test and analysis of variance for 
repeated measures followed by Fisher’s test.  
Results 
Figure 4.1 shows the Holter ECG recordings during the four studied HD 
sessions. In all sessions, the arrhythmia developed between the second and the third 
hour of treatment. The episodes always resolved spontaneously within 2 h from the 
end of the HD session. The intradialytic plasma electrolyte changes (beginning vs. 
end HD) were comparable during the studied sessions. In particular, a significant 
reduction of plasma K+ (from 4.5±0.3 to 3.7±0.1 mM, p<0.05) and an increase of 
plasma Ca2+ (from 1.08±0.1 to 1.29±0.1 mM, p<0.01) concentrations were 
observed. 
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Figure 6.1: ECG Holter recordings during four consecutive HD sessions. Each session started at 8.00 
a.m. and ended at 12.00 p.m. (white line): the patient regularly showed paroxysmal AF episodes, 
triggered during the session and spontaneously terminated at its end. Supraventricular ectopic beats 
(SVEBs) occurrence is shown in the lower section of each panel: single ectopic beats (yellow), 
couples (green), and runs (red) significantly increased in the minutes preceding AF onset. 
During the HD sessions, the weight loss was 2.58±0.40 kg. Spectral analysis of 
HRV at 30, 20, and 10 min before the AF onset showed a progressive reduction of 
LF (from 36.5±14.0 to 26.7±11.2 to 21.3±11.0 nu, p<0.01) with a consequent 
decrease in the LF/HF ratio (from 0.79±0.5 to 0.51±0.3 to 0.39±0.2, p<0.05), 
suggesting a relative increase in vagal compared with sympathetic activity. 
All AF episodes were preceded by an increase of supraventricular ectopic beats 
SVEBs: single (from 4.1±4.8 to 160.5±97.5/30 min), couples (from 0.2±0.2 to 
46.0±28.4/30 min) and runs (from 0.2±0.1 to 43.0±23.7/30 min) as compared with 
the remaining observation period (p<0.05). The duration of the signal-averaged P-
wave, recorded in the same patient during a previous HD session in which no AF 
occurred, increased from 171 ms before the treatment to 185 ms at the end. 
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COMPUTATIONAL ANALYSIS 
Methods 
The Courtemanche model [1] of human atrial action potential (AP) provided the 
basis for simulations. It is not the most recent human atrial model, but it is the one 
best suited to reproduce the low [Ca
2+
]o and [K
+
]o levels occurring during HD [64]. 
We modified the original model by including the known dependency of IK1 and IKr 
currents on [K
+
]o [28], and improving its long-term stability [45], as already 
described in Chapter 5. Moreover, we added the IKACh current, sensible to 
acetylcholine (ACh) concentration, as recently done by Grandi et al.  [5]. These 
have been the only changes to the Courtemanche formulation. Model differential 
equations were implemented in Matlab (Mathworks Inc.) and a variable order 
solver, based on the numerical differentiation formulas, was used to solve them 
(ode 15s) [54]. Pacing was simulated by a current pulse train (pulses of 3 ms, 1 Hz) 
with amplitude about twice the AP threshold: the stimulus was maintained for 300 
s, to reach steady-state condition, i.e. intracellular concentrations (Na
+
, Ca
2+
 and 
K
+
) stable over time. 
We simulated patient’s conditions at the beginning of the HD session (pre-HD) 
and right before the AF onset (pre-AF), by imposing the extracellular electrolyte 
concentrations and average heart rate, as measured in vivo. Two consecutive HD 
sessions (#3 and #4) were considered: electrolyte concentrations hour by hour were 
measured and the value assigned to the pre-AF condition was interpolated in 
correspondence with AF onset.  
Different biomarkers have been considered to quantitatively compare simulation 
results: action potential duration (APD) was measured as the interval between the 
AP upstroke and the 90% repolarization level; resting membrane potential was 
measured at the end of diastole; the AP upstroke duration (APud) was quantified as 
the time needed by membrane voltage to reach 0 mV, starting from the beginning of 
the pacing pulse [30]; the effective refractory period (ERP) was computed by 
simulating a S1–S2 protocol, with S1 and S2 pulses of equal magnitude delivered at 
various rates: ERP was then defined as the longest S1–S2 interval which failed to 
elicit an S2 AP of amplitude <80% of the preceding S1 AP [55].  
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Results 
Representative traces of simulated atrial APs at the beginning of one HD session 
and right before the AF onset, including also the ACh effect, are shown in Figure 
6.2A. For the two considered sessions (#3 and #4), we simulated three different 
conditions: pre-HD, beginning of the HD session; pre-AF, just before the AF onset; 
pre-AF+ACh, just before the AF onset, including acetylcholine effect.  
 
 
Figure 6.2: Simulated APs for the HD Session #3 (A). The changes in extracellular electrolytes and 
heart rate leading to AF onset determine a more hyperpolarized resting potential which in turn 
causes an increase of AP upstroke duration (B). The presence of ACh enhances these effects and 
also reduces the APD considerably. Atrial myocyte response to S1–S2 protocol, considering a 300 ms 
S1–S2 interval (C). The peak elicited by S2 stimulus in pre-HD conditions is remarkably smaller 
(,80%) than the one elicited by S1 (D). This difference becomes less pronounced when considering 
pre-AF conditions and more so after adding ACh, suggesting that the ERP decreases accordingly. 
These differences are mostly due to the greater availability of sodium current at the more negative 
potential reached in the pre-AF conditions (E). 
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The corresponding cycle length, extracellular ion concentrations, and ACh 
concentration (model inputs) have been listed in Table 1, together with all the 
computed indices already defined in the Methods Section, which have been used to 
quantitatively estimate the differences between pre-HD and pre-AF conditions 
(model outputs).  
Table 6.1: Case report computational analysis, simulation data and results 
  
HD Session #3 
 
HD Session #4 
  
pre-HD pre-AF pre-AF+ACh 
 
pre-HD pre-AF pre-AF+ACh 
Model inputs 
        
[Na
+
]o (mM) 
 
132 135 135 
 
129 133 133 
[K
+
]o (mM) 
 
4.6 3.5 3.5 
 
4.6 3.8 3.8 
[Ca
2+
]o (mM) 
 
1.04 1.23 1.23 
 
0.99 1.17 1.17 
CL (ms) 
 
1132 1124 1124 
 
1132 1071 1071 
ACh (nM) 
 
- - 5 
 
- - 5 
Model outputs 
        
APD (ms) 
 
302 306 269 
 
301 304 271 
RMP (mV) 
 
-85 -91 -92 
 
-85 -89 -90 
APud (ms) 
 
3.30 3.80 3.84 
 
3.32 3.64 3.69 
ERP (ms) 
 
308 294 254 
 
307 291 261 
pre-HD, beginning of the HD session; pre-AF, just before the AF onset; pre-AF+ACh, just before 
the AF onset, including acetylcholine effect; CL, cycle length (mean value computed on the last 30 
sinusal beats before the AF onset); ACh, simulated acetylcholine concentration; APD, action 
potential duration at 90% of repolarisation; RMP, resting membrane potential; APud, AP upstroke 
duration; ERP, effective refractory period. 
K
+
 removal during HD induced membrane hyperpolarization, especially in 
Session #3 where [K
+
]o reduction was more pronounced. APud significantly raised 
(15% and 10%, Sessions #3 and #4, respectively), since more time was needed for 
the cell to reach the threshold, starting from a hyperpolarized resting condition 
(Figure 6.2B). Effective refractory period shortening was also significant (-4.55% 
and -5.21%), while APD kept almost constant; in fact, [K]o decrease may have two 
uncoupled effects on APD and ERP [60]. 
As an example, in Figure 6.2C, the APs obtained from a S1–S2 interval of 300 ms 
are shown (Session #3). Since the ERP in pre-HD condition is just above 300 ms, 
the S2 stimulus falls within the refractory period and therefore the elicited peak 
128                                                                                                                        Section II – Chapter 6 
Elisa Passini 
results considerably smaller (<80%) with respect to the S1 one. In the pre-AF 
condition instead, the ERP being shorter, the S2 peak is higher (Figure 6.2D); this 
difference is probably due to a greater availability of sodium current at the more 
negative potential reached in the pre-AF conditions (-69 pA/pF vs. -35 pA/pF, pre-
AF vs. pre-HD, Figure 6.2E). 
When considering both the pre-AF condition and ACh 5 nM, all the effects 
described above are enhanced (Table 1, pre-AF+ACh): ERP decreased considerably 
further (-17.53% and -14.98%, Sessions #3 and #4, pre-AF + ACh with respect to 
pre-HD). Moreover, a significant reduction of APD occurs (-10.64% and -9.93%). 
INSIGHTS INTO THE MECHANISMS OF 
INTRADIALYTIC ATRIAL FIBRILLATION  
Cardiac Morphology in Patients on Haemodialysis Treatment 
Patients with ESRD undergoing HD treatment show deteriorated cardiac 
morphology defined as ‘uraemic cardiomyopathy’, characterized by the presence of 
fibrosis and changes in the microcirculation [85]. Both studies based on animal 
models of renal failure and autopsy of uraemic patients have shown the presence of 
reactive fibrosis (i.e. not due to tissue necrosis), which causes an increase in cardiac 
mass and a reduction in the volume of the capillary circulation within the 
myocardium [86]. The process of fibrosis formation develops early at the onset of 
renal failure [87], is associated with the HD duration, and appears to be independent 
of the contemporaneous presence of hypertension and/or diabetes mellitus [88].  
It has been demonstrated that there are some mediators of cardiac fibrosis that 
are triggered by uraemia and do not depend on both cardiac pre-load and post-load 
changes. Among these mediators the ones most extensively studied are oxidative 
uraemic toxins, parathyroid hormone, hyperphosphataemia, and the renin–
angiotensin–aldosterone system. Each of these factors act by means of specific and 
complex pathways that may be related with one another [89]. 
Left atrial volume, as measured by echocardiography, has recently emerged as a 
predictor of death and cardiovascular events in HD patients [90, 91] beyond left 
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ventricular mass and systolic function. It has also been shown that increased atrial 
dimensions are associated with increased AF prevalence in ESRD patients [81, 92]. 
Electrolyte and volume changes during the haemodialysis session  
Just before undergoing HD session, patients show extracellular volume 
expansion, and Na
+
 and K
+
 overload, associated with metabolic acidosis. Plasmatic 
Ca
2+
 concentration, however, varies among patients. Haemodialysis treatment 
achieves a correction of the electrolyte and volume alterations through mechanisms 
of diffusion and/or convection, which allow the removal of electrolytes and toxins 
from the blood as well as elimination of liquids.  
The main purpose of therapeutic intervention by HD is restoring the right blood 
volume by elimination of the excess Na
+
 and water, that has been accumulated by 
the patient during the interdialytic interval. The level of ultrafiltration is constantly 
adjusted to reach the patients’ ideal dry weight at the end of the HD session. 
Plasmatic K
+
 concentrations increases during the interdialytic interval, mainly due 
to ions leakage from the cells as compensatory mechanism for the metabolic 
acidosis. The nephrologist’s clinical concern is to obtain a level of intradialytic K+ 
removal sufficient to avoid the development of hyperkalaemia before the next HD 
session. Patients receive a certain amount of bicarbonates from the dialysis bath, 
which is useful in the correction of the uraemia-induced metabolic acidosis.  
In conclusion, the HD scheme entails a nonphysiological condition due to the 
intermittent character of the treatment and correction of the uraemia-induced 
alterations. One single HD session causes removal of excess Na
+
 and water, sudden 
changes in potassium levels (often associated with an increase in calcium levels), 
and a complete or even excessive correction of the metabolic acidosis [93]. All 
these processes have important consequences on cardiovascular stability and 
determine the arrhythmogenic effects of HD sessions.  
P-wave and the haemodialysis session 
Several investigators have studied the modifications in atrial depolarization 
during the HD session, examining changes of the P-wave on the surface ECG. The 
studies present a few methodological differences, as some of them are based on 12-
lead ECG registrations and others on high frequency electrocardiography recordings 
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[signal-averaged ECG (SAECG)] [83, 94]. P-wave duration is considered an 
expression of intra-atrial conduction velocity and its prolongation (particularly 
when shown by SAECG) has been associated with a higher incidence of AF, both 
paroxysmal and persistent, AF episodes after cardiac surgery and acute myocardial 
infarction, and AF recurrences after electrical cardioversion [95–99].  
Other authors focus their attention on P-wave dispersion instead, another ECG 
parameter considered to be a possible predictor of AF [100]. The results of 
investigations on Pwd changes HD-related are not univocal. Several studies, 
performed both with 12-lead ECG [101, 102] and with SAECG [30, 103] show a 
significant increase in Pwd at the end of the HD session, whereas others describe no 
Pwd change or even a reduction [104, 105]. Two studies suggest that HD induces 
an increase in Pwd only during the HD session itself and that P-wave return to basal 
levels as soon as the patient is disconnected from the dialysis machine [106, 107]. 
As far as P wave dispersion is concerned, there is general agreement on its increase 
during the post-HD period, compared with the pre-HD one [101, 102].  
There is difference of opinion on the variables that are associated with HD-
related Pwd modifications. When looking at the electrolytes, it seems that K
+
 is the 
ion that is most tightly correlated with Pwd and its changes during the HD session. 
An association between Pwd and plasma K
+
 levels at start [106] and end [102] of 
HD session has been described. Moreover, an inverse correlation between intra-HD 
plasmatic potassium changes and P-wave modifications was found [30, 103]. Other 
studies, however, did not find any relationship between levels or changes of K
+
 
plasma values and Pwd [104, 105, 107]. Any possible associations between P-wave 
and other haematochemical variables (plasma concentrations of Ca
2+
, magnesium, 
phosphate, bicarbonate, and haemoglobin) have been shown by data in literature to 
be weak or absent.  
Several authors have tried to reveal a relationship between the amount of liquids 
removed during the HD session (i.e. the level of ultrafiltration) and the intradialytic 
modifications in Pwd. Madias [108, 109] suggests that the phenomenon of 
intradialytic Pwd prolongation is mediated by the alleviation of the fluid overload. 
This hypothesis was confirmed both by Ozben and Shimada, who found that the 
rate of removal of body fluid was an independent predictor of Pwd prolongation 
during HD [106, 107]. Other authors anyway did not find any significant correlation 
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between levels of intradialytic ultrafiltration and Pwd changes [30, 105]. A 
significant correlation has also been shown between left atrial diameter dimension 
and Pwd [30, 103], indicating an influence of atrial dimensions on the conduction 
velocity of the electrical stimuli across the cardiac chamber. Finally, a significant 
prolongation of basal Pwd in HD patients compared with a group of subjects with 
normal renal function has been reported [103, 104], while pre-HD Pwd was not 
higher in patients with ESRD compared with the control group in the study 
performed by Severi et al. [30]. It should be noted, however, that in the latter study 
the ESRD subjects had been on HD therapy for less than 6 months, whereas in the 
other studies this period was longer.  
As a matter of fact the duration of HD therapy has been associated with an 
increase in Pwd by several authors [103, 104, 107]. In a prospective study, in which 
patients were followed from the start of renal replacement therapy, pre-HD Pwd 
was already significantly increased after 1 year of treatment [110]. These data 
suggest a role for renal replacement therapy per se in inducing an increase in the 
intra-atrial conduction velocity in patients with ESRD. 
Autonomous nervous system and the haemodialysis session  
As discussed before, each HD session causes a reduction in intravascular 
volume, which may vary depending on the dialysis technique used and the level of 
ultrafiltration defined, according to patient’s needs. As a consequence, the HD 
session may become a stimulus for the low-pressure baroreceptors, localized in the 
large veins, in the pulmonary vessels, and in the right atrial and ventricular walls, 
which could induce an activation of the sympathetic output, resulting in an 
increased heart rate [111]. While several patients show this kind of response, other 
patterns of response have been described as well.  
The HD session may in fact be associated with phenomena such as hypotension 
and bradycardia in a considerable proportion of cases [112] and with a reduction of 
the LF and an increase of theHF component in the spectral analysis of heart rate 
[113]. A reduction in heart rate has been described even in the absence of 
intradialytic hypotensive episodes [114–116]. Furthermore, hypotensive-prone 
patients show a reduction in the LF/HF ratio HD-related, even during the sessions 
in which their haemodynamic profile is relatively stable [117, 118].  
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These observations may suggest that, at least in a certain proportion of patients, 
the HD session is accompanied by a stimulation of the parasympathetic rather than 
the sympathetic autonomic nervous system or by a displacement of the sympatho-
vagal balance in favour of vagal activity. It seems that this was the case in our 
patient, in whom the LF component of HRV progressively diminished during the 
phases preceding the arrhythmic episodes, with a consequent reduction in the 
LF/HF ratio. Even if this concept has been challenged [119, 120], LF/HF ratio is 
widely accepted as a measure of cardiac sympatho-vagal balance [121, 122]. The 
HF peak is generally considered to reflect cardiac parasympathetic nerve activity, 
while the LF should be mostly due to the sympathetic component.  
The reasons why vagal stimulation should occur during HD are not clear, but a 
mechanism such as the activation of a Bezold–Jarisch reflex in response to blood 
volume reduction could be hypothesized. The Bezold–Jarisch reflex originates in 
cardiac sensory receptors with non-myelinated vagal afferent pathways, principally 
located in the left ventricle wall. Stimulation of these inhibitory cardiac receptors 
increases parasympathetic activity and inhibits sympathetic activity. These  effects 
promote reflex bradycardia, vasodilation, and hypotension and this reflex can arise 
from the underfilled left ventricle when the intracardiac volume decreases [123].  
It has been described how HD has an arrhythmogenic effect. The majority of the 
studies available in literature deal with the association between HD sessions and 
ventricular arrhythmias [17, 124–126]. However, there are other works that 
demonstrate an increase in the frequency of HD-related premature supraventricular 
beats [17, 125]. In our case report, the number of premature supraventricular 
impulses increased dramatically during the phases immediately preceding AF onset. 
It is known that an increase in premature atrial impulses is present before 
paroxysmal AF episodes, and this increase may have a role in triggering such 
episodes. The role of the autonomous nervous systemand of the vagal stimulation, 
in particular, in the induction of AF in subjects without ESRD is well known.  
The situation observed in our clinical case is probably not infrequent in HD 
patients: the HD session represents a unique model to test in vivo, in human, the 
acute effects of changes in plasma concentrations, and blood volume. It has been 
known since a long time that stimulation of the encephalic trunk shortens atrial 
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refractoriness in a non-homogeneous way and that it causes the appearance of atrial 
ectopic beats, both isolated and runs, which may easily induce AF onsets [127].  
More recently, the existence of an ‘intrinsic’ autonomous nervous system of the 
heart has been taken into consideration, made up of large vessel receptors and 
above all of the ganglionated plexi (GP) on the epicardial surface of the atria, near 
the pulmonary vein ostia [128, 129]. The role of these structures is crucial in the 
induction of many forms of ‘vagal’ paroxysmal AF and maybe of the forms of AF 
that are caused by HD as well. Stimulation of the GP, both pharmacologically with 
mediators such as ACh and electrically, causes the appearance of focal firing from 
the adjacent pulmonary veins [130–136]. GP stimulation also reduces refractoriness 
of the atrial cells, thereby rendering AF more easily inducible by premature ectopic 
beats [137]. The importance of this mechanism, mediated by vagal stimulation of 
the GP, in causing the onset of AF is confirmed by the fact that transcatheter 
ablation of the pulmonary veins with electrical isolation turns out to be more 
effective in suppressing arrhythmias if associated with GP ablation [137, 138].  
Administration of drugs that block vagal stimulation has also been shown to 
suppress firing from the pulmonary veins [139], and to inhibit the appearance of 
those AFs that are related to stimulation of the ‘intrinsic’ autonomous nervous 
system [140]. On the contrary, in this type of vagal-mediated AF, traditional class 
Ic or III antiarrhythmic agents prove to be ineffective. Instead, these molecules have 
been shown to be effective in preventing the onset of arrhythmia in models of AF 
induced by repeated atrial stimulations, which allow longer periods of arrhythmia 
and provoke electrophysiological changes that determine an electrical remodelling 
of the atrial substrate [141].  
In conclusion, there are many similarities between ‘vagal’ paroxysmal AF, very 
frequently seen in those forms which show no structural heart disease or only 
‘minor’ anatomical changes, and the kind of AF provoked by HD sessions; in both 
cases, the presence of vagal stimulation probably induces a reduction in 
refractoriness and an increase in SVEBs, which act as triggers in the arrhythmia 
onset [142]. The phenomenon seems to set in according to a probabilistic 
mechanism: the more supraventricular premature impulses increase and atrial 
refractoriness decreases, the higher becomes the chance of triggering an AF 
episode. 
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DISCUSSION AND CONCLUSIONS 
The onset of paroxysmal AF episodes is induced by the presence of a trigger that 
acts upon a favourable substrate on the background of autonomic nervous system 
changes. In the described case report, all these three elements were present (Figure 
6.3). In fact, the HD session was associated with (i) an increase in SVEBs right  
before the AF onset, (ii) an increase in Pwd, indicating a reduction of intra-atrial 
conduction velocity, (iii) changes in extracellular electrolyte concentrations, i.e. 
increase of Ca
2+
 and decrease of K
+
, and (iv) a reduction of the LF/HF ratio derived 
from the spectral analysis of RR variability, suggesting an increase in the vagal 
component of the autonomic balance. 
 The human atrial AP model used to simulate patient’s conditions showed a 
slower depolarization phase before the AF onset, suggesting a reduction of intra-
atrial conduction velocity, together with a decrease of the ERP. These phenomena 
were enhanced when adding the activity of KACh-dependent channels to the model.  
 
Figure 6.3: Schematic diagram of the mechanisms involved in atrial onset during HD sessions. AF, 
atrial fibrillation; HD, haemodialysis; CV, conduction velocity; ERP, effective refractory period; 
Pwd, P-wave duration; SVEBs, supraventricular ectopic beats; LF/HF, low frequency/high 
frequency ratio. 
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By considering all the elements described above and relating them to data from 
the literature, we can hypothesize that intradialytic AF episodes may constitute a 
kind of ‘in vivo’ model of the vagal-induced paroxysmal forms of AF. As this 
phenomenon is not seen in all patients during HD, we must conclude that the HD 
session acts as a triggering factor only in those subjects whose anatomical 
predisposition and characteristics of sympatho-vagal balance may favour the onset 
of arrhythmia. 
If our hypothesis on the mechanism of arrhythmia triggering is correct, it would 
be possible that prevalence and incidence of AF in HD patients are higher than 
described in literature, particularly in asymptomatic patients whose arrhythmic 
episodes might go unnoticed by the medical staff. It is difficult to find a way to 
reduce the phenomenon. The demonstration that the slowing down of the intra-atrial 
conduction velocity induced by HD is inversely proportional to the extent of 
changes in plasma potassium level [30] would suggest to contain the intradialytic 
shifts of this ion as much as possible, by changing potassium concentrations in the 
dialysate and by trying to reduce pre-HD blood potassium level through diet and 
use of resins. It is even more complicated to find tools to oppose any possible 
increases in vagal tone related to the HD session. Theoretically, in patients suffering 
from AF episodes with the characteristics described above, transcatheter electrical 
isolation of the pulmonary veins could be useful, either with or without ablation of 
the GP. Anyway, before carrying out such a procedure, which undoubtedly affects 
the pathophysiological mechanism of these forms of AF, its clinical risks and 
benefits should be evaluated.  
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Abstract 
Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterised by 
unexplained thickening of the left ventricle, including the septum, and myofibre 
disarray, and is the main cause of sudden cardiac death in young athletes. Usually 
asymptomatic, it leads to diastolic dysfunction and increased arrhythmic risk. 
However, due to the limited understanding of the cellular mechanisms 
underlying the disease, the causes are still unclear and a specific pharmacological 
treatment is lacking. Potential pro-arrhythmic mechanisms may include increased 
temporal and spatial variability in action potential duration (APD) as well as 
repolarisation abnormalities, such as early after-depolarisations (EADs). 
Recently, new experimental data assessed the electrophysiological profile of 
human HCM, compared with control (CTRL): diseased cardiomyocytes are 
characterised by prolonged action potential (AP) and Ca
2+
-transient (CaT), mostly 
related to an increase of Late Na
+
 current (INaL) and L-type Ca
2+
 current (ICaL), 
together with a decrease of K
+
 repolarising currents, and also changes in the Ca
2+
 
subsystem, i.e. decrease in SERCA pump Ca
2+
 uptake (Jup) and ryanodine receptors 
Ca
2+
 release (Jrel), and increase of Na
+
/Ca
+
 exchanger current (INCX). 
The aim of this study has been to investigate the ionic mechanisms underlying 
the electrical remodelling occurring in HCM, in order to identify potential 
therapeutic targets, by using a new computational method: population of models. 
Compared to traditional modelling techniques, in which a single AP model is 
used to reproduce the average cellular behaviour, the population of models 
approach accounts for inter- and intra- subjects variability. Therefore, it is 
particularly appropriate to study HCM, since biological variability seems to play 
an important role in this disease. 
Based on this experimental dataset, we constructed two populations of human 
cardiac AP models, to reproduce CTRL and HCM phenotypes respectively, and to 
account for biological variability.  
We investigated in silico the contribution of each ionic mechanism to the 
electrophysiological phenotype of the disease, by evaluating AP and CaT 
biomarkers, when adding/restoring each remodelling elements, one at a time, 
starting respectively from the CTRL/HCM population. 
The simulated HCM phenotype was in agreement with the experimental 
observations, showing prolonged AP and CaT compared to CTRL, together with an 
increase in their variability. In addition, simulation results show that HCM 
promotes EADs (16%), especially in models characterised by very low IKr, together 
with high INaL, ICaL and INCX.  
Both selective INaL and INCX block partially reversed the HCM phenotype, and 
reduced EADs occurrence. Their simultaneous block turned out to be even more 
effective, suggesting the combination of both treatments as a potential anti-
arrhythmic strategy in HCM. 
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INTRODUCTION 
Hypertrophic Cardiomyopathy 
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac 
disorder and the main cause of sudden cardiac death in young athletes [1], with a 
reported prevalence of 1 in 500 worldwide [2].  
Usually asymptomatic, it is characterised by an unexplained thickening 
(hypertrophy) of the left ventricle, with predominant involvement of the inter-
ventricular septum, and sometime also of the right ventricle; other hallmark features 
of the disease are myocyte disarray and fibrosis (Figure 7.1). 
 
Figure 7.1: Alterations in hypertrophic cardiomyopathy (HCM, right) compared to non-diseased 
control (CTRL, left): HCM promotes disarray and fibrosis, often resulting in hypertrophy, especially 
in the left ventricle and in the inter-ventricular septum (white arrow), as shown on the cardiac 
magnetic resonance images (modified from [3]). 
Hypertrophic cardiomyopathy was defined a “disease of the sarcomere” more 
than 20 years ago [4], when the first three disease genes to be identified were found 
to encode components of the contractile apparatus of heart muscle. Mutations in 
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nine genes encoding sarcomeric proteins have now been convincingly shown to 
cause HCM. These mutations generally increase myofilament activation and result 
in myocyte hyper-contractility and excessive energy use. Alterations in myocardial 
energetics and in Ca
2+
-handling, combined with stimulation of signalling pathways, 
promote myocyte growth with aberrant tissue architecture (i.e. myofibrillar disarray 
and myocardial fibrosis) [3]. In addition, the changes in Ca
2+
-handling confer a 
predisposition to arrhythmias [5] and may be implicated in diastolic dysfunction, 
another trait of this disease.  
At least two mechanisms explain how sarcomeric mutations alter Ca
2+
 balance 
[3]. First, mutations affecting the thin-filament regulatory proteins tropomyosin, 
troponin T, and troponin I all enhance calcium sensitivity by increasing the affinity 
of troponin C for calcium [6]: since troponin is the principal dynamic Ca
2+
 buffer in 
the sarcoplasm the increased affinity should elevate Ca
2+
 levels during diastole. 
Second, sarcomeric mutations increase the energy requirements of myosin ATPase. 
Since the cross-bridge cycle, which generates the contractile force of the myocyte, 
accounts for about 70% of the cardiomyocyte ATP consumption, contractile 
inefficiency could compromise the cell energetics [7]. This would be expected to 
compromise in turn the energy-requiring transporters, e.g. Na
+
/K
+
 and SERCA 
pumps, thus affecting intracellular concentrations (mainly Na
+
 and Ca
2+
). 
More recently, new experimental data assessed the electrophysiological profile 
of human HCM compared with non-diseased controls (CTRL) [8], by highlighting 
the subtle changes occurring at the molecular and cellular levels which had received 
limited attention before, and are likely to play a crucial role in arrhythmias onset.  
Diseased cardiomyocytes are characterised by prolonged action potential (AP) 
and Ca
2+
 transient (CaT), mostly depending on the increase of Late Na
+
 current 
(INaL) and L-type Ca
2+
 current (ICaL), together with a decrease of K
+
 repolarising 
currents. Na
+
/Ca
2+
 exchanger (NCX) activity is enhanced, while cellular Ca
2+
-
handling is impaired, i.e. SERCA uptake and ryanodine receptors (RyRs) release 
are reduced. AP prolongation leads to an increased occurrence of early after-
depolarisations (EADs), i.e. spontaneous depolarisation during the plateau phase, 
often associated with re-opening of Na
+
 or Ca
2+
 channels, and considered a primary 
electrophysiological trigger for ventricular arrhythmias [9]. Also, delayed after-
depolarisations (DADs), occurring during the diastolic period and related to 
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spontaneous Ca
2+
 release, are more frequent in HCM than in CTRL, suggesting 
additional arrhythmogenic mechanisms.  
Intracellular Ca
2+
 concentration during diastole is significantly increased in 
HCM, leading in turn to an enhanced Ca
2+
/calmodulin kinase II (CaMKII) activity 
and phosphorylation of its downstream targets. By slowing down ICaL inactivation 
and increasing INaL amplitude, CaMKII contributes to APD prolongation and related 
arrhythmias. The enhanced INaL is responsible for intracellular Na
+
 overload, which 
favours reverse over forward NCX mode, contributing to cytosolic Ca
2+
 overload 
and further promoting CaMKII activation, thus setting up a vicious circle [8]. 
Finally, an increased background Na
+
 current (INab) may contribute as well to 
intracellular Na
+
 and Ca
2+
 overload, as suggested for heart failure [10]. 
Despite its epidemiological relevance, HCM is largely an orphan condition 
because it still lacks a disease-specific pharmacological treatment [11, 12], and this 
is partly due to the limited understanding of the cellular mechanisms involved. 
Therapeutic targets in HCM are likely to be most effective when directed to the 
molecular predeterminants of the HCM phenotype. As an example, the potential 
implications of INaL inhibition have been already shown: ranolazine at therapeutic 
concentrations partially reverses the HCM-related cellular abnormalities via INaL 
inhibition, with negligible effects in CTRL [8]. Since many other ionic currents and 
mechanisms are affected by this disease, a more detailed understanding of the 
cellular processes underlying the HCM phenotype is definitely needed to highlight 
other potential therapeutic targets and strategies.  
Computational cardiac modelling constitutes a valuable tool in this context: by 
correlating the ion channel remodelling measured in human HCM cells with the 
electrophysiological phenotype of the disease, in silico simulations may help to 
understand the ionic mechanisms involved at the cellular level and to identify 
possible therapeutic targets to reduce the arrhythmic risk in HCM patients. In 
addition, biological variability is very high in HCM [8], and it is likely to play a 
major role in characterising the individual response to drug treatment: therefore, the 
population of models approach (POFs) is particularly appropriate to investigate this 
disease, since it accounts for variability, usually neglected in the traditional 
modelling techniques. 
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Population of Models 
The population of models (POMs) approach, recently developed by the 
University of Oxford (UK) [13–16], is a novel methodology in computational 
cardiac AP modelling. Instead of a single AP model, representative of the average 
cell behaviour, simulations are performed in thousands of models at the same time 
(a population, indeed), all generated by varying some of the model parameters 
around their nominal values. Each model represents a different cell and the cell-to-
cell differences account for both inter- and intra- subject variability.  
As an example, Figure 7.2 shows different experimental APs (pink traces) all 
recorded from rabbit purkinje cells. The biological variability, well represented 
here, is neglected when using a single Purkinje AP model to reproduce these 
experimental data, e.g. the Corrias-Giles-Rodriguez [17] (left panel, black trace), 
while a population of models (right panel, black traces) allows for a better coverage 
of the experimental dataset. 
 
Figure 7.2: Experimental AP recordings (pink traces, both panels) from rabbit purkinje cells (data 
by Janssen Pharmaceutica). When considering only a single AP model (black trace, left panel), the 
biological variability is completely neglected, while the population of models (black traces, right 
panel) is able to better reproduce the experimental dataset (modified from [14]).  
All the models in the population share the same differential equations, but each 
of them has a different parameter set. Depending on the purpose of the study, the 
number of generated models, the parameters to be varied, the scaling factors to 
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apply to the nominal parameter values and the sampling of the parameter space, 
may be different. More details about the POMs approach are given in Appendix B1. 
Aims 
The aim of this work has been to investigate the electrophysiological phenotype 
of human HCM using the population of models approach, to account for the 
biological variability. By integrating experimental data and computer simulations, 
we aimed to improve the understanding of the ionic mechanisms underlying the 
electrical remodelling occurring in this disease, and also their individual 
contribution to the disease-related arrhythmogenicity. The ultimate goal was 
therefore to identify possible therapeutic targets and to test in simulations the 
potential anti-arrhythmic effects of their selective/combined block.   
METHODS 
Experimental Data 
All the experimental data used in this work were collected by our collaborators 
from the University of Florence (Coppini et al. [8]), using human cardiomyocytes 
from n=26 HCM patients, compared with n=8 non-failing non-hypertrophic 
controls (CTRL). HCM cardiomyocytes were hypertrophic, as indicated by an 
increased cell volume and capacitance compared with CTRL. 
AP and CaT recordings 
Single cell patch-clamp measurements and intracellular Ca
2+
 studies produced an 
extensive set of AP and CaT biomarkers: AP duration (APD), computed at 20%, 
50% and 90% of repolarisation (APD20, APD50 and APD90, respectively), AP 
amplitude (APamp), mean upstroke velocity (dV/dtMEAN, computed as the mean 
dV/dt value during the upstroke phase), resting membrane potential (RMP), CaT 
duration (CaTD), computed at 50% and 90% of CaT decay (CaTD50 and CaTD90), 
CaT time to peak (CaTttp), CaT amplitude (CaTamp) and diastolic Ca
2+
 
concentration ([Ca
2+
]iD). A summary of all the AP and CaT biomarkers considered 
in this study is shown in Figure 7.3 and Figure 7.4. In addition, both early and 
delayed after-depolarisations frequencies were monitored in HCM and CTRL. 
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Figure 7.3: Summary and description of the AP biomarkers considered in this study: AP duration 
(APD), computed at 20%, 50% and 90% of repolarisation (APD20, APD50 and APD90, respectively), 
AP amplitude (APamp), mean upstroke velocity (dV/dtMEAN, computed as the mean dV/dt value during 
the upstroke phase), mean resting potential (RMP). 
 
Figure 7.4: Summary and description of the CaT biomarkers considered in this study: CaT duration 
(CaTD), computed at 50% and 90% of CaT decay (CaTD50 and CaTD90), CaT time to peak (CaTttp), 
CaT amplitude (CaTamp) and diastolic Ca
2+ concentration ([Ca2+]iD). 
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Experimental data have been acquired at three different stimulation frequencies 
(0.2, 0.5 and 1 Hz) and results were consistent. In this study, only experiments 
recorded at 1 Hz have been preliminary considered, because low frequencies 
simulations are computationally more expensive. 
Voltage-Clamp experiments 
Voltage clamp experiments were also performed for different ionic currents: late 
component of Na
+ 
current (INaL), L-type Ca
2+
 current (ICaL), transient outward K
+
 
current (Ito) and in the inward rectifier K
+
 current (IK1).  
Protein and mRNA expression 
Protein and mRNA expressions were analysed, in order to quantify the changes 
occurring in the main ionic current subunits. In addition to all the currents already 
considered for Voltage-Clamp (INa, ICaL, Ito and IK1), data have been acquired for the 
rapid and slow delayed rectifier K
+
 currents (IKr and IKs), Na
+
/Ca
2+
 exchanger 
(NCX), SERCA pump and ryanodine receptors (RyRs).  
INaL inhibition 
The effect of 10 µM of Ranolazine, a selective INaL inhibitor [18], have been 
evaluated to assess the role of this current, highly increased in HCM compared to 
CTRL. All the AP and CaT biomarkers have been measured 3 min after drug 
exposure and repeated 5 min after washout, both for HCM and CTRL cells, and 
together with INaL Voltage-Clamp recordings. 
Baseline Model 
As baseline to build the population, we used the endocardial version of the 
human ventricular AP model published by O’Hara-Rudy in 2011 (ORd [19]): it is 
the most recent human ventricular AP model and it has been developed and 
extensively validated on experimental data acquired in small tissue preparations 
from more than 100 undiseased human hearts.  
A schematic representation of this model, showing all its ionic currents, 
pumps/exchangers, buffers, fluxes and compartments is shown in Figure 7.5. 
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Figure 7.5: Schematic representation of the ORd model, showing all its ionic currents, 
pumps/exchangers, buffers, fluxes and compartments [19]. 
However, a few changes have been required to the original model, in order to 
better reproduce the experimental CTRL data considered in this study: the maximal 
conductance of the transient outward K
+
 current (Ito) has been increased 2.5 times, 
based on the corresponding experimental Ito I-V curve; intra- and extra-cellular 
ionic concentrations have been set as in the AP experimental recordings; since the 
resting membrane potential in the experiments was about 10 mV higher than the 
one of the ORd model, and the K
+
 equilibrium potential was different from the one 
resulting from the Nernst equation, using the experimental K
+
 concentrations, we 
fixed the K
+ 
equilibrium potential to the one measured for the IK1 I-V curve. 
In addition, the fast Na
+
 current (INa) inactivation gates have been modified, to 
fix a well-known problem concerning the INa in the ORd model, which prevent 
propagation in 2D or 3D tissue when considering hyperkalaemia. 
Finally, the current stimulus duration has been extended to 1 ms, and the current 
stimulus amplitude has been set to twice the AP threshold, to allow a larger 
integration step to solve the model ODEs. All the changes to the original ORd 
model mentioned above are discussed in details in Appendix B2. 
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The CTRL population 
An initial population of 30,000 models was developed, starting from the baseline 
model and varying a total of 11 parameters, including the maximal conductances of 
the main ionic currents/pumps/exchangers characterising the human ventricular AP. 
These parameters were probabilistically sampled in the [0-200%] range, with 
respect to their baseline parameter values, using the Latin Hypercube Sampling 
(LHS) [20]. The list of all the parameters which have been varied, together with 
their original value in the ORd model, is shown in Table 7.1. 
Table 7.1: List and description of all the parameters scaled to build the CTRL population: 
# Parameter Description Original Value 
1 gKr max conductance of rapid delayed rectifier K
+ current (IKr) 0.046 mS/μF 
2 gKs max conductance  of slow delayed rectifier K
+ current (IKs) 0.0034 mS/μF 
3 gK1 max conductance of inward rectifier K
+ current  (IK1)  0.1908 mS/μF 
4 gto max conductance of transient outward K
+ current  (Ito) 0.02 mS/μF 
5 PCa permeability of L-type Ca
2+ channel (ICaL current) 0.0001 1/s 
6 gNaL max conductance of Late Na
+ current (INaL) 0.0075 mS/μF 
7 gNa max conductance Fast Na
+ current (INa) 75 mS/μF 
8 gNCX max current of Na
+/Ca2+ exchanger (INCX) 0.0008 μA/μF 
9 PNaK max conductance of Na
+/K+ pump (INaK) 30 mS/μF 
10 SF_Jrel scaling factor for Ca
2+ release, via ryanodine receptors (Jrel) 1 nu * 
11 SF_Jup scaling factor for Ca
2+ uptake, via SERCA pump (Jup)  1 nu * 
* In the ORd model, Jrel and Jup do not have any parameter to represent their max conductances. 
Therefore, SF_Jrel and SF_Jup were added to the original formulations, to scale both currents in the 
selected range, and to allow these currents to vary in the CTRL population models. 
Hereafter, all the variables listed above will be referred to using their 
corresponding scaling factors, i.e. SF_IKr, SF_IKs, SF_IK1, SF_Ito, SF_ICaL, SF_INaL, 
SF_INa, SF_INCX, SF_INaK, SF_Jrel and SF_Jup. All these variables will be ranging 
from 0 to 2, according to the [0-200%] range used to build the CTRL population. 
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Population results will be often presented using boxplots of these scaling factors, 
in order to highlight the currents whose densities are particularly high/low with 
respect to the baseline model (in which all the scaling factors are equal to one). On 
each box, the central mark is the median, the edges of the box are the 25th and 75th 
percentiles, the whiskers extend to the most extreme data points not considered 
outliers, and outliers are plotted individually. To compute statistical significance,  
two-sample t-test (function ttest2 in Matlab) has been used for samples comparison. 
When considering a special subgroup of models (e.g. all the models showing 
EADs), a scaling factor distributed only in a small portion of the whole [0-200%] 
range may imply an important role played by its corresponding current in that 
special subgroup. In the initial population, all the scaling factors have a similar 
distribution, and they cover the whole range from 0 to 2, where 1 indicates that the 
corresponding ionic current is unaltered from the baseline model, while big/small 
scaling factors correspond to its up/down regulation. Therefore, for the initial 
population, all the scaling factor boxplots will be equally distributed (Figure 7.6). 
 
Figure 7.6: Scaling factors distribution in the initial population of 30,000 models. Parameters have 
been probabilistically sampled with LHS in the [0-200%] range with respect to their original value. 
They span from 0 to 2, where 1 indicates that the corresponding ionic current is unaltered from the 
baseline model, while big/small scaling factors correspond to its up/down regulation. 
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After running simulations for the initial 30,000 models, a calibration process is 
required, in order to select only the ones fully in agreement with the experimental 
data described in the corresponding Methods section. Examples of this calibration 
process are shown in Figure 7.7, considering only 2 AP/CaT biomarkers at a time. 
Calibration ranges (thick black lines) are defined considering the minimum and 
maximum values of the experimental data (light blue squares), except outliers (dark 
grey squares). Models whose biomarkers are within these ranges are accepted (blue 
dots), while the other ones are discarded (light grey dots). The baseline model is 
shown as a white diamond. This calibration is repeated for all the AP and CaT 
biomarkers available, and only the models satisfying all the considered constraints 
at the same time are included in the final CTRL population. 
 
Figure 7.7: Two examples of the CTRL calibration process, considering two AP and two CaT 
biomarkers: experimental data/outliers (light blue/dark grey dots); calibration ranges (thick black 
lines); accepted/discarded models (blue/light grey dots); baseline model (white diamond). Models 
satisfying the single AP or CaT constraints are selected in every step, and only the ones which 
satisfy all of them at the same time are included in the final CTRL population. 
The HCM population 
The HCM population was built from the CTRL one, by applying the electrical 
remodelling experimentally found in HCM ventricular myocytes [8], as described in 
the Experimental Data Methods section. All the ionic currents have been modified 
by up- or down- regulating the corresponding conductance. Based on V-clamp 
experiments, we included an increase of INaL (+165%) and ICaL (+30%), and a 
decrease of Ito (-70%) and IK1 (-30%), together with an increase of ICaL inactivation 
slow and fast time constants (+20% and 30%, respectively). In addition, 
experimental data on mRNA expressions were used to modulate the K
+
 repolarizing 
Section III – Chapter 7                                                                                                                       165 
Computational Modelling of Cardiac Electrophysiology: from Cell to Bedside 
currents (IKr, -45% and IKs, -60%), SERCA pump (Jup, -15%), RyRs release (Jrel, -
15%) and Na
+
/Ca
2+
 exchanger (INCX, +25%). Finally, we increased cell volume 
(+90%) and, based on literature review, we included an increased affinity of 
Troponin for Ca
2+
 (TRPNmax, +50%) [6], a reduction of Na
+
/K
+
 pump (INaK, -30%) 
[21] and an increase of background Na
+
 current (INab, +165% as for INaL) [10].  
All the changes listed above have been tested in the baseline model first, and 
then extended to the whole CTRL population, in order to build the HCM one. 
Simulation Details 
All models were paced at 1 Hz until steady state (500 s). For every model, the 
last ten AP and CaT traces were saved and used to compute an average set of AP 
and CaT biomarkers, as done in the experiments. All numerical simulations and 
biomarkers evaluation were performed with the open source cardiac software 
Chaste [22], using a CellML [23] implementation of the ORd model, modified as 
described in the CTRL population methods section. Post-processing of AP and CaT 
traces, together with data analysis, were performed in Matlab (Mathworks, Inc.). 
INaL and INCX inhibition 
The effects of INaL and INCX inhibition have been tested in simulation by reducing 
the corresponding maximal conductance by 60% and 30%, respectively, in both the 
CTRL and HCM populations. INaL block percentage has been set accordingly to 
experimental data acquired in presence of Ranolazine 10 µM [8], also used to 
compare simulation results. Since no experimental data were available for INCX, we 
tried different block percentages and we finally chose 30% because many models, 
both CTRL and HCM, were not repolarising properly for higher block values. 
Repolarisation Abnormalities 
All the 10 saved APs have been checked for repolarisation abnormalities. The 
AP traces not able to repolarise properly during the diastole (Vm > -65 mV) or 
showing a positive derivative of voltage over time after the AP peak (150 ms) have 
been selected as abnormal. Repolarisation abnormalities were divided in: short 
EADs (when the model repolarised before 1000 ms), long EADs (when the model 
was able to repolarise, but it required more than 1000 ms) and repolarization 
failures (RF), when the model was not going back to its resting potential. 
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RESULTS 
The CTRL population 
As a result of the calibration process, only 2,254 models out of the initial 30,000 
were accepted in the final CTRL population. The calibration was based on the 
experimental data presented in the corresponding Methods section, and it was 
divided into two steps.  
As first step, all the models in which Chaste failed to compute AP and CaT 
biomarkers were discarded (1897 models, about 6% of the population). These are 
models which often fail to repolarise: therefore, the software is not able to find the 
reference points needed to compute AP and CaT biomarkers. As expected, these 
models are usually characterised by a very low IKr when compared to the baseline 
model, but other mechanisms are involved too, e.g. low IKs and IK1, high ICaL and 
INCX and low INaK. Figure 7.8 shows the scaling factors distribution for these 
rejected models, using a boxplot for each parameter varied in the population. 
 
Figure 7.8: Scaling factor boxplots for the models in which Chaste was unable to compute the AP 
and CaT biomarkers. Among other ionic mechanisms, these models are characterised by a very low 
IKr and a high ICaL, compared to the baseline model: therefore they often fail to repolarise  
(* p<0.01,* p<0.001,*** p<0.0001, compared to all the initial population of 30,000). 
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To highlight potential correlations between the scaling factors of these rejected 
models, Figure 7.9 shows all the 2-by-2 combinations of each scaling factor against 
the other ones. Each grey dot corresponds to a different model, and it is quite 
interesting to see how these models are distributed in the scaling factors space, e.g. 
almost all the models have a very small SF_IKr (from 0 to 0.5) while only a few of 
them have a low SF_ICaL, in agreement with the results shown in Figure 7.8. 
 
Figure 7.9: 2-by-2 plots of the scaling factors space, for the AP models in which Chaste was unable 
to compute the AP and CaT biomarkers. This representations highlights scaling factor distributions, 
e.g. almost all the models have a very small SF_IKr while only a few of them have a low SF_ICaL. 
As second step, calibration ranges based on the minimum and maximal 
experimental data for the AP and CaT biomarkers were considered: only the models 
satisfying all the experimental constraints at the same time were included in the 
final CTRL population, for a total amount of 2,254 models out of the 28,104 
remaining after the previous calibration step. 
As shown in Table 7.2, the major constraints for the population were the ones 
defined by the CaT biomarkers, especially CaTttp and CaTamp, while most of the 
simulated AP biomarkers were within the corresponding experimental ranges. 
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[Ca
2+
]iD was not considered in the calibration process because the model values 
were completely out of range with respect to the experimental data: since [Ca
2+
]iD 
has been computed by converting a fluorescence signal, with poor quantitative 
reliability, we used this biomarker only to compare HCM vs CTRL, and we didn’t 
consider its numerical value per se.  
Table 7.2: Number of models satisfying the single/combined AP and CaT biomarker constraints.  
 Biomarkers 
Models satisfying the single/combined 
biomarker constraints 
All AP 
Biomarkers 
APD20 23,306 
22,725 
17,551 
APD50 26,231 
APD90 26,618 
RMP 27,994 - 
dV/dtMEAN 22,207 - 
APamp 27,163 - 
All CaT 
Biomarkers 
CaTD50 16,663 
15,048 
  3,509 
CaTD90 18,086 
CaTttp   7,104 - 
CaTamp   4,558 - 
[Ca
2+
]iD 11,626 not included in the final population 
Final Calibration 2,254 
Figure 7.10 shows the accepted/discarded models distribution for the CTRL 
population, considering 2-by-2 plots of the biomarkers space, together with the 
experimental data and the corresponding calibration ranges. As for AP biomarkers 
(top half), APD90 is plotted against all the other ones, while for CaT biomarkers 
(bottom half) CaTD90 is plotted vs all the other ones. Since [Ca
2+
]iD was not 
considered in the calibration, its experimental ranges are marked with a dotted line. 
Representative AP and CaT traces of both accepted and discarded models in the 
CTRL population are shown in Figure 7.11 and Figure 7.12. 
Finally, the scaling factors distribution in the CTRL population is shown as both   
boxplots and 2-by-2 plots in Figure 7.13 and Figure 7.14, respectively. Compared to 
the initial population, the accepted models have a slightly higher IKr, INa and Jup. 
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Figure 7.10: Calibration process of the CTRL population, showing how the accepted/discarded 
model biomarkers. The models included in the population are the ones in agreement with the 
experiments and their corresponding calibration ranges, defined considering the minimum and 
maximum experimental value. [Ca2+]iD has not been considered in the calibration process. 
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Figure 7.11: Representative AP traces of accepted/discarded (blue/grey lines) models in the CTRL population. 
The baseline model AP is shown in white. 
 
Figure 7.12: Representative CaT traces of accepted/discarded (blue/grey lines) models in the CTRL population. 
The baseline model CaT is shown in white. 
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Figure 7.13: Scaling factor boxplots for the CTRL population. Compared to the initial population, 
the accepted models have a slightly higher IKr, INa and Jup (* p<0.01,* p<0.001,*** p<0.0001). 
 
Figure 7.14: 2-by-2 plots of the scaling factors space for the models in the CTRL population. 
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Table 7.3 reports the average AP and CaT biomarker values in the CTRL 
population, compared with the corresponding experiments (both data are shown as 
mean±stdTD). As already evident from Figure 7.10, the calibrated CTRL 
population well represents the experimental data ranges (apart from [Ca
2+
]iD). 
Table 7.3: Comparison of the AP and CaT biomarkers computed from the experimental 
CTRL data and the ones from the experimentally-calibrated population of models. 
AP Biomarkers in CTRL CaT Biomarkers in CTRL 
 Experiments 
(n = 24) 
Models  
( n = 2,254) 
 
Experiments 
(n = 12) 
Models  
(n = 2,254) 
APD20 115±40 ms 117±29 ms CaTD50 175±89 ms 187±43 ms 
APD50 230±77 ms 212±58 ms CaTD90 364±161 ms 492±86 ms 
APD90 354±117 ms 285±91 ms CaTttp 50±10 ms 50±8 ms 
APamp 110±9 mV 118±6 mV CaTamp 351±72 mV 359±84 mV 
RMP -77.6±3.5 mV -77.9±0.5 mV [Ca
2+
]iD 140±32 nM 81±23 nM 
dV/dtMEAN 24±8 V/s 32±8 V/s [Na
+
]i N.A. 7.1±1.7 mM 
An additional comparison between the CTRL population and experimental 
biomarkers is shown in Figure 7.15. Statistical significance is not shown because p-
values were all very small due to the high difference in sample sizes (n=12/24 cells 
vs n=2,254 models), even when the values were very close one another. 
Finally, to determine correlations between the properties of individual ionic 
currents, represented by the corresponding scaling factors, and the AP and CaT 
biomarkers, we used partial correlation method [24]. We chose to use partial 
correlation over other correlation measures because partial correlation controls for 
the effects of one or more additional variables when looking for correlations 
between two quantities, which is particularly important here, given that our models 
are generated by varying multiple parameters simultaneously. Partial correlation 
coefficients span from -1 to +1, where -1 indicates a strong negative correlation 
between the two considered variables, and +1 a strong positive one. Results are 
shown in Figure 7.16: as expected, K
+
 repolarising currents are negatively 
correlated with APDs, while INaL and ICaL are positively correlated with it. Jup and 
Jrel have a strong influence on CaT, and both dV/dtMEAN and APamp are positively 
correlated with INa. 
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Figure 7.15: Comparison of the AP and CaT biomarkers between the CTRL population (blue 
boxplot) and the experiments (black boxplots): on each box, the central mark is the median, the 
edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data 
points not considered outliers, and outliers are plotted individually (light grey crosses). The 
experimental data have been superimposed to their boxplot (light blue squares), as well as the 
experimental outlier (dark grey squares), not considered for the calibration process. The 
experimental data and their variability are well reproduced by the CTRL population for all the 
biomarkers, apart from [Ca2+]iD which is lower in most of the models. 
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Figure 7.16: Partial correlation coefficients to highlight the potential correlations between each of 
the parameters varied in the CTRL population and the corresponding model biomarkers. As 
expected, K+ repolarising currents are negatively correlated with APDs, while INaL and ICaL are 
positively correlated with it. Jup and Jrel have a strong influence on CaT, and both dV/dtMEAN and 
APamp are positively correlated with INa.  
The HCM population 
In agreement with experiments, all the APDs were significantly longer in HCM 
than in CTRL (e.g. APD90 458±109 vs 285±91 ms). Moreover, the HCM population 
showed an increased CaTD, smaller CaTamp and higher [Ca
2+
]iD, all consistent with 
experiments. From a qualitative point of view, the simulated HCM phenotype is 
fully in agreement with the experimental data, even if the quantitative variations are 
sometimes different. 
The full list of AP and CaT biomarkers in the HCM experimental data and in the 
corresponding POMs is shown in Table 7.4, followed by a quantitative comparison 
between HCM and CTRL, both for experiments and POMs (Table 7.5). It is worth 
noticing that only the models with normal APs (i.e. not showing any repolarisation 
abnormalities) have been considered to compute the reported values. 
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Table 7.4: Comparison of the AP and CaT biomarkers computed from the experimental 
HCM data and the ones computed from the HCM population of models (data are presented 
as mean±std). 
AP Biomarkers in HCM CaT Biomarkers in HCM 
 
Experiments 
(n = 57) 
Models  
( n = 1,894) 
 
Experiments 
(n = 19) 
Models  
(n = 1,894) 
APD20 298±123 ms 165±26 ms CaTD50 329±121 ms 287±76 ms 
APD50 428±170 ms 321±58 ms CaTD90 602±174 ms 677±86 ms 
APD90 578±217 ms 458±109 ms CaTttp 116±36 ms 60±12 ms 
APamp 111±11 mV 120±5 mV CaTamp 292±63 mV 282±104 mV 
RMP -77.2±7.8 mV -77.3±1.0 mV [Ca
2+
]iD 222±81 nM 100±28 nM 
dV/dtMEAN 21±3 V/s 24±6 V/s [Na
+
]i N. A. 8.1±1.7 mM 
Table 7.5: Comparison of HCM vs CTRL for both experiments and POMs (data are 
presented as mean±std) 
AP Biomarkers in HCM vs CTRL CaT Biomarkers in HCM vs CTRL 
 Experiments Models  Experiments Models 
APD20 +159% (***) +40% CaTD50 +88% (**) +53% 
APD50 +86% (***) +52% CaTD90 +66% (**) +38% 
APD90 +63% (***) +61% CaTttp +131% (***) +19% 
APamp +2.0% +1.8% CaTamp -17% -22% 
RMP -0.6% -0.7% [Ca
2+
]iD +58% (*) +24% 
dVdtMEAN -11% -25% [Na
+
]i N. A. +14% 
* p<0.01, ** p<0.001, *** p<0.0001 (statistical significance not shown for POMs, since 
all p values were really small due to the high number of models) 
To better show the HCM population and its variability, both in comparison with 
the CTRL one and the experimental data, alternative representations are shown in 
Figure 7.17 and Figure 7.18, considering 2-by-2 plots of the AP and CaT 
biomarkers space and boxplots. In addition, some representative AP, CaT, INaL and 
ICaL traces are shown in Figure 7.19, Figure 7.20, Figure 7.21 and Figure 7.22 
respectively. 
176                                                                                                                       Section III – Chapter 7 
Elisa Passini 
 
Figure 7.17: Visual representation of the HCM POMs in the biomarkers space, compared to CTRL. 
The POMs is able to reproduce quite well the HCM phenotype from a qualitative point of view, even 
if with respect to the corresponding experimental data, HCM models have a shorter APD20 and a 
shorter CaTttp.  
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Figure 7.18: Comparison of the AP and CaT biomarkers between the HCM population (pink 
boxplots) and the experiments (black boxplot): on each box, the central mark is the median, the 
edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data 
points not considered outliers, and outliers are plotted individually (light grey crosses). The 
experimental data have been superimposed to their boxplot (light pink squares), as well as the 
experimental outlier (purple squares). The experimental data and their variability is well 
reproduced by the HCM population for most of the biomarkers, apart from APD20 and CaTttp, both 
shorter in the models, and [Ca2+]iD, already out of range in the CTRL population. 
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Figure 7.19: Representative AP traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
 
Figure 7.20: Representative CaT traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
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Figure 7.21: Representative INaL traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
 
Figure 7.22: Representative ICaL traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
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As already done for the CTRL population, we computed the partial correlation 
coefficients to verify the effect of the electrical remodelling occurring in HCM on 
the correlations between ionic currents and AP and/or CaT biomarkers. Partial 
correlation results are shown in Figure 7.23, with the same colour code used for 
Figure 7.16. Compared to CTRL, in the HCM population INaL (highly increased in 
HCM) has a much stronger effect on APDs, while IK1 and Ito (both reduced in 
HCM) have a lighter effect on RMP, dV/dtMEAN and APamp. As for CaT biomarkers, 
Jrel and Jup seem to have a stronger effect on CaTD, together with INCX and INaK. 
 
Figure 7.23: Partial correlation coefficients to highlight the potential correlations between each of 
the parameters varied in the HCM population and the corresponding model biomarkers. Compared 
to CTRL (Figure 7.16) the currents which are increased in HCM have a bigger effects on 
biomarkers (e.g. INaL on APDs), while the ones which are reduced have lower impact. 
Finally, a comprehensive comparison of HCM vs CTRL, considering all the AP 
and CaT biomarkers, and showing both POMs and experimental data, is given in 
Figure 7.24. The simulated HCM phenotype well reproduces the experimental 
dataset and its variability, although there are some qualitative differences, which 
may be related to intrinsic characteristics of the baseline model used to build the 
CTRL population or to choice of parameters varied to build the population. 
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Figure 7.24: Visual comparison of HCM vs CTRL, showing both POMs and experimental data. For 
each of the 11 AP and CaT biomarkers, the boxplots represent POMs values, while the experiments 
are shown individually as small squares. The colour legend is the same used for the entire Results 
chapter: CTRL is blue (light blue for data) and HCM is pink (light pink for data). The simulated 
HCM phenotype well reproduces the experimental dataset and its variability, although there are 
some qualitative differences: the APD20 increase in HCM vs CTRL is much higher in the 
experimental data than in the POMs. The same happens for CaTttp and [Ca
2+]iD, already out of 
range in the CTRL population. Some of these limitations may be overcome by slightly tuning the 
electrical remodelling considered to build the HCM population, starting from the CTRL one (e.g. 
[Ca2+]iD),while other are more related to the baseline model and the population design, e.g. the 
increase in CaTttp cannot be achieved by acting on current conductances only. 
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Repolarisation Abnormalities 
Repolarisation abnormalities have been found in 360 HCM models out of 2,254 
(16%), and they have been classified as described in the Methods section, i.e. 
short/long EADs and repolarisation failure (RF). Their relative occurrence, together 
with a representative trace for each type, is shown in Figure 7.25. 
 
Figure 7.25: Occurrence of repolarisation abnormalities in the HCM population, classified 
in three different types: short/long EADs and RF. For each type, a representative trace is 
shown, in agreement with the colour legend (green, pink and grey respectively). 
To better understand the ionic mechanisms underlying these repolarisation 
abnormalities, scaling factor boxplots for each of the subgroups have been 
compared: normal APs (Figure 7.26), short EADs (Figure 7.27), long EADs (Figure 
7.28) and RF (Figure 7.29). 
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Figure 7.26: Scaling factor boxplots of the HCM models having a normal AP, i.e. not showing any 
repolarisation abnormality. As for the CTRL population, these models have a slightly higher IKr, INa 
and Jup (* p<0.01,* p<0.001, *** p<0.0001 compared to the initial parameter distribution). 
 
Figure 7.27: Scaling factor boxplots of the HCM models showing short EADs, compared to the ones 
with a regular AP (* p<0.01,* p<0.001,*** p<0.0001). These models are characterised by low IKr, 
high ICaL and INaL, slightly high INCX and low Jup.  
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Figure 7.28: Scaling factor boxplots of the HCM models showing long EADs, compared to the ones 
with a regular AP (* p<0.01,* p<0.001,*** p<0.0001). These models are characterised by low IKr, 
high ICaL and INaL, very high INCX and lower Jrel. 
 
Figure 7.29: Scaling factor boxplots of the HCM models showing RF, compared to the ones with a 
regular AP (* p<0.01,* p<0.001,*** p<0.0001). These models are characterised by a very low IKr, 
high ICaL, INa and INCX and low Jrel. 
Section III – Chapter 7                                                                                                                       185 
Computational Modelling of Cardiac Electrophysiology: from Cell to Bedside 
Therefore, the ionic mechanism who seems to play the major role in 
repolarisation abnormalities is IKr: the smaller its scaling factor, and therefore the 
current density, the more severe the EADs, up to RF. In addition, short and long 
EADs are often characterised by a high INaL and ICaL, both contributing toward an 
additional increase of APDs, and also an increased activity of NCX.  
The link between low scaling factors for IKr and repolarisation abnormalities is 
even more evident when considering 2-by-2 plots of the scaling factors space, 
comparing the EADs/RF subgroups with the normal APs one (Figure 7.30, Figure 
7.31 and Figure 7.32 for short EADs, long EADs and RF, respectively). 
In the different subgroups, the models are always clustered in the bottom half of 
the SF_IKr range, with values decreasing from short/long EADs to RF. Additional 
correlations between other ionic mechanisms (INaL, ICaL and INCX) is emerging as 
well, e.g. many of the models showing short EADs have both INaL and ICaL up-
regulated at the same time. 
 
Figure 7.30: 2-by-2 plots of the scaling factors space for the HCM models showing short EADs 
(green dots), compared the ones with normal APs (black dots). 
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Figure 7.31: 2-by-2 plots of the scaling factors space for the HCM models showing long EADs (pink 
dots), compared the ones with normal APs (black dots). 
 
Figure 7.32: 2-by-2 plots of the scaling factors space for the HCM models showing RF (grey dots), 
compared the ones with normal APs (black dots). 
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In order to highlight the main ionic currents who seems to play a role in 
repolarisation abnormalities, the corresponding scaling factor boxplots have been 
compared in Figure 7.33, considering their distribution in the different subgroups: 
normal HCM APs, short/long EADs and repolarisation failure.  
All these subgroups are characterised by a very low IKr: indeed, this current is the 
main contributor to APD prolongation in HCM.  Most of the models show a high 
ICaL, further increasing the APD. INaL is higher in the subgroups showing short/long 
EADs. INCX is increased in all the subgroup, but especially in long EADs and RF. 
This analysis provided the basis to identify possible anti-arrhythmic therapies in 
HCM, which will be discussed in the Ionic Current Block section below. 
 
Figure 7.33: Boxplots comparison of the scaling factors for the ionic currents who seems to be 
involved in repolarisation abnormalities in HCM (***p<0.0001, with respect to normal HCM APs). 
The reduced IKr density seems to play the major role in determining repolarisation abnormalities: 
the lower its scaling factor range, the more severe they are. Also, a high ICaL, further increasing the 
APD, is present in all the subgroups. The INaL density is higher in the subgroups showing EADs, 
while the INCX is increased mostly in long EADs and RF subgroups. 
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Ionic Mechanisms contribution to the HCM Phenotype 
In order to analyse the contribution of every single ionic mechanisms to the 
global HCM phenotype, we ran some additional simulations. 
As first, starting from the CTRL POMs, we introduced the HCM remodelling 
mechanisms, one at a time, and we evaluated their impact on the considered AP and 
CaT biomarkers (Figure 7.34). As expected, IKr and INaL are contributing to APD 
prolongation, while ICaL, INCX, Jup and TRPNmax have a high effect on CaT. 
 
Figure 7.34: Summary of the contribution of each ionic mechanism to the global HCM phenotype. 
Starting from the CTRL POMs, the single remodelling mechanisms have been included individually, 
and their effect on AP and CaT biomarkers has been evaluated. Numerical values represent the % 
changes induced by each mechanism on the corresponding biomarker, with respect to CTRL POMs. 
As second, starting from the HCM POMs, we restored the HCM remodelling 
mechanisms, one at a time, and we evaluated their impact on the considered AP and 
CaT biomarkers (Figure 7.35). As expected, IKr and INaL are contributing to APD 
prolongation, while ICaL, INCX, Jup and TRPNmax have a high effect on CaT. 
In both simulation series, we monitored the occurrence of short/long EADs and 
RFs, and results are shown in Figure 7.36: the numerical values represent the % 
changes in EADs/RF occurrence compared to CTRL (left panel) or HCM (right 
panel), depending on weather the mechanisms where individually added or restored. 
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Figure 7.35: Summary of the contribution of each ionic mechanism to the global HCM phenotype. 
Starting from the HCM POMs, the single remodelling mechanisms have been restored individually, 
and their effect on AP and CaT biomarkers has been evaluated. Numerical values represent the % 
change induced by each mechanism on the corresponding biomarker, with respect to HCM POMs. 
 
Figure 7.36: EADs/RF occurrence changes when adding a single remodelling mechanisms to the 
CTRL POMs (left panel) or restoring it in the HCM POMs (right panel). 
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Ionic Current Blocks 
Based on the ionic mechanisms identified as relevant in the HCM models 
showing repolarisation abnormalities, we investigated in silico the effects of INaL 
and INCX blocks (-60% and -30%, respectively), since specific compounds are 
already available for these currents. The currents have been blocked both 
individually and simultaneously, and the effects have been evaluated on AP and 
CaT biomarkers, and repolarisation abnormalities occurrence. As a comparison, 
current blocks have been applied also to the CTRL models. Simulations results for 
selective INaL block have been compared with experimental data acquired with 
Ranolazine 10 µM, while no experiments are available for INCX block. 
A summary of current block effects on AP and CaT biomarkers is shown in 
Table 7.6 and Table 7.7, for CTRL and HCM respectively. Only the HCM models 
that didn’t show repolarisation abnormalities in any of the simulation settings were 
considered to compute the numerical values, presented as mean±std. 
Table 7.6: Summary of current block effects for CTRL (experimental data and POMs). 
CTRL AP  
biomarkers 
INaL block INCX block Both blocks 
Experiments 
(n = 10) 
Models  
(n = 2,254) 
Models 
(n = 2,254) 
Models 
(n = 2,254) 
APD20 (ms) 87±46 -6.0% 112±29 -5% 116±27 -2% 110±27 -6% 
APD50 (ms) 175±73 -5.2% 202±55 -5% 204±55 -4% 194±52 -8% 
APD90 (ms) 261±115 -8.3% 273±86 -4% 276±87 -3% 263±82 -7% 
APamp (mV) 109±11 +0.1% 118±6 +0.0% 118±6 +0.5% 119±6 +0.2% 
RMP (mV) -82±8 +0.7% -78±1 +0.1% -78±0.5 +0.1% -78±0.5 +0.1% 
dV/dt (V/s) 29±12 +0.6% 33±8 +1.2% 32±7 -0.0% 33±7 +2% 
CTRL CaT  
biomarkers 
INaL block INCX block Both blocks 
Experiments 
(n = 12) 
Models  
(n = 2,254) 
Models 
(n = 2,254) 
Models 
(n = 2,254) 
CaTD50 (ms) N.A. 190±43 +1% 160±35 -15% 161±35 -14% 
CaTD90 (ms) N.A. 492±84 +0.1% 446±76 -9% 446±75 -9% 
CaTttp (ms) N.A. 51±11 +2% 45±14 -11% 45±11 -10% 
CaTamp (nM) N.A. 344±82 -4% 538±144 +50% 519±139 +44% 
[Ca
2+
]iD (nM) N.A. 80±23 -1% 91±25 +12% 90±26 +12% 
[Na
+
]i (mM) N.A. 7.0±1.7 -2% 7.0±1.7 -1% 6.9±1.6 -3% 
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Table 7.7: Summary of current block effects for HCM (experimental data and POMs). 
HCM AP  
biomarkers 
INaL block INCX block Both blocks 
Experiments 
(n = 26) 
Models  
( n = 1,891) 
Models 
( n = 1,891) 
Models 
( n = 1,891) 
APD20 (ms) 251±124 -18% 152±25 -7% 162±26 -1% 150±23 -9% 
APD50 (ms) 350±164 -20% 294±53 -8% 308±60 -3% 282±51 -12% 
APD90 (ms) 536±190 -19% 419±101 -8% 440±110 -4% 402±97 -12% 
APamp (mV) 106±12 -3% 120±5 +0.5% 120±8 +0.3% 121±5 +0.7% 
RMP (mV) -82±8 +3% -78±2 +0.7% -77±5 +0.2% -78±2 +0.9% 
dV/dt (V/s) 21±3 -5% 25±6 +3% 25±6 +4% 26±6 +7% 
HCM CaT  
biomarkers 
INaL block INCX block Both blocks 
Experiments 
(n = 25) 
Models  
( n = 1,891) 
Models 
( n = 1,891) 
Models 
( n = 1,891) 
CaTD50 280±95 -18% 293±72 +3% 245±65 -14% 252±60 -12% 
CaTD90 501±129 -19%* 670±80 -1% 635±91 -6% 629±76 -7% 
CaTttp 100±30 -15% 62±12 +3% 53±18 -11% 55±11 -9% 
CaTamp 231±52 -28%** 259±90 -8% 387±137 +38% 360±115 +28% 
[Ca
2+
]iD 163±50 -28%* 99±28 -1% 109±31 +9% 108±30 +9% 
[Na
+
]i N.A. 7.9±1.6 -3% 8.0±1.7 -2% 7.7±1.6 -5% 
Considering the AP biomarkers, results of INaL block are qualitatively similar 
between models and experiments, both in HCM and CTRL. All the APDs are 
reduced when blocking INaL, and the effect is stronger in HCM where this current 
plays a major role. INCX alone doesn’t affect much the AP biomarkers, but the 
variations are in the same direction, so that the APD shortening increases when 
blocking both currents at the same time.  
As for CaT biomarkers, Ranolazine seems to affect them in the experiments 
much more than what blocking INaL does in models: probably a more detailed 
simulation of Ranolazine should consider its effect on other ionic currents as well 
(e.g. IKr and ICaL) [25]. However, we are not interested in simulating Ranolazine but 
rather a very selective INaL block, since hopefully more specific compounds will be 
available soon [26]. As for INCX block, it reduces CaTD both in CTRL and HCM, 
while increasing CaTamp and [Ca
2+
]iD. The same effects are shown when 
considering INCX in association with INaL block. Both CaTD and CaTamp variations 
are contrasting the changes induced by HCM remodelling, while the increase in 
[Ca
2+
]iD, already higher in HCM, may be a drawback of blocking the exchanger. 
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We also analysed how the repolarisation abnormalities occurrence changed when 
considering current blocks. Both selective INaL and INCX blocks had a strong anti-
arrhythmic effect in HCM, reducing especially short/long EADs. The simultaneous 
block of both currents proved to be even more successful, suppressing all the short 
EADs and 83% of the long ones. RF occurrence was reduced as well, but in a minor 
percentage. The distribution of repolarisation abnormalities in HCM with and 
without current blocks is shown in Figure 7.37.  
It is worth noticing that about 20% of short/long EADs (33 models) were not 
suppressed by INaL nor INCX selective block, while they disappeared when 
considering the simultaneous block of both currents. A representative trace of a 
HCM model in this subgroup is shown in Figure 7.38. 
Actually, the number of models in each subgroup is not enough to have a full 
comprehension of the current block effect on repolarisation abnormalities, since 
models can change subgroup: e.g. some of long EADs which appear in the 
population with INaL block were RF in the HCM population and not long EADs not 
suppressed by the considered block. Therefore, a full description of EADs/RF 
distribution is shown in Table 7.8. In addition, an alternative visual representation is 
given in Figure 7.39, using Circos, a software package for visualizing data and 
information in a circular layout [27], which is ideal for exploring relationships 
between objects or subgroups. 
 
Figure 7.37: Repolarisation abnormalities occurrence in the HCM population, and the relative 
changes induced by current blocks. The values refer to the number of models in each subgroup.  
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Figure 7.38: Representative AP traces of a HCM model showing long EAD, before and after adding 
in simulation the different current blocks. Both selective blocks failed to suppress the EAD, while the 
simultaneous INaL and INCX block proved to be successful. This happened in 33 HCM models. 
Table 7.8: Detailed description of repolarisation abnormalities changes in HCM when considering 
the different current blocks. The percentage in bold shows the fraction of models in which the 
repolarisation abnormalities was successfully suppressed, leading to a normal HCM APs. 
HCM population 
HCM + 
INaL block 
HCM + 
INCX block 
HCM + 
both blocks 
short 
EADs 
38 
 
normal 
APs 
37 
(97%) 
normal 
APs 
27 
(71%) 
normal 
APs 
38 
(100%) 
short 
EADs 
1 
short 
EADs 
9 
short 
EADs 
- 
long 
EADs 
- 
long 
EADs 
2 
long 
EADs 
- 
RF - RF - RF - 
long 
EADs 
118 
 
normal 
APs 
60 
(51%) 
normal 
APs 
30 
(25%) 
normal 
APs 
98 
(83%) 
short 
EADs 
15 
short 
EADs 
18 
short 
EADs 
2 
long 
EADs 
35 
long 
EADs 
68 
long 
EADs 
17 
RF 8 RF 2 RF 1 
RF 
204 
 
normal 
APs 
13 
(6%) 
normal 
APs 
10 
(5%) 
normal 
APs 
31 
(15%) 
short 
EADs 
1 
short 
EADs 
- 
short 
EADs 
1 
long 
EADs 
23 
long 
EADs 
30 
long 
EADs 
24 
RF 167 RF 164 RF 148 
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Figure 7.39: Circos plots to represent repolarisation abnormalities distribution in the HCM 
population. Every plot shows the number of models for each subgroup, before and after adding the 
current block, together with the incoming and outgoing fluxes from one subgroup to all the other 
ones. Considering e.g. the pink section in the top plot: when including INaL block, many long EADs 
disappear (they go into normal HCM APs subgroup), some of them become short EADs and some 
other just remain long EADs. A few models change from long EADs to RF, instead. In addition, 
there is an incoming flux of models from the RF subgroup, which have now become long EADs. The 
same apply to all the other subgroups and for all the considered ionic current blocks  [27]. 
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The population of model approach has been used to reproduce experimental data 
acquired from healthy (CTRL) and diseased (HCM) human single cells. Starting 
from the baseline AP model, an initial population has been generated, by varying 11 
parameters probabilistically sampled in the [0%-200%] range, with respect to their 
original values. This initial population have been calibrated using the experimental 
data, i.e. by including only the models fully in agreement with a set of AP and CaT 
biomarkers: the final CTRL population consists of 2,254 models. 
Starting from the CTRL population, we built the corresponding HCM one, by 
applying the electrical remodelling observed in experiments. Most of the main ionic 
currents have been modified according to voltage-clamp and protein expression 
data. In addition, we made three novel hypotheses, based on a literature review on 
HCM: an increased affinity of TRPN for Ca
2+
, which is likely to elevate Ca
2+
 levels 
during diastole [3], a reduced maximal current of the Na
+
/K
+
 pump, due to energy 
depletion, which would be expected to compromise the regulation of energy-
requiring transporters [7, 12], and an increase of the background Na
+
 current, likely 
to be involved in the process of intracellular Ca
2+
 accumulation as well, by means 
of an increase in intracellular Na
+
 and the consequent increase of Na
+
/Ca
2+
 
exchanger current [10].  
The simulated HCM phenotype was found qualitatively in agreement with the 
HCM experimental data, e.g. HCM population showed increased AP and CaT 
durations, reduced upstroke velocity and high intracellular Ca
2+
 concentration 
during diastole.  
The contribution of each remodelling element has been investigated, by running 
two additional sets of simulations. As first, starting from the CTRL population, we 
introduced each remodelling mechanism, one at a time. Then, starting from the 
HCM population, we restored each one of them, again one at a time. In each of 
these stages, we evaluated the considered set of AP and CaT biomarkers.  
About 16% of the HCM population showed EADs or repolarization failures. By 
analysing the population parameters, we pointed out the ionic mechanisms more 
likely underlying these repolarisation abnormalities, i.e. a very low IKr, high ICaL, 
INaL and INCX. 
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Since specific compounds are already available for INaL and INCX, we investigated 
in simulation the effects occurring when blocking these currents. Both INaL and INCX 
blocks proved to have an anti-arrhythmic effect in HCM, partially reversing the 
HCM remodelling. In particular, their simultaneous block is suggested as an 
effective anti-arrhythmic therapy to suppress repolarisation abnormalities in HCM. 
ICaL block has not been included up to now, since most of the compounds currently 
blocking this current are also reducing IKr, which is already compromised in HCM.  
In conclusions, this study confirmed the population of models as a valid 
approach to include biological variability in computational modelling, especially 
when considering potential therapeutic targets and drug blocks. The HCM 
phenotype has been reproduced by using experimental data together with some 
novel hypotheses based on literature, thus highlighting the ionic mechanisms more 
likely to be involved in the electrical remodelling observed in this disease. In 
addition, current block results about the simultaneous block of INaL and INCX may 
constitute the basis for a new set of experiments, in order to check if model 
predictions are actually verified in single cells.  
Future works will address the analysis of other pro-arrhythmic mechanisms, e.g. 
APD alternans and DADs, and the evaluation of other potential therapeutic targets, 
e.g. ICaL. In addition, it would be interesting to replicate the same study considering 
a different AP model as baseline to build the population, to verify how much these 
results are dependent on the considered model. In particular, since Ca
2+
 handling 
seems to play a major role in HCM and the O’Hara-Rudy ventricular AP model has 
been used as baseline to generate the population of models considered in this study, 
it would be interesting to replicate it with the hybrid model introduced in Chapter 3, 
where the Ca
2+
 subsystem has been partly revisited. 
Finally, some additional work has already been done: since most of the models 
showing repolarisation abnormalities, and especially RF, were characterised by a 
very low IKr, we repeated part of this study considering a new population of models, 
in which the same parameters have been varied in a reduced range ([50-150%], with 
respect to their original values). Results for the new population are consistent with 
the ones presented here, and RF occurrence is much lower in the population (0.5% 
compared to 9%). Some of the Figures/Tables presented in this chapter have been 
reproduced for the new population, and they have been included in Appendix B3.  
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“For over half a century now, computational models have been used in synergy 
with experimental techniques to improve our understanding of the heart in health 
and disease. The contributions of computational modelling in cardiac physiology 
are numerous and the methodology is now well established within the cardiac basic 
science community. Currently, one of the challenges that the scientific community is 
facing is its translation to research closer to the bedside, through investigating the 
pathological states of the human heart and improving diagnosis and therapy”. 
from “Computational cardiac electrophysiology is ready for prime time” 
S Severi, B Rodriguez and A Zaza, Europace 2014 
The research discussed in this thesis aims to contribute to this translation, 
focusing in particular on human cardiac action potential (AP) models. Definitely, 
there are still a lot of challenges to be solved before these models may be fully 
useful in translational research and clinical practice.  
Here, some of these challenges have been faced: 
 To extend models applicability, in order to reproduce in vivo more than 
in vitro conditions. As a relevant example, we investigated what happens 
when extracellular Ca
2+
 is set to the values measured in the interstitial 
fluid instead of the ones used for Tyrods’e solutions and how its 
variations affect the cardiac AP (Section I, Chapter 3 and Chapter 4). 
 To find clinical contexts in which it is possible to compare macroscopic 
measures with simulation results, in order to better understand the 
correlation between the ionic mechanisms involved at a single cell level 
and the clinical patient phenotype. As a relevant example, we considered 
haemodialysis therapy (Section II, Chapter 5 and Chapter 6). 
 To include biological variability in computational modelling, in order to 
extend model predictions to a population level, instead of considering 
results referring only to the average cell behaviour. As a relevant 
example, we considered hypertrophic cardiomyopathy (HCM), where 
variability seems to play a major role, especially when considering 
patient response to drugs (Section III, Chapter 7). 
All these aspects have been investigated by using human cardiac AP models, and 
each one is discussed in details in a separate Section of this thesis. Every chapter 
has its own detailed conclusions at the end: therefore, here is only a brief summary 
of the main objectives achieved, together with a description of future works. 
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As discussed in Chapter 3, a new Markov model for the L-type Ca
2+
 current has 
been developed and integrated into the most recently published human ventricular 
AP model (O’Hara-Rudy, 2011), to improve its response to extracellular Ca2+ 
([Ca
2+
]o) variations. The design of the new current model has been based on the 
hypothesis that Ca
2+
-dependent inactivation is actually a fast voltage-dependent 
gating mechanism, activated when there is a high Ca
2+
 concentration in the cell, and 
also assuming that this inactivation is underestimated in most of the human cardiac 
AP models currently available. Based on these assumptions, the new hybrid model 
is indeed able to reproduce the inverse dependence experimentally observed 
between AP duration (APD) and [Ca
2+
]o, not properly reproduced in the original 
O’Hara-Rudy one. The hybrid model has already been validated against a wide 
range of experimental data, to check its consistency with the original one. Once 
fully validated, it will constitute a great tool to explore those clinical contexts in 
which electrolyte variations may occur, to evaluate the corresponding changes in 
cardiac electrophysiology, and to assess the possibly increased arrhythmic risk.  
As future works, we are planning a more comprehensive analysis of electrolyte 
variations (considering also extracellular Na
+
 and K
+
) and the evaluation of their 
combined effects on a set of AP and Ca
2+
 transient (CaT) biomarkers, taking into 
account also potential pro-arrhythmic mechanisms, such as APD alternans and 
early/delayed after-depolarisations (EADs/DADs). 
As an example, in Chapter 4 the hybrid model has been used to analyse 
experimental data acquired during a bed-rest campaign organised by the European 
Space Agency, to assess the possibly increased arrhythmic risk for astronauts 
during space flights, due to microgravity exposure. Single cell and 1D simulation 
results were in agreement with ECG data analysis, providing evidence of a biphasic 
change in repolarisation occurring during bed-rest. Moreover, simulations 
supported a causal relation between the observed QT prolongation and the changes 
in electrolytes occurring during bed-rest. Unfortunately, the variability was really 
high among the volunteers and data acquisitions have been performed only a few 
times in the whole campaign: therefore, additional data are required to have a more 
accurate analysis. A new bed-rest experiment has been recently completed by ESA 
and new experimental data are expected to be available for further investigations in 
the near future.  
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In Chapter 5 and Chapter 6, the haemodialysis (HD) therapy effects on cardiac 
AP have been investigated in end-stage renal disease (ESRD) patients, taking into 
account changes in extracellular electrolyte concentrations, heart rate and cell 
volume, together with the effect of different acetylcholine concentrations. Here, 
human atrial AP models have been considered, since atrial fibrillation (AF) 
incidence is high in ESRD patients.  
The case report of a patient showing recurring paroxysmal AF during HD 
therapy has been used to speculate on intra-dialytic AF onset mechanisms, by 
combining experimental data, ECG analysis and computational simulations 
(Chapter 6). The HD therapy induces a slowdown in conduction velocity and a 
decrease of the refractory period, thus producing a vulnerable acute substrate which, 
in presence of a trigger (e.g. ectopic beats), may lead to AF.  
The model used to analyse the patient data has been chosen after benchmarking 
all the available atrial AP models, with respect to their suitability to the HD context 
(Chapter 5).  
Since none of the considered models was fully able to reproduce all the HD-
induced effects on human atrial AP, future works will address specific changes in 
the most recent atrial models, in order to improve their performance in HD-related 
conditions. In addition, a similar benchmark of human ventricular models may be 
useful to explore the pro-arrhythmic mechanisms potentially induced by HD in 
ventricular cells. 
Finally, Chapter 7 shows an example of the population of models approach, 
used to investigate the electrical remodelling occurring in human HCM, based on 
experiments acquired in human single cells. The ionic mechanisms underlying the 
electrical remodelling and their contribution to the HCM phenotype have been 
evaluated, based on the experimental data available and new original hypotheses. 
Late Na
+
 current (INaL) and Na
+
/Ca
2+
 exchanger (INCX), both up-regulated in HCM, 
have been identified as potential therapeutic targets in this disease. Since 
compounds to block these currents are already available on the market, both INaL 
and INCX inhibitions have been tested in the HCM population of models, evaluating 
the occurrence of pro-arrhythmic mechanisms, such as EADs and repolarisation 
failure. Simulation results showed that both current blocks have a positive effect, 
partially reversing the HCM phenotype and reducing repolarisation abnormalities 
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occurrence. In particular, the combined block of both INaL and INCX is suggested as 
an effective anti-arrhythmic strategy in human HCM. 
Future works will address the analysis of other pro-arrhythmic mechanisms, e.g. 
APD alternans and DADs, and the evaluation of other potential therapeutic targets, 
e.g. ICaL. In addition, since the O’Hara-Rudy ventricular AP model has been used as 
baseline to generate the population of models considered in this study, it would be 
very interesting to see how model dependent are these results, by reproducing the 
same study with a different model as baseline. In particular, since Ca
2+
 handling 
plays a big role in HCM, it would be worth considering the hybrid model 
introduced in Chapter 3, where the Ca
2+
 subsystem has been partly revisited. 
As general conclusions, a few observations can be made: 
 The currently published AP models, both atrial and ventricular, still have 
some open issues, especially when applied to contexts different from those 
considered for their development and validation. An accurate description of 
the cellular electrophysiology is particularly crucial to avoid 
misinterpretations when model are needed for predictions. 
 Biological variability plays a major role in cardiac electrophysiology and it 
cannot be ignored in computational modelling. The population of models 
approach proved to be a valid tool to account for it, providing the means to 
investigate pro-arrhythmic mechanisms or drug action in a probabilistic way: 
e.g. % of EADs occurrence in HCM. 
 Nowadays, models allow to investigate and understand very specific clinical 
situations, such as the patient-specific response to a therapy (e.g. the patient 
with paroxysmal AF during HD), or the effect of current blockers in a cell 
population. This is particularly relevant for drug action studies, for which the 
importance of in silico techniques is increasing year by year. The US Food 
and Drug administration, recently announced a new paradigm for the 
evaluation of new molecular entities: “the comprehensive in-vitro pro-
arrhythmia assay” (Sager et al. “Rechanneling the cardiac pro-arrhythmia 
safety paradigm: a meeting report from the Cardiac Safety Research 
Consortium”, Am. Heart J. 2014), in which the integration of ion 
channel/drug interaction data into in silico models of human ventricular 
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electrophysiology is proposed, to predict and evaluate the corresponding 
changes in the human AP. 
From all these observations, the need for a close link between experimental data 
and computational models clearly emerges. In fact, in vivo observations, in vitro 
experiments and in silico predictions have to be combined together to gain new 
insights into cardiac electrophysiology, linking ionic mechanisms to clinical patient 
phenotypes both in physiological and pathological conditions, thus improving 
patient diagnosis and treatment. 
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This Appendix includes part of the Matlab code used to generate the results 
presented in Chapter 3 and Chapter 4: 
1. Modified ORd model: Matlab function file modORd.m 
2. Script with the model parameters: file modORd_par.m 
3. Script to run the model: file modORd_main.m 
1. Modified ORd model: Matlab function file modORd.m 
function output = modORd(t,X,varargin)  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% O'Hara-Rudy Human Ventricular Model (2011) 
% 
% Original Matlab file from: 
% http://rudylab.wustl.edu/research/cell/code/AllCodes.html 
%  
% Related Journal Paper 
% http://www.ncbi.nlm.nih.gov/pubmed/21637795 
% 
% * Structure & ICaL modified by Ely (Last Update: Jan 2014) 
% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
global kCDI cPCa cVss cVsr cJup bJdiff bGncx bGKr k1r_down... 
jncass_n jncass_s jncass_d jncass_k...  % jca 
tau_nca Kmn_nca k2n_nca km2n_nca...     % nca 
dss_n dss_k dss_s dss_d taud_k taud_k1 taud_k2 taud_s1 taud_s2... % d 
jss_n jss_s jss_d jss_k tj_max tj_min tj_media tj_sd... % j 
f1ss_n f1ss_s f1ss_d f1ss_k...  % f1 
tf1_kk tf1_n tf1_k tf1_k1 tf1_k2 tf1_s1 tf1_s2 tf1_d1 tf1_d2... % tf1 
tf2_kk tf2_n tf2_k tf2_k1 tf2_k2 tf2_s1 tf2_s2 tf2_d1 tf2_d2... % tf2 
a2_rel n_rel s_rel exp_rel ntau1_rel ntau2_rel n2_rel % RyRs 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Optional Inputs: 
% (Default values *) 
% 1) flag_ode:  
%    - flag_ode=0  -> "computed variables" output 
%    - flag_ode=1* -> dX output 
% 2) celltype: 
%    - celltype=0* -> endo 
%    - celltype=1  -> epi 
%    - celltype=2  -> M 
% 3) pstim: stimulation protocol and parameters 
%    - pstim=1*             -> I-clamp, single beat 
%    - pstim=[2 CL] -> I-clamp, multiple beats with CL as input 
%    - pstim=[3 vclamp] -> Ely V-clamp, single V-step 
%    - pstim=[4 vclamp] -> Grandi-Bers 2010 V-clamp, single V-step 
% 4) Extracellular Ionic Concentrations [cCao cNao cKo] mM: 
%    default values: Cao = 1.8mM*; Nao = 140mM*; cKo  = 5.4mM* 
%    - if length=1 -> [cCao] only 
%    - if length=2 -> [cCao cNao] 
%    - if length=3 -> [cCao cNao cKo] 
% 5) bn: % of ICaL CDI block (VDI-only ICaL) 
%    - bn=1* -> no CDI block 
%    - bn=0  -> CDI total block 
% 6) Ib: currents block -> [0-1] for each current/flux (11 total): 
%    Ib=[bINa bINaL bIto bICaL bIKr bIKs bIK1 bINaCa bINaK bJup bJrel]; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Optional Inputs setting: 
% Set default values for optional inputs 
cEx0 = [1.8, 140.0, 5.4]; 
Ib0 = ones(11,1); 
ki_cost0 = 0; 
optargs = {1,0,1,cEx0,1,Ib0,ki_cost0}; 
% skip any new inputs, if empty 
newVals = cellfun(@(x) ~isempty(x), varargin); 
% overwrite inputs specified in varargin 
optargs(newVals) = varargin(newVals); 
% [optargs{1:length(varargin)}] = varargin{:}; 
[flag_ode, celltype, pstim, cEx, bn, Ib,ki_cost]=optargs{:}; 
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% State Variables 
% -> Membrane Potential V 
v = X(1); 
% -> Ionic Concentrations 
nai = X(2);     nass = X(3);   
if ki_cost==0;  
ki  = X(4);     kss  = X(5);     
else 
ki  = ki_cost;  kss  = ki_cost;    
end    
cai = X(6);     cass = X(7);    casr = X(9); 
% -> INa gv 
m = X(10);     hf  = X(11);   hs = X(12); 
j = X(13);     hsp = X(14);   jp = X(15); 
% -> INaL gv 
mL = X(16);    hL = X(17);    hLp = X(18); 
% -> Ito gv 
a  = X(19);    iF  = X(20);   iS  = X(21); 
ap = X(22);    iFp = X(23);   iSp = X(24); 
% -> ICaL gv 
% d     ff      fs    
% fcaf  fcas    jca   
% nca   ffp     fcafp 
% -> IKr 
xrf = X(34);   xrs = X(35); 
% -> IKs 
xs1 = X(36);   xs2 = X(37); 
% -> IK1 
xk1 = X(38); 
% -> Fluxes 
Jrelnp = X(39); Jrelp = X(40); 
% -> CaMKt 
CaMKt = X(41); 
% -> ICaL Markov 
I1k  = X(42);   I2k  = X(43);   Ck  = X(44); 
I1kp = X(45);   I2kp = X(46);   Ckp = X(47); 
I1Cak  = X(48); I2Cak  = X(49); CCak  = X(50); 
I1Cakp = X(51); I2Cakp = X(52); CCakp = X(53); 
Ok = X(26);     Okp = X(27); 
jnca = X(54);   nca  = bn*X(31); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Extracellular Ionic Concentrations [mM] 
if length(cEx)==1 
    nao = cEx0(2);   %[Na]o mM 
    cao = cEx;     %[Ca]o mM 
    ko  = cEx0(3);     %[K]o  mM 
elseif length(cEx)==2 
    nao = cEx(2);  %[Na]o mM 
    cao = cEx(1);  %[Ca]o mM 
    ko  = cEx0(3);     %[K]o  mM 
elseif length(cEx)==3 
    nao = cEx(2);  %[Na]o mM 
    cao = cEx(1);  %[Ca]o mM 
    ko  = cEx(3);  %[K]o  mM 
else 
    error('Extracellular Concentrations Error!!!'); 
end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Physical Constants: 
R = 8314.0;   % J/kmol/K 
T = 310.0;    % K 
F = 96485.0;  % C/mol 
vffrt = v*F*F/(R*T); 
vfrt  = v*F/(R*T); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Cell Geometry (approxymate by a cylinder of length L and radius r) 
L = 0.01;                         % cm 
rad = 0.0011;                     % cm 
vcell = 1000*pi*rad^2*L;          % 38e-6 uL 
% Geometric Area 
Ageo = 2*pi*rad^2 + 2*pi*rad*L;   % cm^2 
% Capacitive Area 
Acap = 2*Ageo;                    % cm^2 
% Compartment Volumes (4) 
vmyo = 0.68*vcell;                % uL 
vnsr = 0.0552*vcell;              % uL 
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vjsr = 0.0048*vcell;              % uL 
vsr = cVsr*(vnsr+vjsr);           % uL 
vss  = cVss*0.02*vcell;           % uL 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% CaMK Constants 
KmCaMK = 0.15;  aCaMK  = 0.05;  bCaMK  = 0.00068; 
CaMKo  = 0.05;  KmCaM  = 0.0015; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% update CaMK -> X(41) 
CaMKb = CaMKo*(1.0-CaMKt) / (1.0+KmCaM/cass); 
CaMKa = CaMKb+CaMKt; 
dCaMKt = aCaMK*CaMKb*(CaMKb+CaMKt) - bCaMK*CaMKt; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Reversal Potentials 
ENa  = (R*T/F)*log(nao/nai); 
EK   = (R*T/F)*log(ko/ki); 
PKNa = 0.01833; 
EKs  = (R*T/F)*log((ko+PKNa*nao)/(ki+PKNa*nai)); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% INa current 
mss=1.0/(1.0+exp((-(v+39.57))/9.871)); 
tm=1.0/(6.765*exp((v+11.64)/34.77)+8.552*exp(-(v+77.42)/5.955)); 
dm=(mss-m)/tm; 
hss=1.0/(1+exp((v+82.90)/6.086)); 
thf=1.0/(1.432e-5*exp(-(v+1.196)/6.285)+6.149*exp((v+0.5096)/20.27)); 
ths=1.0/(0.009794*exp(-(v+17.95)/28.05)+0.3343*exp((v+5.730)/56.66)); 
Ahf=0.99; 
Ahs=1.0-Ahf; 
dhf=(hss-hf)/thf; 
dhs=(hss-hs)/ths; 
h=Ahf*hf+Ahs*hs; 
jss=hss; 
tj=2.038+1.0/(0.02136*exp(-(v+100.6)/8.281)+0.3052*exp((v+0.9941)/38.45)); 
dj=(jss-j)/tj; 
hssp=1.0/(1+exp((v+89.1)/6.086)); 
thsp=3.0*ths; 
dhsp=(hssp-hsp)/thsp; 
hp=Ahf*hf+Ahs*hsp; 
tjp=1.46*tj; 
djp=(jss-jp)/tjp; 
GNa=75; 
fINap=(1.0/(1.0+KmCaMK/CaMKa)); 
INa=Ib(1)*GNa*(v-ENa)*m^3.0*((1.0-fINap)*h*j+fINap*hp*jp); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% INaL current 
mLss=1.0/(1.0+exp((-(v+42.85))/5.264)); 
tmL=tm; 
dmL=(mLss-mL)/tmL; 
hLss=1.0/(1.0+exp((v+87.61)/7.488)); 
thL=200.0; 
dhL=(hLss-hL)/thL; 
hLssp=1.0/(1.0+exp((v+93.81)/7.488)); 
thLp=3.0*thL; 
dhLp=(hLssp-hLp)/thLp; 
GNaL=0.0075; 
if celltype==1 
    GNaL=GNaL*0.6; 
end 
fINaLp=(1.0/(1.0+KmCaMK/CaMKa)); 
INaL=Ib(2)*GNaL*(v-ENa)*mL*((1.0-fINaLp)*hL+fINaLp*hLp); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Ito current 
ass=1.0/(1.0+exp((-(v-14.34))/14.82)); 
ta=1.0515 / (1.0/(1.2089*(1.0+exp(-(v-18.4099)/29.3814)))+... 
                     3.5/(1.0+exp((v+100.0)/29.3814))); 
da=(ass-a)/ta; 
iss=1.0/(1.0+exp((v+43.94)/5.711)); 
if celltype==1 
    delta_epi=1.0-(0.95/(1.0+exp((v+70.0)/5.0))); 
else 
    delta_epi=1.0; 
end 
tiF=4.562+1/(0.3933*exp((-(v+100.0))/100.0)+0.08004*exp((v+50.0)/16.59)); 
tiS=23.62+1/(0.001416*exp((-(v+96.52))/59.05)+... 
             1.780e-8*exp((v+114.1)/8.079)); 
tiF=tiF*delta_epi; 
tiS=tiS*delta_epi; 
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AiF=1.0/(1.0+exp((v-213.6)/151.2)); 
AiS=1.0-AiF; 
diF=(iss-iF)/tiF; 
diS=(iss-iS)/tiS; 
i=AiF*iF+AiS*iS; 
assp=1.0/(1.0+exp((-(v-24.34))/14.82)); 
dap=(assp-ap)/ta; 
dti_develop=1.354+1.0e-4/(exp((v-167.4)/15.89)+exp(-(v-12.23)/0.2154)); 
dti_recover=1.0-0.5/(1.0+exp((v+70.0)/20.0)); 
tiFp=dti_develop*dti_recover*tiF; 
tiSp=dti_develop*dti_recover*tiS; 
diFp=(iss-iFp)/tiFp; 
diSp=(iss-iSp)/tiSp; 
ip=AiF*iFp+AiS*iSp; 
Gto=0.02; 
if celltype==1 
    Gto=Gto*4.0; 
elseif celltype==2 
    Gto=Gto*4.0; 
end 
fItop=(1.0/(1.0+KmCaMK/CaMKa)); 
Ito=Ib(3)*Gto*(v-EK)*((1.0-fItop)*a*i+fItop*ap*ip); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% ICaL, ICaNa, ICaK current section 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% -> p vs np ICaL 
fICaLp=(1.0/(1.0+KmCaMK/CaMKa)); 
% -> up/down rates 
r_down = bn*(k1r_down); 
r_up = bn*(r_down*nca/(1-nca)); 
% n gate -> CDI vs VDI 
jncass = jncass_n/(1.0+exp((v+jncass_s)/jncass_d))+jncass_k; 
tjnca  = tau_nca; 
djnca  =(jncass-jnca)/tjnca; 
Kmn  = Kmn_nca; 
k2n  = k2n_nca; 
km2n = km2n_nca*jnca; 
anca=1/(k2n/km2n+(1.0+Kmn/cass)^4.0); 
dnca=bn*(anca*k2n-nca*km2n); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Activation (d) rates: alpha/beta 
% dss = 1.0/(1.0+exp((-(v+3.940))/4.230)); 
% td  = 0.6+1.0/(exp(-0.05*(v+6.0))+exp(0.09*(v+14.0))); 
dss = dss_n/(1.0+exp((-(v+dss_s))/dss_d))+dss_k; 
td  = (taud_k+1.0/( exp(taud_k1*(v+taud_s1))+exp(taud_k2*(v+taud_s2))) ); 
alpha = dss/td; 
beta = (1-dss) / td; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Recovery (j) rates: psi/omega 
jcass_new= jss_n/(1.0+exp((v+jss_s)/jss_d)) + jss_k; 
jcass_VD = jcass_new;   jcass_CD = jcass_new; 
jcass_VDp = jcass_new;  jcass_CDp = jcass_new; 
tjca_new = tj_min + tj_max*exp(-(v-tj_media)^2/(2*tj_sd^2)); 
tjca_VD = tjca_new;     tjca_VDp = tjca_new; 
tjca_CD = tjca_new;     tjca_CDp = tjca_new; 
psi_VD=jcass_VD/tjca_VD;    psi_VDp=jcass_VDp/tjca_VDp; 
psi_CD=jcass_CD/tjca_CD;    psi_CDp=jcass_CDp/tjca_CDp; 
omega_VD=(1-jcass_VD)/tjca_VD;  omega_VDp=(1-jcass_VDp)/tjca_VDp; 
omega_CD=(1-jcass_CD)/tjca_CD;  omega_CDp=(1-jcass_CDp)/tjca_CDp; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Fact Inactivation (f1) rates: gamma/delta 
% f1ss  = 1.0 / (1.0+exp((v+19.58)/3.696)); 
% tff   = 7.0 + 1.0/(0.0045*exp(-(v+20.0)/10.0)+0.0045*exp((v+20.0)/10.0)); 
% tfcaf = 7.0 + 1.0/(0.04*exp(-(v-4.0)/7.0)+0.04*exp((v-4.0)/7.0)); 
f1ss_0 = f1ss_n / (1.0+exp((v+f1ss_s)/f1ss_d)) + f1ss_k; 
tf1_0   = tf1_kk*(tf1_k + tf1_n./ (tf1_k1*exp((v+tf1_s1)/tf1_d1)+... 
                                   tf1_k2*exp((v+tf1_s2)/tf1_d2))); 
ktaup = 2.5; 
gamma_VD  = (1-f1ss_0)/ tf1_0;          
delta_VD  =    f1ss_0 / tf1_0;     
gamma_VDp  = gamma_VD/ktaup;          
delta_VDp  = delta_VD/ktaup;     
gamma_CD=gamma_VD*kCDI;     delta_CD=delta_VD*kCDI; 
gamma_CDp=gamma_VDp*kCDI;   delta_CDp=delta_VDp*kCDI; 
tf1_VD = 1/(gamma_VD+delta_VD); 
tf1_CD = 1/(gamma_CD+delta_CD); 
f1ss_VD = gamma_VD / (gamma_VD+delta_VD); 
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f1ss_CD = gamma_CD / (gamma_CD+delta_CD); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Slow Inactivation (f2) rates: gamma/delta 
% fss=1.0/(1.0+exp((v+19.58)/3.696)); 
% tfs=1000.0+1.0/(0.000035*exp(-(v+5.0)/4.0)+0.000035*exp((v+5.0)/6.0)); 
% tfcas=100.0+1.0/(0.00012*exp(-v/3.0)+0.00012*exp(v/7.0)); 
tf2_VD   = tf2_kk*(tf2_k + tf2_n./ (tf2_k1*exp((v+tf2_s1)/tf2_d1)+... 
                                     tf2_k2*exp((v+tf2_s2)/tf2_d2))); 
tf2_CD = tf2_VD/kCDI; 
tf2_VDp = tf2_VD*ktaup; 
tf2_CDp = tf2_VD/kCDI*ktaup; 
% Reversibility 
theta_VD = alpha*gamma_VD*psi_VD/tf2_VD/... 
            (alpha*gamma_VD*psi_VD+beta*delta_VD*omega_VD); 
theta_CD = alpha*gamma_CD*psi_CD/tf2_CD/... 
            (alpha*gamma_CD*psi_CD+beta*delta_CD*omega_CD); 
theta_VDp = alpha*gamma_VDp*psi_VDp/tf2_VDp/... 
            (alpha*gamma_VDp*psi_VDp+beta*delta_VDp*omega_VDp); 
theta_CDp = alpha*gamma_CDp*psi_CDp/tf2_CDp/... 
            (alpha*gamma_CDp*psi_CDp+beta*delta_CDp*omega_CDp); 
eta_VD=1/tf2_VD - theta_VD; 
eta_VDp=1/tf2_VDp - theta_VDp; 
eta_CD=1/tf2_CD - theta_CD; 
eta_CDp=1/tf2_CDp - theta_CDp; 
tf2_VD = 1/(eta_VD+theta_VD); 
tf2_CD = 1/(eta_CD+theta_CD); 
f2ss_VD=eta_VD/(eta_VD+theta_VD); 
f2ss_CD=eta_CD/(eta_CD+theta_CD); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Driving Forces 
PhiCaL=4.0*vffrt*(cass*exp(2.0*vfrt)-0.341*cao)/(exp(2.0*vfrt)-1.0); 
PhiCaNa=1.0*vffrt*(0.75*nass*exp(1.0*vfrt)-0.75*nao)/(exp(1.0*vfrt)-1.0); 
PhiCaK=1.0*vffrt*(0.75*kss*exp(1.0*vfrt)-0.75*ko)/(exp(1.0*vfrt)-1.0); 
PCa=0.0001*cPCa; 
if celltype==1 
    PCa=PCa*1.2; 
elseif celltype==2 
    PCa=PCa*2.5; 
end 
PCap=1.1*PCa; 
PCaNa=0.00125*PCa; 
PCaK=3.574e-4*PCa; 
PCaNap=0.00125*PCap; 
PCaKp=3.574e-4*PCap; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Markov Model: VDI states 
OCak = 1-CCak-I1Cak-I2Cak-Ck-I1k-I2k-Ok; 
OCakp = 1-CCakp-I1Cakp-I2Cakp-Ckp-I1kp-I2kp-Okp; 
dOk =  alpha*Ck        + delta_VD*I1k    - (beta+gamma_VD)*Ok      - r_up*Ok + 
r_down*OCak; 
dI2k = eta_VD*I1k      + omega_VD*Ck     - (theta_VD+psi_VD)*I2k   - r_up*I2k + 
r_down*I2Cak; 
dI1k = theta_VD*I2k    + gamma_VD*Ok     - (eta_VD+delta_VD)*I1k   - r_up*I1k + 
r_down*I1Cak; 
dCk  = beta*Ok         + psi_VD*I2k      - (omega_VD+alpha)*Ck     - r_up*Ck + 
r_down*CCak; 
dOkp = alpha*Ckp       + delta_VDp*I1kp  - (beta+gamma_VDp)*Okp    - r_up*Okp + 
r_down*OCakp; 
dI2kp = eta_VDp*I1kp    + omega_VDp*Ckp   - (theta_VDp+psi_VDp)*I2kp - r_up*I2kp + 
r_down*I2Cakp; 
dI1kp = theta_VDp*I2kp  + gamma_VDp*Okp   - (eta_VDp+delta_VDp)*I1kp - r_up*I1kp + 
r_down*I1Cakp; 
dCkp  = beta*Okp       + psi_VDp*I2kp    - (omega_VDp+alpha)*Ckp   - r_up*Ckp + 
r_down*CCakp;  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> Markov Model: CDI states 
dI2Cak = eta_CD*I1Cak     + omega_CD*CCak   - (theta_CD+psi_CD)*I2Cak + r_up*I2k - 
r_down*I2Cak; 
dI1Cak = theta_CD*I2Cak   + gamma_CD*OCak   - (eta_CD+delta_CD)*I1Cak + r_up*I1k - 
r_down*I1Cak; 
dCCak  = beta*OCak     + psi_CD*I2Cak    - (omega_CD+alpha)*CCak + r_up*Ck - 
r_down*CCak; 
dI2Cakp = eta_CDp*I1Cakp   + omega_CDp*CCakp - (theta_CDp+psi_CDp)*I2Cakp + 
r_up*I2kp - r_down*I2Cakp; 
dI1Cakp = theta_CDp*I2Cakp + gamma_CDp*OCakp - (eta_CDp+delta_CDp)*I1Cakp + 
r_up*I1kp - r_down*I1Cakp; 
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dCCakp  = beta*OCakp   + psi_CDp*I2Cakp  - (omega_CDp+alpha)*CCakp + r_up*Ckp - 
r_down*CCakp; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% -> ICaL ICaNa ICaK currents 
ICaL_VD   = Ib(4) * PCa    * PhiCaL  * Ok; 
ICaL_VDp  = Ib(4) * PCap   * PhiCaL  * Okp; 
ICaL_CD   = Ib(4) * PCa    * PhiCaL  * OCak; 
ICaL_CDp  = Ib(4) * PCap   * PhiCaL  * OCakp; 
ICaNa_VD  = Ib(4) * PCaNa  * PhiCaNa * Ok; 
ICaNa_VDp = Ib(4) * PCaNap * PhiCaNa * Okp; 
ICaNa_CD  = Ib(4) * PCaNa  * PhiCaNa * OCak; 
ICaNa_CDp = Ib(4) * PCaNap * PhiCaNa * OCakp; 
ICaK_VD   = Ib(4) * PCaK   * PhiCaK  * Ok; 
ICaK_VDp  = Ib(4) * PCaKp  * PhiCaK  * Okp; 
ICaK_CD   = Ib(4) * PCaK   * PhiCaK  * OCak; 
ICaK_CDp  = Ib(4) * PCaKp  * PhiCaK  * OCakp; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% ICaL VD vs CD & ICaL p vs np 
ICaLnp = ICaL_VD  + ICaL_CD; 
ICaLp  = ICaL_VDp + ICaL_CDp; 
ICaLVD = ICaL_VD*(1-fICaLp)  + ICaL_VDp*fICaLp; 
ICaLCD = ICaL_CD*(1-fICaLp)  + ICaL_CDp*fICaLp; 
  
ICaNanp = ICaNa_VD  + ICaNa_CD; 
ICaNap  = ICaNa_VDp + ICaNa_CDp; 
ICaKnp = ICaK_VD  + ICaK_CD; 
ICaKp  = ICaK_VDp + ICaK_CDp; 
  
ICaL  = ICaLp*fICaLp + ICaLnp*(1-fICaLp); 
ICaNa = ICaNap*fICaLp + ICaNanp*(1-fICaLp); 
ICaK  = ICaKp*fICaLp + ICaKnp*(1-fICaLp); 
  
% ICaL "experimental conductance" 
gICaL = ICaL/PhiCaL; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% IKr current 
xrss=1.0/(1.0+exp((-(v+8.337))/6.789)); 
txrf=12.98+1.0/(0.3652*exp((v-31.66)/3.869)+... 
            4.123e-5*exp((-(v-47.78))/20.38)); 
txrs=1.865+1.0/(0.06629*exp((v-34.70)/7.355)+... 
            1.128e-5*exp((-(v-29.74))/25.94)); 
Axrf=1.0/(1.0+exp((v+54.81)/38.21)); 
Axrs=1.0-Axrf; 
dxrf=(xrss-xrf)/txrf; 
dxrs=(xrss-xrs)/txrs; 
xr=Axrf*xrf+Axrs*xrs; 
rkr=1.0/(1.0+exp((v+55.0)/75.0))*1.0/(1.0+exp((v-10.0)/30.0)); 
GKr=0.046*bGKr; 
if celltype==1 
    GKr=GKr*1.3; 
elseif celltype==2 
    GKr=GKr*0.8; 
end 
IKr=Ib(5)*GKr*sqrt(ko/5.4)*xr*rkr*(v-EK); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% IKs current 
xs1ss=1.0/(1.0+exp((-(v+11.60))/8.932)); 
txs1=817.3+1.0/(2.326e-4*exp((v+48.28)/17.80)+... 
                0.001292*exp((-(v+210.0))/230.0)); 
dxs1=(xs1ss-xs1)/txs1; 
xs2ss=xs1ss; 
txs2=1.0/(0.01*exp((v-50.0)/20.0)+0.0193*exp((-(v+66.54))/31.0)); 
dxs2=(xs2ss-xs2)/txs2; 
KsCa=1.0+0.6/(1.0+(3.8e-5/cai)^1.4); 
GKs=0.0034; 
if celltype==1 
    GKs=GKs*1.4; 
end 
IKs=Ib(6)*GKs*KsCa*xs1*xs2*(v-EKs); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% IK1 current 
xk1ss=1.0/(1.0+exp(-(v+2.5538*ko+144.59)/(1.5692*ko+3.8115))); 
txk1=122.2/(exp((-(v+127.2))/20.36)+exp((v+236.8)/69.33)); 
dxk1=(xk1ss-xk1)/txk1; 
rk1=1.0/(1.0+exp((v+105.8-2.6*ko)/9.493)); 
GK1=0.1908; 
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if celltype==1 
    GK1=GK1*1.2; 
elseif celltype==2 
    GK1=GK1*1.3; 
end 
IK1=Ib(7)*GK1*sqrt(ko)*rk1*xk1*(v-EK); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% INaCa current (i + SS) 
kna1=15.0;      kna2=5.0;       kna3=88.12;     kasymm=12.5; 
wna=6.0e4;      wca=6.0e4;      wnaca=5.0e3;    KmCaAct=150.0e-6; 
kcaon=1.5e6;    kcaoff=5.0e3;   qna=0.5224;     qca=0.1670; 
zna=1.0;        Gncx=0.0008*bGncx;    zca=2.0; 
if celltype==1 
    Gncx=Gncx*1.1; 
elseif celltype==2 
    Gncx=Gncx*1.4; 
end 
% INaCa_i current 
hca=exp((qca*v*F)/(R*T));       hna=exp((qna*v*F)/(R*T)); 
h1=1+nai/kna3*(1+hna);          h2=(nai*hna)/(kna3*h1); 
h3=1.0/h1;                      h4=1.0+nai/kna1*(1+nai/kna2); 
h5=nai*nai/(h4*kna1*kna2);      h6=1.0/h4; 
h7=1.0+nao/kna3*(1.0+1.0/hna);  h8=nao/(kna3*hna*h7); 
h9=1.0/h7;                      h10=kasymm+1.0+nao/kna1*(1.0+nao/kna2); 
h11=nao*nao/(h10*kna1*kna2);    h12=1.0/h10; 
k1=h12*cao*kcaon;   k2=kcaoff;        k3p=h9*wca;     k3pp=h8*wnaca;       
k3=k3p+k3pp;        k4p=h3*wca/hca;   k4pp=h2*wnaca;  k4=k4p+k4pp; 
k5=kcaoff;          k6=h6*cai*kcaon;  k7=h5*h2*wna;   k8=h8*h11*wna; 
x1=k2*k4*(k7+k6)+k5*k7*(k2+k3); x2=k1*k7*(k4+k5)+k4*k6*(k1+k8); 
x3=k1*k3*(k7+k6)+k8*k6*(k2+k3); x4=k2*k8*(k4+k5)+k3*k5*(k1+k8); 
E1=x1/(x1+x2+x3+x4);    E2=x2/(x1+x2+x3+x4); 
E3=x3/(x1+x2+x3+x4);    E4=x4/(x1+x2+x3+x4); 
allo=1.0/(1.0+(KmCaAct/cai)^2.0);    
JncxNa=3.0*(E4*k7-E1*k8)+E3*k4pp-E2*k3pp;    
JncxCa=E2*k2-E1*k1; 
% 
INaCa_i=Ib(8)*0.8*Gncx*allo*(zna*JncxNa+zca*JncxCa); 
% INaCa_ss current 
h1=1+nass/kna3*(1+hna);         h2=(nass*hna)/(kna3*h1); 
h3=1.0/h1;                      h4=1.0+nass/kna1*(1+nass/kna2); 
h5=nass*nass/(h4*kna1*kna2);    h6=1.0/h4; 
h7=1.0+nao/kna3*(1.0+1.0/hna);  h8=nao/(kna3*hna*h7); 
h9=1.0/h7;                      h10=kasymm+1.0+nao/kna1*(1+nao/kna2); 
h11=nao*nao/(h10*kna1*kna2);    h12=1.0/h10; 
k1=h12*cao*kcaon;   k2=kcaoff;      k3p=h9*wca;     k3pp=h8*wnaca; 
k3=k3p+k3pp;        k4p=h3*wca/hca; k4pp=h2*wnaca;  k4=k4p+k4pp; 
k5=kcaoff;          k6=h6*cass*kcaon;   k7=h5*h2*wna;   k8=h8*h11*wna; 
x1=k2*k4*(k7+k6)+k5*k7*(k2+k3);     x2=k1*k7*(k4+k5)+k4*k6*(k1+k8); 
x3=k1*k3*(k7+k6)+k8*k6*(k2+k3);     x4=k2*k8*(k4+k5)+k3*k5*(k1+k8); 
E1=x1/(x1+x2+x3+x4);    E2=x2/(x1+x2+x3+x4); 
E3=x3/(x1+x2+x3+x4);    E4=x4/(x1+x2+x3+x4); 
allo=1.0/(1.0+(KmCaAct/cass)^2.0); 
JncxNa=3.0*(E4*k7-E1*k8)+E3*k4pp-E2*k3pp; 
JncxCa=E2*k2-E1*k1; 
% 
INaCa_ss=Ib(8)*0.2*Gncx*allo*(zna*JncxNa+zca*JncxCa); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% INaK current 
k1p=949.5;      k1m=182.4;      k2p=687.2;      k2m=39.4; 
k3p=1899.0;     k3m=79300.0;    k4p=639.0;      k4m=40.0; 
Knai0=9.073;    Knao0=27.78;    delta2=-0.1550;   
Knai=Knai0*exp((delta2*v*F)/(3.0*R*T)); 
Knao=Knao0*exp(((1.0-delta2)*v*F)/(3.0*R*T)); 
Kki=0.5;            Kko=0.3582;     MgADP=0.05;     MgATP=9.8; 
Kmgatp=1.698e-7;    H=1.0e-7;       eP=4.2;         Khp=1.698e-7;    
Knap=224.0;         Kxkur=292.0; 
P=eP/(1.0+H/Khp+nai/Knap+ki/Kxkur); 
a1=(k1p*(nai/Knai)^3.0)/((1.0+nai/Knai)^3.0+(1.0+ki/Kki)^2.0-1.0); 
b1=k1m*MgADP; 
a2=k2p; 
b2=(k2m*(nao/Knao)^3.0)/((1.0+nao/Knao)^3.0+(1.0+ko/Kko)^2.0-1.0); 
a3=(k3p*(ko/Kko)^2.0)/((1.0+nao/Knao)^3.0+(1.0+ko/Kko)^2.0-1.0); 
b3=(k3m*P*H)/(1.0+MgATP/Kmgatp); 
a4=(k4p*MgATP/Kmgatp)/(1.0+MgATP/Kmgatp); 
b4=(k4m*(ki/Kki)^2.0)/((1.0+nai/Knai)^3.0+(1.0+ki/Kki)^2.0-1.0); 
x1=a4*a1*a2+b2*b4*b3+a2*b4*b3+b3*a1*a2; 
x2=b2*b1*b4+a1*a2*a3+a3*b1*b4+a2*a3*b4; 
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x3=a2*a3*a4+b3*b2*b1+b2*b1*a4+a3*a4*b1; 
x4=b4*b3*b2+a3*a4*a1+b2*a4*a1+b3*b2*a1; 
E1=x1/(x1+x2+x3+x4);    E2=x2/(x1+x2+x3+x4); 
E3=x3/(x1+x2+x3+x4);    E4=x4/(x1+x2+x3+x4); 
zk=1.0;   JnakNa=3.0*(E1*a3-E2*b3);   JnakK=2.0*(E4*b1-E3*a1);    Pnak=30; 
if celltype==1 
    Pnak=Pnak*0.9; 
elseif celltype==2 
    Pnak=Pnak*0.7; 
end 
INaK=Ib(9)*Pnak*(zna*JnakNa+zk*JnakK); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Background currents: IKb, INab, ICab 
% IKb current 
xkb = 1.0 / (1.0+exp(-(v-14.48)/18.34));     
GKb = 0.003; 
if celltype==1 
    GKb = GKb*0.6; 
end 
IKb = GKb*xkb*(v-EK); 
% INab current 
PNab = 3.75e-10; 
INab = PNab*vffrt*(nai*exp(vfrt)-nao)/(exp(vfrt)-1.0); 
% ICab current 
PCab = 2.5e-8; 
ICab = PCab*4.0*vffrt*(cai*exp(2.0*vfrt)-0.341*cao)/(exp(2.0*vfrt)-1.0); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% IpCa current 
GpCa = 0.0005; 
IpCa = GpCa*cai/(0.0005+cai); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Simulation Procotols 
switch pstim(1) 
    case 1 
    % 1 - Current_Clamp -> Single Istim current 
        amp = -80.0;       
        duration = 0.5; 
        if t <= duration 
            Istim = amp; 
        else 
            Istim = 0.0; 
        end 
        % update V -> X(1) 
        dv = - (INa+INaL+Ito+ICaL+ICaNa+ICaK+IKr+IKs+IK1+... 
                INaCa_i+INaCa_ss+INaK+INab+IKb+IpCa+ICab+Istim); 
    case 2 
    % 2 - Current_Clamp -> Istim current with fixed CL 
        CL = pstim(2); 
        amp = -80.0;       
        duration = 0.5; 
        trem = rem(t,CL); 
        if trem <= duration 
            Istim = amp; 
        else 
            Istim = 0.0; 
        end         
        % update V -> X(1) 
        dv = - (INa+INaL+Ito+ICaL+ICaNa+ICaK+IKr+IKs+IK1+... 
                INaCa_i+INaCa_ss+INaK+INab+IKb+IpCa+ICab+Istim); 
    case 3 
    % 3 - Voltage_Clamp (by Ely), with single Vclamp-step 
        Istim = 0; 
    % update V -> X(1) 
        dv = 0; 
    case 4 
    % 4 - Voltage_Clamp (as in Grandi-Bers 2010), with single Vclamp-step 
    Rclamp=0.02; 
    Istim = (v-pstim(2))/Rclamp; 
    % update V -> X(1) 
    dv = - (INa+INaL+Ito+ICaL+ICaNa+ICaK+IKr+IKs+IK1+... 
            INaCa_i+INaCa_ss+INaK+INab+IKb+IpCa+ICab+Istim); 
end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Diffusion Fluxes 
JdiffNa = (nass-nai) /2.0; 
JdiffK  = (kss-ki)   /2.0; 
Jdiff   = (cass-cai) *bJdiff/0.2; 
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% RyRs CICR from JSR 
bt=4.75;        a_rel=a2_rel*0.5*bt;    
Jrel_inf=a_rel*(-ICaL)/(n2_rel+(n_rel/(casr+s_rel))^exp_rel); 
if celltype==2 
    Jrel_inf=Jrel_inf*1.7; 
end 
tau_rel=ntau1_rel*bt/(1.0+ntau2_rel/casr); 
if tau_rel<0.001 
   tau_rel=0.001;  
end 
dJrelnp=(Jrel_inf-Jrelnp)/tau_rel; 
  
btp=1.25*bt;    a_relp=a2_rel*0.5*btp;  
Jrel_infp=a_relp*(-ICaL)/(n2_rel+(n_rel/(casr+s_rel))^exp_rel); 
if celltype==2 
    Jrel_infp=Jrel_infp*1.7; 
end 
tau_relp=ntau1_rel*btp/(1.0+ntau2_rel/casr); 
if tau_relp<0.001 
   tau_relp=0.001;  
end 
dJrelp=(Jrel_infp-Jrelp)/tau_relp; 
fJrelp=(1.0/(1.0+KmCaMK/CaMKa)); 
Jrel=Ib(11)*((1.0-fJrelp)*Jrelnp+fJrelp*Jrelp); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Ca2+ Uptake Flux 
Jupnp=0.004375*cai/(cai+0.00092); 
Jupp=2.75*0.004375*cai/(cai+0.00092-0.00017); %provare a cambiare la parentesi 
if celltype==1                               %(cai + 0.00092-0.00017) 
    Jupnp=Jupnp*1.3; 
    Jupp=Jupp*1.3; 
end 
fJupp=(1.0/(1.0+KmCaMK/CaMKa)); 
Jleak=0.0039375*casr/15.0; 
Jup = cJup*Ib(10)*((1.0-fJupp)*Jupnp+fJupp*Jupp-Jleak); 
Vmax_SRCaP = 1.0*5.3114e-3;  % [mM/msec] (286 umol/L cytosol/sec) 
Kmf = 0.246e-3;          % [mM] default 
Kmr = 1.7;               % [mM]L cytosol 
hillSRCaP = 1.787;       % [mM] 
Jup2=Vmax_SRCaP*((cai/Kmf)^hillSRCaP-(casr/Kmr)^hillSRCaP)... 
    /(1+(cai/Kmf)^hillSRCaP+(casr/Kmr)^hillSRCaP); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Calcium Buffer Constants 
cmdnmax=0.05; 
if celltype==1 
    cmdnmax=cmdnmax*1.3; 
end 
kmcmdn=0.00238;     trpnmax=0.07;   kmtrpn=0.0005; 
BSRmax=0.047;       KmBSR=0.00087; 
BSLmax=1.124;       KmBSL=0.0087; 
csqnmax=10.0;       kmcsqn=0.8; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% update [Na+]i, [K+]i and [Ca2+]i 
% -> [Na] 
dnai=-(INa+INaL+3.0*INaCa_i+3.0*INaK+INab)*Acap/(F*vmyo)+JdiffNa*vss/vmyo; 
dnass=-(ICaNa+3.0*INaCa_ss)*Acap/(F*vss)-JdiffNa; 
% -> [K] 
if ki_cost==0 
dki=-(Ito+IKr+IKs+IK1+IKb+Istim-2.0*INaK)*Acap/(F*vmyo)+JdiffK*vss/vmyo; 
dkss=-(ICaK)*Acap/(F*vss)-JdiffK; 
else 
dki=0; 
dkss=0; 
end 
% -> [Ca] 
Bcai   = 1.0 / (1.0+cmdnmax*kmcmdn/(kmcmdn+cai)^2.0 +... 
                    trpnmax*kmtrpn/(kmtrpn+cai)^2.0); 
dcai   = Bcai*(-(IpCa+ICab-2.0*INaCa_i)*Acap/(2.0*F*vmyo) -... 
                    Jup*vsr/vmyo+Jdiff*vss/vmyo); 
Bcass  = 1.0/(1.0+BSRmax*KmBSR/(KmBSR+cass)^2.0 +... 
                  BSLmax*KmBSL/(KmBSL+cass)^2.0); 
dcass  =  Bcass*(-(ICaL-2.0*INaCa_ss)*Acap/(2.0*F*vss) +... 
                    Jrel*vsr/vss-Jdiff); 
Bcasr = 1.0/(1.0+csqnmax*kmcsqn/(kmcsqn+casr)^2.0); 
dcasr = Bcasr*(Jup-Jrel); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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%% Output Computation 
% When flag==1 -> dX 
if flag_ode==1 
    output=[dv      dnai    dnass   dki     dkss...     %   1 
            dcai    dcass   0       dcasr   dm...       %   2 
            dhf     dhs     dj      dhsp    djp...      %   3 
            dmL     dhL     dhLp    da      diF...      %   4 
            diS     dap     diFp    diSp    0 ...       %   5  
            dOk     dOkp    0       0       0 ...       %   6 
            dnca    0       0       dxrf    dxrs...     %   7 
            dxs1    dxs2    dxk1    dJrelnp dJrelp...   %   8      
            dCaMKt  dI1k    dI2k    dCk     dI1kp...    %   9 
            dI2kp   dCkp    dI1Cak  dI2Cak  dCCak...    %  10 
            dI1Cakp dI2Cakp dCCakp  djnca   ]';         %  11 
% When flag==0 -> Computed Variables: currents, concentrations and fluxes 
else 
    output=[INa       INaL     Ito       ICaL       IKr...      %  1 
            IKs       IK1      INaCa_i   INaCa_ss   INaK...     %  2 
            IKb       INab     ICab      IpCa       Jdiff...    %  3 
            JdiffNa   JdiffK   Jup       Jleak      0...        %  4 
            Jrel      CaMKa    Istim     ICaK       ICaNa...    %  5 
            fICaLp    PhiCaL   Kmn       k2n        km2n...     %  6 
            Jup       Jup2     anca      r_up       dss...      %  7     
            r_up      r_down   eta_VDp   eta_CDp    td...       %  8 
            tjca_VD   tf1_VD   tf2_VD    tf1_CD     tf2_CD...   %  9 
            alpha     beta     theta_VDp theta_CDp  omega_VD... % 10 
            omega_VDp omega_CD omega_CDp psi_VD     psi_VDp...  % 11 
            psi_CD    psi_CDp  gamma_VD  gamma_VDp  gamma_CD... % 12 
            gamma_CDp delta_VD delta_VDp delta_CD   delta_CDp...% 13 
            eta_VD    eta_CD   theta_VD  theta_CD   f1ss_VD...  % 14            
            f1ss_CD   f2ss_VD  f2ss_CD   jcass_VD   jcass_CD... % 15 
            tjca_VD   tjca_CD  jcass_VDp jcass_CDp  gICaL...    % 16 
            ICaLVD    ICaLCD   ICaLp     ICaLnp     OCak...     % 17 
            ICaL_VDp ICaL_CDp ICaL_VD    ICaL_CD    OCakp]';    % 18 
end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% END FILE 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
2. Script with the model parameters: file modORd_par.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% Global parameters for the modified ORd model 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
global kCDI cPCa cVss cVsr cJup bJdiff bGncx bGKr k1r_down... 
jncass_n jncass_s jncass_d jncass_k...  % jca 
tau_nca Kmn_nca k2n_nca km2n_nca...     % nca 
dss_n dss_k dss_s dss_d taud_k taud_k1 taud_k2 taud_s1 taud_s2... % d 
jss_n jss_s jss_d jss_k tj_max tj_min tj_media tj_sd... % j 
f1ss_n f1ss_s f1ss_d f1ss_k...  % f1 
tf1_kk tf1_n tf1_k tf1_k1 tf1_k2 tf1_s1 tf1_s2 tf1_d1 tf1_d2... % tf1 
tf2_kk tf2_n tf2_k tf2_k1 tf2_k2 tf2_s1 tf2_s2 tf2_d1 tf2_d2... % tf2 
a2_rel n_rel s_rel exp_rel ntau1_rel ntau2_rel n2_rel % RyRs 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% CDI vs VDI 
kCDI = 10; 
%% r_up & down 
k1r_up = 3;     k2r_up = 6e-3;      k1r_down = 1e-1; 
%% nca & jnca 
tau_nca = 1;        
Kmn_nca = 0.025;   
k2n_nca  = 1000;   
km2n_nca = 1*150; 
jncass_n = 1; 
jncass_s = 19.58+25; 
jncass_d = 3.696; 
jncass_k = 0; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Activation d -> steady state 
dss_n = 1; 
dss_s = 3.940; 
dss_d = 4.230; 
dss_k = 0; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Activation d -> tau 
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taud_k = 0.6; 
taud_k1 = -0.05; 
taud_s1 = 6; 
taud_k2 = 0.09; 
taud_s2 = 14; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Recovery j -> steady state 
jss_n = 1; 
jss_s = 19.58; 
jss_d = 3.696; 
jss_k = 0; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Recovery j -> tau 
tj_min = 35; 
tj_max = 350; 
tj_media = -20; 
tj_sd = 10; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Fast Inactivation f1 -> tau 
tf1_kk = 1;         % scaling factor 
tf1_k  = 70;        % basal value 
tf1_n  = 1.2;       % num 
% - (v-vm) 
tf1_k1 = 0.0045;    % scaling factor 
tf1_s1 = 20;        % shift   
tf1_d1 = -50;       % den 
% + (v-vm) 
tf1_k2 = 0.0045;    % scaling factor 
tf1_s2 = 30;        % shift  
tf1_d2 = 10;        % den 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Fast Inactivation f1 -> f1ss 
f1ss_n=0.8;         % num 
f1ss_s=19.58;       % shift 
f1ss_d=3.696;       % den 
f1ss_k=0.2;         % basal value 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Slow Inactivation f2 -> tau 
tf2_kk = 1;         % scaling factor 
tf2_k  = 100;       % basal value 
tf2_n  = 0;         % num 
% - (v-vm) 
tf2_k1 = 0.0035;    % scaling factor 
tf2_s1 = 5;         % shift   
tf2_d1 = -84;       % den 
% +(v-vm) 
tf2_k2 = 0.0035;    % scaling factor 
tf2_s2 = 5;         % shift  
tf2_d2 = 4;         % den   
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Slow Inactivation f2 -> f2ss 
% 
% ***reversibility*** 
% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% RyRs parameters 
a2_rel = 1; 
n_rel = 1.5; 
n2_rel = 1; 
s_rel = 0; 
exp_rel = 8; 
ntau1_rel = 1; 
ntau2_rel = 0.0123; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Other Variables 
bGKr = 1;       % IKr scaling 
bGncx = 1.2;    % INCX scaling 
cPCa = 0.9;     % ICaL scaling 
bJdiff=2;       % Jdiff Ca2+ scaling 
cJup = 10;      % Jup Ca2+ scaling 
cVss = 1;       % SS volume scaling 
cVsr=0.95;      % SR volume scaling 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% END FILE 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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3. Script to run the model: file modORd_main.m 
clear all; close all; clc; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Main Settings: 
nb = 1000;   % number of beats to run             
BCL = 1000;  % basic cycle length (ms)          
ODEstep = 1; % max time step (ms)  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Parameters cyBCLe 
AP_model = @modORd;    % AP file function model 
file_pars = 'modORd_par';   % ICaL parameters 
run(file_pars); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Initial Conditions: 
% Original ORd state variables: 
v=-87;      nai=7;      nass=nai;       ki=145;         kss=ki; 
cai=1.0e-4; cass=cai;   casr=1.2;      m=0;            hf=1; 
hs=1;       j=1;            hsp=1;      jp=1;           mL=0; 
hL=1;       hLp=1;          a=0;        iF=1;           iS=1; 
ap=0;       iFp=1;          iSp=1;      nca=0;          xrf=0; 
xrs=0;      xs1=0;          xs2=0;      xk1=1;           
Jrelnp=0;   Jrelp=0;        CaMKt=0;    jrec=1; 
% Modified ORd model NEW state variables: 
I1k=0;      I2k=0;      Ck=1;          
I1kp=0;     I2kp=0;     Ckp=1;          
I1Cak=0;    I2Cak=0;    CCak=0;          
I1Cakp=0;   I2Cakp=0;   CCakp=0;          
% Initial Conditions vector: 
% N.B. the old gating variables for ICaL have been set to 0  
CI = [  v       nai     nass    ki      kss... 
        cai     cass    0       casr    m...  
        hf      hs      j       hsp     jp...  
        mL      hL      hLp     a       iF... 
        iS      ap      iFp     iSp     0 ... 
        0       0       0       0       0 ... 
        nca     0       0       xrf     xrs... 
        xs1     xs2     xk1     Jrelnp  Jrelp... 
        CaMKt   I1k     I2k     Ck      I1kp... 
        I2kp    Ckp     I1Cak   I2Cak   CCak ... 
        I1Cakp  I2Cakp  CCakp   jrec    ]'; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Simulations: 
input_args ={}; % see model file for input details 
options=odeset('MaxStep',ODEstep); 
y0 = CI; 
for n=1:nb 
        [time,y] = ode15s(AP_model,[0 BCL],y0,options,input_args{:}); 
        fprintf('Beat %i of %i\n',n,nb); 
        y0 = y(end,:);    
end 
y0_SS = y(end,:);    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Computed variables recovery: 
input_args{1}=0; % see model file for input details  
lCVs=size(feval(AP_model,time(1),y(1,:),input_args{:}),1); 
CVs = zeros(length(time),lCVs); 
for j=1:length(time) 
    CVs(j,:)=feval(AP_model,time(j),y(j,:),input_args{:}); 
end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% AP plot: 
figure('Name','Report');  
subplot(2,1,1); 
plot(time,y(:,1),'m'); 
title('Action Potential'); 
xlabel('time (ms)'); ylabel('membrane voltage (mV)'); 
subplot(2,1,2); 
title('L-type Ca^{2+} current');  
plot(time,CVs(:,4),'m'); 
xlabel('time (ms)'); ylabel('I_{CaL} (uA/uF)'); 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% END FILE 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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Figure A.1 shows representative plot reproduced by using the Matlab code 
above. The hybrid model has been paced for 1000 s at 1 Hz, and action potential 
and L-type Ca
2+
 current traces have been displayed. 
 
Figure A.1: Action Potential and L-type Ca2+ current traces for the hybrid model described in 
Chapter 3 and Chapter 4. This figure has been obtained by running in Matlab the script given in 
Appendix A3, who in turn recalls the model and the corresponding parameter files. 
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1. The Population of Models Approach 
The population of models (POMs) approach, recently developed by the 
Computational Cardiovascular Science group (Department of Computer Science, 
University of Oxford, UK) and already applied to different contexts [1–4], is a 
novel methodology in computational cardiac AP modelling. It provides the means 
to explore the effects of biological variability, usually neglected when using the 
traditional modelling techniques. Each individual may have a different response to 
disease and drug action, and biological variability is the key to understand why.  
Instead of considering a single AP model, representative of the average cell 
behaviour, simulations are performed in thousands of models at the same time (a 
population, indeed), all generated by varying some of the model parameters around 
their nominal values. Each model represents a different cell (of the same cell-type) 
and the cell-to-cell differences account for both inter- and/or intra- subject 
variability. It is worth noticing that the population is calibrated considering 
experimental data, either original or from literature (i.e. only the models in 
agreement with these data are “accepted” in the final population). 
As an example, Figure 7.2Errore. L'origine riferimento non è stata trovata. 
shows different experimental APs (pink traces), all recorded from the same cell 
type, i.e. rabbit purkinje cells (data by Janssen Pharmaceutica). The biological 
variability is well represented here: although overall similar, every cell has quite a 
distinct AP, and the differences are especially evident in the repolarisation phase, 
leading to a wide range of AP durations (from about 200 to 400 ms). All this 
information is actually lost when using a single Purkinje AP model to reproduce 
these experimental data, e.g. the Corrias-Giles-Rodriguez (left panel, black trace) 
[5]. Even if this single model well represents the average cell behaviour, a 
population of models (right panel, black traces) allow for a better coverage of the 
experimental dataset, well reproducing cell-to-cell variability. 
All the models in the population share the same differential equations, but each 
of them has a different parameters set. Indeed, the main hypothesis behind the 
POMs methodology is that all the cells of the same type (e.g. human ventricular 
endo- or epi- cardiac cells) share the same structure (ion channels, pumps, 
exchangers, etc.) and variability may be mostly related to differences in the density 
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of channels for each cell, leading to different ionic currents and in turn to different 
APs. Therefore, most of the biological variability observed should be reproduced by 
varying the maximal conductances of the main ionic currents, related to channel 
density in the cells. It would be definitely interesting to analyse also variability in 
current kinetics, e.g. varying the time constants of gating variable, but up to know 
we have modified ionic current densities only by acting on conductances. 
 
Figure B.1: Experimental AP recordings (pink traces, both panels) from rabbit purkinje cells (data 
by Janssen Pharmaceutica). When considering only a single AP model (black trace, left panel), the 
biological variability is completely neglected, while the population of models (black traces, right 
panel) is able to better reproduce the experimental dataset (modified from [2]).  
Depending on the purpose of the study, the number of generated models, the 
parameters to be varied, the scaling factors to apply to the nominal parameter values 
and the sampling of the parameter sets, may be different. 
In theory, the bigger the population, the more reliable the results: of course, the 
limitation here is mainly due to the computational costs. It is worth starting with a 
small population (about 10,000 models) and then increase the size (up to 30,000 or 
100,000 or more) if the accepted models resulting from the calibration process are 
not enough to properly evaluate the results. 
As for the parameters to vary, all the ones that may play a role in the study 
should be considered for the population, e.g. INaL in HCM. At the same time, 
varying too many parameters definitely increases complexity, especially when 
trying to analyse/classify simulation results, e.g. to identify the main ionic 
mechanisms involved in a specific phenomenon.  
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Parameter ranges also need to be chosen carefully. The wider the range, the more 
the models in the population deviate from the original AP model, and sometimes 
they are not even showing a regular AP. The commonly used range is [0-200%], i.e. 
±100% with respect to the original parameter values. This implies that there may be 
models included in the population having some currents with a very low (close to 
zero) density, as long as other currents compensate for them, allowing for a 
physiological AP. These models may represent pathological conditions, and 
therefore they can provide valuable insights, especially when evaluating in silico 
the effect of specific current blockers. However, to explore variability in healthy 
controls without including “extreme” pathological conditions, the parameter range 
can be reduced to [50%-150%], i.e. ±50% with respect to the original parameter 
values, or even less than that (±30%, ±10%). Sometimes, it may be worth to extend 
the upper limit e.g. up to 300% or more, to represent a pathological condition in 
which some currents are highly over-expressed. However, as shown in Figure B.2, 
the AP is much more sensitive to parameter scaling towards the lower values (from 
0 to 100% of the original values) than towards the lower ones.  
 
Figure B.2: Effect of parameters scaling on simulated AP: 9 major current conductances of the 
O’Hara-Rudy model [6] have been simultaneously modified from 0 to 10 times their original value, 
with a 0.1 step. Step-by-step changes are remarkable when considering low scaling factors (from 0 
to 4) while the AP changes very little for high scaling factors (Britton et al. unpublished). 
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Finally, the different parameter sets have to be probabilistically sampled in the 
parameter space. The methods which has been used up to now is Latin hypercube 
sampling, developed by McKay in 1979 [7]. It consists of a generalisation of the 
Latin square, i.e. a 𝑛 × 𝑛 matrix filled with different symbols, each one occurring 
exactly once in each row and exactly once in each column: each sample is the only 
one in each axis-aligned hyper-plane containing it. Recently, two papers have been 
published, estimating the coverage of parameter space for POMs when using Latin 
hypercube sampling [8, 9].  
It is worth notice than we don’t claim to sample the whole parameter space: we 
rather aim to explore the chosen range for each of the parameters varied in the 
population. The goodness of the sampling is therefore evaluated when comparing 
the simulations results and the experimental data, by the ability of the POMs to 
capture the biological variability observed. 
Once the parameters and their relative ranges have been fixed, the initial 
simulations may be run, using the same baseline AP model with all the sampled 
parameter sets. Simulated AP traces have to be compared with the experimental 
data available, usually considering a set of AP or CaT biomarkers: only the models 
whose biomarkers satisfy all the experimental constraints will be included in the 
final population, while the other ones will be discarded.  
This process (“experimentally-based calibration”) may considerably reduce the 
size of the initial population. It is important to have enough models left (a few 
hundreds) to analyse simulation results using statistic tools. When too many models 
are discarded, it is worth to re-build the population from the beginning, changing 
the parameters and/or their ranges. Also, it is always very important to check that 
the baseline model is not too far from the average behaviour of the cells in the 
considered experimental dataset: if so, some small modifications to the original 
model may be required before building the population. 
A schematic representation of the POMs approach is given in Figure B.3, 
considering a hypothetic four-dimensional parameter space: simulations are run for 
the same model with many parameter sets, each of them resulting in a different 
biomarkers set. Only the models fully in agreement with the experimental data are 
selected in the final population, while the other ones are discarded. 
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Figure B.3: Simple representation of the population of models technique: simulations are run for 
the same model with many parameter sets, each of them resulting in a different AP and a 
corresponding set of biomarkers. Only the models whose biomarkers fall within experimental ranges 
(black lines) are selected in the final population (black dots/squares) while the other ones are 
discarded (grey dots/squares). To clarify the links between panels, three models have been 
highlighted with colours. 
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2. The Baseline Model 
As baseline model to build the CTRL and HCM population, we used the O’Hara-
Rudy model (ORd [6]), published in 2011.  
However, a few changes have been required to the original model, in order to 
better reproduce the experimental CTRL data, and to fix a well-known problem 
concerning the INa inactivation gates, which prevent propagation in 2D or 3D tissue 
when considering hyperkalaemia. 
Fast Na
+
 Current Formulation 
Inactivation gates for the fast Na
+
 current (INa), “h” and “j”, are partially closed 
at normal resting membrane potentials in the ORd model. This was the result of 
using Sakakibara et al. [10] nonfailing human ventricular INa data (17° C), corrected 
for temperature using Nagatomo et al. [11] HEK-expressed hH1 data and also for 
the time after patch-clamp beginning using Hanck & Sheets data [12]. This is 
ultimately why the maximum conductance was set to 75 mS/μF, substantially larger 
than in other models, but there are no independent human INa data available to 
determine whether the temperature/time corrections applied were in fact accurate.  
With hyperkalaemia, “h” and “j” gates are further closed as resting membrane 
potential depolarises through the steep portion of the steady state inactivation 
curves. In single cells, this reduces the action potential upstroke velocity within the 
physiological range. However, in 2D or 3D simulations, where the cells experience 
a large electrical load, it might cause conduction block at lower levels of 
hyperkalaemia than observed experimentally. 
The solution suggested by the authors was to replace the INa formulation in the 
original ORd model with the one from ten Tusscher et al. [13] (TT04). Here, INa 
steady state inactivation curves are based on Nagatomo et al. [11] data extrapolated 
to 37° C, but not corrected for time after patch-clamp beginning. The resulting 
inactivation curves are about 10 mV depolarised compared to ORd, and therefore 
less sensitive to resting membrane voltage elevation under hyperkalemic conditions.  
Even if we were planning to use the population of models only at single cell 
level, we decided to modify the INa as first thing, to save possible problems with 
future works on 2D or 3D tissues. We didn’t follow completely the authors’ 
232                                                                                                                                         Appendix B 
Elisa Passini 
suggestion, because the Ten Tusscher formulation is quite complicated and not al 
all immediate to understand, while the ORd one follows the Hodgkin and Huxley 
formalisms. Moreover, we were interested in the phosphorylation of the INa current, 
considered in the ORd formulation only.  
Since the propagation problem is ultimately due to the steady state formulation 
of  “h” and “j” gates, which share the same sigmoidal function, we changed their 
V½ and slope to get them as close as possible to the ones in Ten Tusscher et al. 
[13], using the Matlab (Mathworks Inc.) built-in function fminsearch, based on the 
Nelder-Mead Simplex Method [14]. As for the phosporilated gates, we just applied 
a -6.2 mV shift in V½, as already done in the original ORd model, based on the 
work by Wagner et al. [15].  
Here below, the three different hss formulations are shown and the corresponding 
plots are compared in Figure B.4. 
ℎ𝑂𝑅𝑑 = 𝑗𝑂𝑅𝑑 =  
1
1 + 𝑒
𝑣+82.9
6.09
   
ℎ𝑇𝑇04 = 𝑗𝑇𝑇04 =  
1
(1 + 𝑒
𝑣+71.6
7.43 )2
   
ℎ𝑜𝑝𝑡 = 𝑗𝑜𝑝𝑡 =  
1
1 + 𝑒
𝑣+78.5
6.22
   
 
Figure B.4: Comparison of Fast Na+ current inactivation gates for ORd, TT04 and the baseline 
model used to build the population of models. 
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After changing the two inactivation curves, we checked the consistency of the 
modified ORd model with the original one, pacing the model at 1 Hz until steady 
state (about 1000 s). The new formulation leads to an increased Na
+
 current which, 
over time, produces some discrepancy with the original ORd model. Therefore, we 
reduced the maximal INa conductance in the modified model, to match the original 
one in steady state conditions (scaling factor 0.66). 
Ionic Concentrations 
To match the experimental data, we set the intra- and extra- cellular ionic 
concentration to the ones used in the experiments for the AP and CaT recording: 
 Extracellular concentrations: 
 Na+  = 132 mM  (140 mM in ORd) 
 K+    = 5.4 mM 
 Ca2+ = 1.8 mM 
 
 Intracellular concentrations: 
 Na+  no changes  (7 mM) 
 K+    = 140 mM (145 mM in ORd) 
 Ca2+ no changes (1e-4 mM) 
  
The only exception is the extracellular K
+
 concentrations ([K
+
]o), which was 4 
mM in the experiments. In fact, the ORd model uses [K
+
]o 5.4 mM even if it has 
been built using experiments recorded with [K
+
]o 4 mM, as in our data. Therefore, 
we decided to keep its original value in our simulations. 
New Current Stimulus 
In the original ORd model, the stimulus is set to a current pulse of amplitude -80 
uA/uF and duration 0.5 ms. When pacing for more than one cycle length, however, 
the minimum time step has to be equal/smaller than the duration of the current 
stimulus; otherwise, there are chances of the model missing the upstroke. Since we 
were planning to use 1 ms as max time step, to reduce simulation time, we 
increased the stimulus duration to 1 ms. We changed the stimulus amplitude 
accordingly, considering twice the AP threshold: the new current stimulus 
amplitude is therefore -53 uA/uF.  
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Ito I-V Curve 
We compared the experimental I-V curve for Ito and the one obtained for the 
modified model. When normalised, the two curves are quite similar. However, the 
experimental CTRL data seem to have a much higher Ito than the original ORd 
model. Therefore, to match the experimental data, we increased the maximal Ito 
conductance of 2.5 fold. As a supporting experimental evidence, the CTRL cells in 
the experiments show a pronounced notch, which is not present in the original ORd 
endocardial model, and usually related to Ito. 
K
+
 Equilibrium Potential 
When we compared the measured I-V curve of IK1 with the one obtained for the 
model, following the same voltage-clamp protocol, we immediately found out that 
the reversal potential of K
+
 was quite different between model and experiments. In 
fact the cell RMP, mostly dependent on IK1 is more depolarised in the ORd model. 
As first, we tried to match the RMP acting on intra- and extra-cellular K
+
 
concentrations, but this lead to values which were too far from the ones actually 
used into the experimental solutions. Therefore, we decided to use a fixed 
equilibrium potential for K
+
, instead of using Nernst equation, to match the 
experimental data. 
Once modified the K
+
 equilibrium potential, other small changes were needed to 
preserve consistency with the original ORd model. In particular, the activation 
cuves for INa, INaL and IK1 have been shifted by the difference between the old and 
the new K
+
 reversal potential (-9.2 mV). 
To verify that this change had not any major drawback, we actually generated 
two populations of models for the CTRL dataset, one with and one without the new 
RMP. Simulation results were qualitatively similar in terms of number of models 
and AP and CaT and biomarkers, so we chose to continue using the population with 
the modified RMP, since a more depolarized membrane potential may have an 
impact on pro-arrhythmic mechanisms occurrence. 
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3. Additional Results 
The following pages show the simulation results obtained considering an 
additional population of models, in which the parameters have been varied in a 
smaller range, i.e. [50-150%], with respect to their original value.  
There are no models discarded from the initial population before the 
experimentally-based calibration, i.e. models in which Chasted failed to compute 
AP and CaT biomarkers (about 2,000 in the previous one). Since the variability is 
reduced, more models are in agreement with the experimental data. Accepted CTRL 
models in this population are 9,124, compared to the 2,254 of the previous one. 
Simulation results are consistent with the ones presented in Chapter 7, especially 
when considering the current block effects on repolarization abnormalities 
occurrence. In general, RF occurrence is significantly reduced in this new 
population, while short/long EADs are present in the same fraction (Figure B.5). 
Indeed, many of the models showing RF in the previous population, as well as 
short/long EADs, were characterized by very low IKr scaling factors, which is this 
population is limited from [50-150%] compared to the original values. 
 
Figure B.5: Comparison of the two different HCM population, generated varying 11 paramenters in 
the [0-200%] (left) or [50-150%] (right) range, with respect to their original values. 
 
Hereafter, a few Tables/Figures from Chapter 7 have been reproduced for the 
new population. Labels and numbers are unaltered, to facilitate the comparison. 
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Figure 7.11 (B): Representative AP traces of accepted/discarded (blue/grey lines) models in the 
CTRL population. The baseline model AP is shown in white. 
 
 
Figure 7.12 (B): Representative CaT traces of accepted/discarded (blue/grey lines) models in the 
CTRL population. The baseline model CaT is shown in white. 
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Figure 7.19 (B): Representative AP traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
 
 
Figure 7.20 (B): Representative CaT traces from the HCM POMs (pink lines), compared with the 
corresponding CTRL ones (blue lines). The baseline CTRL model and its correspondent HCM 
version are shown in white and black, respectively. 
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Figure 7.26 (B): Scaling factor boxplots of the HCM models having a normal AP, i.e. not showing 
any repolarisation abnormality. These models have a slightly higher IKr and Jup. 
 
Figure 7.27 (B): Scaling factor boxplots of the HCM models showing short EADs, compared to the 
ones with a regular AP. These models are characterised by low IKr, high ICaL, INaL and INCX.  
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Figure 7.28 (B): Scaling factor boxplots of the HCM models showing long EADs, compared to the 
ones with a regular AP. These models are characterised by low IKr, high ICaL and INaL, very high INCX. 
 
Figure 7.29 (B): Scaling factor boxplots of the HCM models showing RF, compared to the ones with 
a regular AP. These models are characterised by a very low IKr, high ICaL, INa and INCX and low INaK. 
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Figure 7.37 (B): Repolarisation abnormalities occurrence in the HCM population, and the relative 
changes induced by current blocks. The values refer to the number of models in each subgroup.  
 
Table 7.8 (B): Detailed description of repolarisation abnormalities changes in HCM when 
considering the different current blocks. The percentage in bold shows the fraction of models in 
which the repolarisation abnormalities was successfully suppressed, leading to a normal HCM APs. 
HCM population 
HCM + 
INaL block 
HCM + 
INCX block 
HCM + 
both blocks 
short 
EADs 
141 
 
normal 
APs 
136 
(96%) 
normal 
APs 
119 
(84%) 
normal 
APs 
140 
(99%) 
short 
EADs 
2 
short 
EADs 
16 
short 
EADs 
- 
long 
EADs 
3 
long 
EADs 
6 
long 
EADs 
1 
RF - RF - RF - 
long 
EADs 
419 
 
normal 
APs 
257 
(61%) 
normal 
APs 
177 
(42%) 
normal 
APs 
393 
(94%) 
short 
EADs 
29 
short 
EADs 
42 
short 
EADs 
7 
long 
EADs 
127 
long 
EADs 
200 
long 
EADs 
19 
RF 6 RF - RF - 
RF 
42 
 
normal 
APs 
- 
 (0%) 
normal 
APs 
- 
 (0%) 
normal 
APs 
11 
(26%) 
short 
EADs 
- 
short 
EADs 
- 
short 
EADs 
4 
long 
EADs 
23 
long 
EADs 
30 
long 
EADs 
17 
RF 19 RF 10 RF 10 
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Figure 7.39 (B): Circos plots to represent repolarisation abnormalities distribution in the HCM 
population. Every plot shows the number of models for each subgroup, before and after adding the 
current block, together with the incoming and outgoing fluxes from one subgroup to all the other 
ones. Considering e.g. the pink section in the top plot: when including INaL block, many long EADs 
disappear (they go into normal HCM APs subgroup), some of them become short EADs and some 
other just remain long EADs. A few models change from long EADs to RF, instead. In addition, 
there is an incoming flux of models from the RF subgroup, which have now become long EADs. The 
same apply to all the other subgroups and for all the considered ionic current blocks  [16]. 
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